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Outline
The purpose of these studies was to investigate a new 
method of measuring the blood flow of the eye, namely 
colour Doppler imaging (CDI), and to use this method in 
an investigation of the pathogenesis of the condition 
of central retinal vein occlusion. The studies can be 
divided into two parts: chapters 1-7 deal with the 
examination of CDI in normal individuals and chapters 
8-11 examine the use of CDI in the investigation of 
central retinal vein occlusion. In chapter 1, 
descriptions of other techniques used in the investiga­
tion of blood flow are provided and the current 
knowledge of the haemodynamic properties of the human 
eye are outlined, including changes associated with 
physiological variation and pharmacological effects.
The haemodynamics of common ocular diseases and, in 
chapter 2, a summary of previously published colour 
Doppler studies of the eye are described. Our 
investigations assessing the technique are then 
presented.
In chapter 7 evidence is provided that blood viscosity 
has important effects on the haemodynamics of the eye 
and a study examining the interrelationship between 
blood flow and blood viscosity is described.
In Chapter 8 the reader is introduced to the condition 
of central retinal vein occlusion with descriptions of 
epidemiology, classification, aetiology, pathogenesis.
investigation, outcome and treatment. The condition is 
then studied using the colour Doppler technique and the 
results analysed with reference to the pathogenesis of 
the condition and to the use of CDI in the routine 
clinical investigation of the disease.
Chapter 11 examines the role of blood viscosity in the 
pathogenesis of CRVO.
In Chapter 12 the relationship between blood flow and 
viscosity in patients with central retinal vein 
occlusion is analysed, thereby allowing the description 
of a mechanism for the occurence of the condition. 
Finally an overview of the findings from these studies 
is provided in Chapter 13 which ultimately examines the 
potential for further study and the possibilities for 
the use of therapeutic strategies in CRVO and the 
assessment of these strategies by colour Doppler 
imaging.
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Summary
The study of the circulation of the eye has been taxing 
the imaginations of ocular investigators for 100 years, 
and has resulted in various and ingenious methods for 
its assessment. In recent decades technological 
advances have provided even more scope for examination. 
In these studies the method of colour Doppler imaging 
(which has considerably improved the localisation and 
measurement of blood flow in small blood vessels) was 
investigated as a means of examining the haemodynamics 
of the eye.
The examination of 95 normal individuals showed that 
many orbital blood vessels could be examined but that 
only the Doppler recordings (blood velocities and 
resistive index) from the ophthalmic artery, central 
retinal artery and vein were reproducible. Normal 
ranges for the Doppler measurements from these vessels 
were defined. The results were infuenced by the age of 
the patient, by systemic blood pressure and by smoking 
habit. The identity of individual blood vessels was 
confirmed by examining patients with occlusive vascular 
disease.
According to the Hagen Poiseuille law an increase in 
the viscosity of a fluid reduces its flow. In a group 
of normal individuals the interrelationship between 
blood velocity (from colour Doppler imaging) and 
systemic blood viscosity was examined. No effect of
viscosity on the blood velocities was found but a 
negative correlation between viscosity and resistive 
indices (a Doppler measure of resistance to flow) was 
detected. This result suggested that in normal 
individuals there was compensation for increased blood 
viscosity by a reduction in peripheral resistance 
thereby maintaining blood flow to the eye.
The method of colour Doppler imaging was then applied 
to the examination of a 80 patients with central 
retinal vein occlusion in whom significantly reduced 
blood velocities were found in the retinal vessels. In 
fact the values of the velocities (a minimum peak 
velocity in the central retinal vein of less than 3.0 
cm/sec) could be used to predict the development of the 
blinding and painful complication of iris neovasculari­
sation.
Investigation of the systemic blood viscosity in these 
patients revealed elevated viscosity compared to 
population based controls and the examination of 
haemostatic factors demonstrated a thrombotic tendency 
particularly in those who developed iris neovasculari­
sation. In contrast to normal individuals, the orbital 
blood velocities from the patients with central retinal 
vein occlusion were negatively correlated with their 
blood viscosities whereas resistive indices were 
unaffected, indicating that a reduction in peripheral 
resistance did not occur. In these patients therefore
'  ________________________________________
not only was blood viscosity elevated but there was no 
evidence of compensation for this by reduction of 
peripheral resistance. Potentially therefore retinal 
blood flow is reduced in eyes with central retinal vein 
occlusion by increased blood viscosity and poor 
vascular compensation to such an extent that 
"occlusion" of flow in the vein occurs.
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"The world is as it is; men who are nothing, who allow 
themselves to become nothing, have no place in it."
V. S. Naipaul, from A Bend in the River.
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Preface.
The inadequacy of our understanding of the condition of 
central retinal vein occlusion first became obvious to 
me when two patients presented with blinding and 
painful neovascular complications from the condition.
My knowledge obtained from the standard texts lead me 
to believe that such complications should be rare and 
begged the question:
Why was fluorescein angiography unable to determine the 
risk of neovascular complications which could then be 
avoided by the application of prophylactic photocoagu­
lation?
Around the same time I was using the technique of 
colour Doppler imaging to study the effects of topical 
Timolol on the ocular circulation. I had approached 
this method with some scepticism because of the 
considerable difficulty in recording the subtle changes 
of beta blockade on the small sized vessels of the eye. 
To my surprise our results revealed a detectable change 
and my interest was aroused. Little was known about 
the technique but the potential application of the 
method for the examination of retinal vein occlusion 
became obvious. This lead to the design and pursuit of 
the projects which are presented.
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1 Chapterl
1.1SUMMARY.
OCULAR BLOOD FLOW MEASUREMENT.
A critical review is provided of the currently applied 
methodologies for the measurement of blood flow in the 
eye in experimental circumstances and in the human.
The haemodynamics of the normal human eye is outlined 
with reference to blood flow in different regions of 
the eye, autoregulation and the responses of the ocular 
circulation to changes in systemic blood pressure, p02 
and pC02, posture and intraocular pressure. The often 
conflicting results of studies examining the influences 
of topical pharmacological agents upon the eye's 
circulation are examined and the findings of the latest 
studies of the effects of ocular disease on ocular 
blood flow presented.
_____ ___
1.2 INTRODUCTION.
Many techniques have been devised to measure the 
haemodynamics of the human and animal eye. In this 
chapter these are outlined and their use in ophthalmo- 
logical investigation summarised. Some have exploited 
the ability of an observer to visualise the
retinal vasculature by optical means, others have been 
designed to study the haemodynamics of the invisible 
parts of the eye such as the choroid, optic nerve head 
and ciliary body. Although useful in ophthalmic 
investigation, none has satisfied all of the 
requirements of the researchers in this field and most 
have not achieved regular use in clinical practice.
In any examination of blood flow a multitude of 
parameters must be studied (table 1.1). The interrela­
tionship of these parameters must be determined whilst 
considering physical or physiological principles (table 
1.2) which are often not strictly applicable to the 
vasculature, eg., the Hagen Poiseuille law was 
described for a rigid tube and not for elastic walled 
tubes such as blood vessels. In the human, study of 
the circulation is further hindered by the requirement 
for a noninvasive and safe method for obtaining 
measurements. Even so, study of the haemodynamics must 
be performed if we are to understand the mechanisms 
leading to the large variety of vascular diseases which 
affect the eye.
Table 1.1
Haemodynamic Measurements 
Vessel length
Vessel Cross-Sectional Area 
Blood Pressure 
Blood Flow 
Pulsatile flow 
Intraocular pressure 
Vessel Wall Tension 
Resistance to flow Blood Viscosity 
Turbulence
Critical Closing Pressure
Table 1.1. Some of the measurements which might be 
required to allow an assessment of the haemodynamics of 
the ocular circulation.
Table 1.2. Physical and Physiological Principles in 
Blood Flow.
Flow (Q) 
Ohm's Law
Velocity x Cross Sectional Area 
Pressure differenceQ =
Reynold's number(R) 
(Turbulence)
Hagan Poiseuille Law
(R)
Resistance
p2rV
n
(Pa-Pb) TTT
L 8 n 
L 8 n
7rr
Wall Tension
Resistance =
Laplace's Law
Trans Mural Pressure - ------------- ---
r
p = density of the fluid 
r = radius of the tube 
V = velocity of the fluid 
n - viscosity of the fluid 
Pa ” Pb = pressure difference 
L = length of the tube
Bernoulli's Principle: A constriction of a vessel
causes a conversion of pressure into kinetic energy 
thereby increasing the velocity and decreasing the 
pressure of the fluid in the vessel.
Doppler Equation Df cV =
2 Fo Cos A
V = velocity
Df = Doppler frequency shift c - Propagation frequency 
Fo = Transmit frequency
A = Angle of incidence of Doppler beam to direction of 
flow
The blood flow to the eye is of particular interest 
because:
1. Many localised and systemic disorders affect the 
vasculature of the eye.
2. The eye has unusual haemodynamic properties because 
the tissues are subjected to a high intraocular 
pressure.
3. Ocular blood flow is autoregulated for example 
during changes in retinal illumination, blood pressure 
or posture.
4. Pharmacological agents which are routinely used in 
systemic and ocular diseases may affect the blood 
supply of the eye.
__________________________  J
1.3 TECHNIQUES FOR THE MEASUREMENT OF OCULAR BLOOD 
FLOW.
Many ingenious and varied techniques exist for the 
measurement of ocular blood flow but some are 
restricted to experimental studies on animal models 
because of their destructive or invasive nature. For 
example, unlabelled or radioactively labelled 
microspheres in cats 292,294^ dogs and monkeys
1,2,72 injected into the left ventricle of the
heart andj after the animal is sacrificed, histological 
or radiographic measurement of the density of the 
microspheres is performed to allow an estimation of 
blood flow. Dye enclosed within heat labile liposomes 
has also been used to examine flow in localised areas 
of the retina 128,129,308 involves an intravenous
injection and release of the dye from the liposomes 
using laser light of the appropriate wavelength. The 
velocity of the dye as it passes through the vessel is 
recorded allowing a calculation of flow if the diameter 
of the vessel is measured. Radioactive tracers and 
radiography have also been employed, eg., 14C- 
iodoantipyrine has been used to estimate optic nerve 
blood flow in cats 292^ By cutting a hole in the 
sclera blood velocity measurements have been taken from 
the retinal circulation . The Fick principle using 
nitrous oxide concentrations in uveal blood samples has
also been employed 214
V'.-
These methods are invasive and not applicable to the 
investigation of the human for obvious reasons. The 
minimally invasive procedure of fluorescein angiography 
remains the mainstay of clinical vascular investigation 
and has resulted in a number of techniques for the 
estimation of retinal blood flow. In particular, the 
time required for the dye to pass through the 
circulation has been estimated. Dye dilution curves 
produced from the intensity of the fluorescence in the 
retinal vessels have been calculated more recently
employing videoangiography and computerised image 
analysis 140,3 04^ Two curves of the intensity of 
fluorescence are plotted against time, for example from 
a retinal arteriole and an adjacent venule, figure 1.1, 
and the time delay between these two curves measured at 
various intensity levels of the dye, eg., at 0%, 25%, 
50%, 75% and 100% of the peak fluorescence , The 
time delay between the passage of dye is presumably 
inversely proportional to the blood flow rate through 
the retinal vessels therefore providing a measure of 
the retinal haemodynamics.
The temporal resolution of the scanning laser 
ophthalmoscope can be exploited to allow measurement of 
macular blood velocities from fluorescein angiography 
5,207,268^ This is performed by injecting a bolus of 
dye and measuring the velocity of fluorescent white 
blood cells or gaps in columns of red blood cells as
fj r. 7
t - lf ip o o d  T im e  /  soft
Figure 1.1. The dye bolus intensity curves from a fluorescein angiogram of an adjacent retinal arteriole (E) and venule (F) are shown from a patient with central retinal vein occlusion. The delay between the two curves provides a measure of the rapidity of the flow through the retinal circulation.
I
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they pass through the perifoveal capillaries. These may 
be travelling at different speeds dependent on the 
orientation of the vessel, therefore multiple gaps or 
cells must be measured to provide an assessment of mean 
velocity in the capillaries. The capillary diameters 
are too small to be measured and therefore the flow in 
the vessels cannot be estimated from these velocities.
It is also uncertain whether the rate of flow of the 
leucocytes which may stick to the endothelium of the 
capillaries, particularly in disease processes, is the 
same as the erythrocytes or plasma.
The pattern of flow in the choroicapillaris can be 
observed by using videoangiography and intravenous 
injection of indocyanine green . This requires video 
recordings of 15 or 3 0 frames per second and digital 
subtraction of sequential frames to show the change in 
fluorescence in the blood vessels of the choroid. The 
rate of change of fluorescence in the choriocapillaris 
is faster than in the underlying blood vessels so that 
the images produced primarily show the changes in the 
capillaries.
Many studies examining the blood flow in the retinal 
circulation have been performed with bidirectional 
laser Doppler velocimetry (BLDV) which measures the 
velocity of blood in the intraocular retinal circula­
tion by detecting the frequency shifts in laser light 
caused by the flow of erythrocytes 231^ The Doppler 
principle is applied, ie., the change in frequency of
.Ai:
the waveform is proportional to the velocity of the 
object. Often the results are averaged over measure­
ment times of a few seconds to provide mean blood 
velocity. The measurement of the diameter of retinal 
arterioles or venules from monochromatic fundus 
photographs thereafter allows estimation of the blood 
flow from the formula:
7T X Diameter^
Blood Flow =   X  Mean velocity
Estimation of total retinal volumetric flow in this way 
requires measurements of each major branch of the 
central retinal artery and vein. Although estimation 
from one branch alone may correlate well with total 
retinal blood flow in healthy subjects this is unlikely 
to be the case in disease where areas of the retina are 
often disparately affected. Reproducibility from the 
retinal arterioles is poorer than from the venules, 
probably because the short examination interval of a 
few seconds results in error from the pulsatility of 
the arteriolar blood flow. The technique may be 
difficult to perform because of a susceptibility to 
error from saccadic eye movements and requires 
specialised equipment which has confined its use so far 
to the research laboratory. Recently laser Doppler 
velocimetry has also been applied to the measurement of 
choroidal and optic nerve head blood flow in
animals.
Another method employing laser light to estimate 
retinal blood flow is the laser speckle phenomenon 
2 66,2 67^ The scatter of laser light caused by movement 
of an object is proportional to the velocity of the 
object. Measurement of the scatter from a retinal 
vessel allows an estimation of the velocity of the 
blood cells in the vessel. This technique may be 
useful for the estimation of capillary flow but as yet 
has not been extensively investigated.
Any determination of blood flow by visualisation of the 
retina, eg., by fluorescein angiography, bidirectional 
laser Doppler velocimetry or laser speckle phenomenon, 
requires the use of mydriatics in most circumstances. 
These agents by their sympathomimetic or anticholiner­
gic actions may affect blood flow. In addition, any 
system which requires the measurement of the diameter 
of retinal blood vessels requires adjustment of those 
measurements for the refractive error, axial length or 
keratometry of the eye. Correction factors have been 
devised by Littman 1^3,164 Bengetson but their
accuracy has recently been questioned ^. If serial 
measurements are being used and absolute blood flow 
values are not required then a measurement of the 
distance between the disc and the fovea may be used to 
standardise the magnification of photographs of the 
same individual The use of light to examine the
retina can also affect the blood flow which may vary
______________________ ________
after short durations of retinal illumination and dark 
adaptation .
Blood velocities in the macular capillaries are 
assessable by nonoptical means using the blue field 
entoptic phenomenon, appreciable if we look at a deep 
blue sky 233,253^ This method presents a diffuse blue 
light (430nm) to one eye of a subject allowing 
visualisation of their own white blood cells in their 
macular capillaries (seen as multiple white "comma" 
shaped flecks momentarily crossing the paracentral 
visual field). The density and velocity of these are 
matched by the subject to the density and velocity of 
spots on a VDU screen which is observed simultaneously 
with the other eye. The system therefore requires the 
cooperation of the subject, good vision and introduces 
an unavoidable subjective component.
A number of methods have been devised for the 
estimation of the pulsatile component of total ocular 
blood flow from the variations that occur in intraocu­
lar pressure with the systemic pulse 152,252_ These 
variations in pressure can be measured by tonography, 
figure 1.2, and have been related to volume changes in 
cadaver eyes allowing extrapolation of the intraocular 
pressure changes to variations in blood volume with the 
systemic pulse. Such an extrapolation may however be 
inaccurate when the size of the eye or the ocular 
rigidity is changed, eg., in myopia 141,152^ Several
__________ _______
Left
Figure 1.2. A tonography tracing is shown, illustrating the variations in the intraocular pressure from which the pulsatile flow in the eye (mostly choroidal) can be estimated.
assumptions which must be applied with these techniques 
have been outlined 113,252. The change in intraocu­
lar pressure is related to the change in volume induced 
by the flow of blood into the eye with each pulse. 2. 
Retrograde blood flow does not occur. 3. The outflow 
of blood is constant and nonpulsatile. 4. The 
formulae for the calculation of pulsatile blood flow 
from the pressure changes are valid. 5, The blood 
vessels do not collapse 1"^ .^ Furthermore, pulsitometry 
measurements only detect the pulsatile component of 
blood flow, the nonpulsatile component is not measured. 
Furthermore the relationship between pulsatile and 
total blood flow is unclear.
In oculo-oscillo-dynamography a tonometer and suction 
cup are applied to the sclera of the eye 280^ The 
intraocular pressure is raised and changes in the 
waveform from tonometry are interpreted to indicate 
cessation of flow in the retinal and choroidal 
vasculature allowing, it is claimed, measurements of 
retinal and choroidal pulse pressure. The rise in 
intraocular pressure results in the undesirable side 
effect of obscuration of vision when systolic retinal 
blood pressure is reached and the use of the scleral 
suction cup also introduces an invasive component which 
may induce unphysiological circumstances such as 
ischaemia on the eye which may alter its blood flow.
The effect of the suction cup in raising intraocular 
pressure may be altered by the size of the eye as has
10
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been show to occur with ocular pnuemoplethysmography, a 
similar technique employing a pneumatic tonometer .
1.4 BLOOD FLOW IN THE NORMAL EYE
Total human ocular blood flow is estimated to be 
approximately 1 ml/min, most of which supplies the 
vasculature of the uvea (primarily the choroid), only 2 
to 5% supplying the retina 3-11^  The eye is supplied by 
the ophthalmic artery, in this vessel blood pressure is 
estimated to be 2/3 of brachial blood pressure. The 
perfusion pressure of the eye is however less than this 
because the intraocular pressure is 10 to 21 mmHg, A 
formula has been used to estimate mean ocular perfusion 
pressure:
mean OPP = 2/3(DBP + 1/3(SBP - DBP)) - lOP 
OPP = Ocular Perfusion Pressure 
DBP = Diastolic Blood Pressure (Brachial)
SBP = Systolic Blood Pressure (Brachial) 
lOP = Intraocular Pressure
The blood flow to the eye is pulsatile and induces 
intraocular pressure variations from which the mean 
pulsatile component of the blood flow to the eye has 
been estimated at approximately 0.724ml/min 3.52^
In the human, the retinal circulation has a mean flow
of 0.033ml/min 231 In the retinal arterioles blood
flow probably exhibits a shearing core with blood
11
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flowing at a uniform rate centrally and more slowly 
peripherally and conforms to the principles of an end 
artery system with equal flow in the retinal arterioles 
and venules Regional differences in the retina
exist with higher flow in the vasculature of the 
temporal region than the nasal region, reflecting the 
increased retinal area supplied by the temporal vessels 
and the increased metabolic activity of the macula 
The mean blood velocity in the arterioles is higher 
than in the venules because the diameter of the 
intraocular retinal arterioles is less than the retinal 
venules. In the retina autoregulation of blood flow 
exists, probably as a local response of the vessels to 
metabolites from the retinal cells. The role of the 
autonomic nervous system is uncertain for although 
autonomic receptors have been detected in the retinal 
blood vessels in their extra-ocular course, they are 
thought to be absent from the intraocular retinal 
circulation .
In the uveal tissues autonomic receptors are present 
and blood flow can be altered by manipulation of the 
autonomic system, eg., stimulation of the sympathetic 
system reduces blood flow whereas cervical sympathecto­
my causes an increase in flow 293^ in contrast to the 
retinal circulation autoregulation of blood flow 
probably does not occur in the choroid, possibly 
because the choriocapillaris separates the choroidal 
arterioles and venules from the retina and therefore
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from its metabolites , The high blood flow and low 
utilisation of nutritive substrates in this circulation 
may also reduce the effect of retinal metabolism. The 
difference in the responses of the retinal and 
choroidal circulations is evident when ocular perfusion 
pressure is reduced, resulting in reduced choroidal 
blood flow whilst retinal blood flow remains stable 
The choriocapillaris fills first at the macula and then 
in the periphery .
Blood flow in the eye can be affected by both systemic 
and ocular factors. Changes in posture should be 
expected to alter the perfusion pressure in the 
ophthalmic artery pulse pressure but this varies only 
by lOmmHg or less when standing , The confusing 
relationship of pulsatile blood flow in the eye to 
total blood flow is highlighted by the reduction in 
pulsatile blood flow of 27.5% on the assumption of the 
supine position in healthy volunteers despite a rise in 
the perfusion pressure Retinal blood velocities
are stable during postural changes despite alterations 
in perfusion pressure and flow is effectively
autoregulated during increased systemic blood pressure 
from isometric exercise until mean brachial artery 
blood pressures reach 115 mmHg after which the blood 
flow increases 234^
Evidence that autoregulation in the retinal circulation 
is controlled by metabolites has been provided by the
13
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observed responses to hyperoxia or hypercapnia 96 In
one study, retinal arteriolar vasoconstriction and 
venular dilation were observed after high concentration 
oxygen breathing but no change was detected with 
variation of blood C02 levels , Dilation of the 
retinal blood vessels and shortening of fluorescein dye 
transit times have, however, been detected in monkeys
with increasing arterial pC02 279 and more recently in
humans . In the macular circulation during isocapnic 
hypoxia blood velocities have been found to increase by 
38% (the diameter of the arterioles and the venules 
increased by 8.2% and 7.4%, respectively), whereas 
hyperoxia reduced the velocity by 3 6% (the diameter of 
arterioles and the venules reduced by 5.6% and 10% 
respectively) . These variations were unexpectedly 
large considering the small rise in blood oxygen 
content that can be induced by hyperoxia (oxygenised 
haemoglobin does not rise significantly), In recent 
studies performed with scanning laser ophthalmoscopy, 
changes in blood velocity (10% variation) were found to 
be more in keeping with the expected changes associated 
with isocapnic hyperoxia and hypoxia . The changes 
in the diameter of the larger retinal vessels are 
believed to be too small to account for the changes in 
blood flow seen with such alterations in oxygen 
concentration 330^ As elsewhere in the body, it is 
postulated that the smaller retinal arterioles and 
venules contribute most to the regulation of blood
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flow.
Raised intraocular pressure causes a reduction in blood 
flow to the anterior uvea, choroid and retina ^94^ The 
retinal blood flow is however autoregulated up to 
intraocular pressures of 3 0-3 4 mmHg after which the 
perfusion decreases whilst intraocular pressures lower 
than 10 mmHg cause the retinal blood flow to increase 
230,294^ With high intraocular pressures the perfusion 
of the eye continues until the pressure reaches 6 mmHg 
below the perfusion pressure of the blood in the 
ophthalmic circulation, at which point the critical 
closing pressure of the ocular vascular bed is reached 
and blood flow ceases .
The effect of illumination of the retina has been 
investigated by a number of techniques. In animal 
models, flickering light increases the retinal blood 
flow whereas constant illumination reduces retinal 
blood flow . In humans increases of 65% in retinal 
blood velocity, 5% in venular diameter and 82% in 
calculated blood flow rate have been reported in the 
first seconds after dark exposure with peak
measurements reached after 5 minutes dark adaptation 
when the velocity in the venules was 47% higher than 
light adapted levels. In another study of the retinal 
arterioles increases in blood velocity of 40-55% were 
detected with negligible dilatation of the arterioles 
of 2 to 3% and increases in the calculated flow rate of
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40-70% . In contrast no change in blood flow in the
choroid with dark adaptation was found using infrared 
absorption cineangiography with indocyanine green . 
Measuring the response of the retinal blood flow to 
dark adaptation may provide a means of assessing the 
autoregulatory capacity of the retina and may be used 
in the investigation of conditions such as diabetes.
1.5 BLOOD FLOW MEASUREMENTS IN OCULAR PHARMACOLOGY.
A number of topical and systemic medications may 
influence the blood flow to the eye and have particular 
relevance, therefore, to different disease processes 
such as diabetes, glaucoma, systemic hypertension and 
ocular vascular occlusion. Beta blockers and 
sympathomimetics may affect blood flow because an 
imbalance is produced between the influence of the 
alpha and beta sympathetic receptors on the ocular 
vasculature. The effect of this imbalance has often 
been difficult to ascertain and differing results have 
been found in various studies. Even though these 
agents can affect various measurements which are 
relevant to blood flow it is often difficult to 
determine whether these effects are beneficial or 
detrimental to the eye. The effects of the agents upon 
systemic blood pressure, intraocular pressure and the 
untreated fellow eye often confound the interpretation 
of the results. For example, the contralateral eye has
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often been used to apply placebo drops, this however 
does not take into account the systemic absorption of 
the active agent nor the interrelationships which may 
exist between eyes for the control of intraocular 
pressure.
The imbalance of sympathetic stimulation induced by 
medications may cause changes in blood vessel calibre. 
Indeed vasoconstriction has been detected in the ocular 
circulations with both sympathomimetics and beta 
blockers. For example, vasoconstriction was produced 
in the ciliary body after instillation of topical 
phenylephrine hydrochloride, timolol maleate and 
betaxolol hydrochloride into rabbit eyes 281^
Tolerance developed to betaxolol and partially to 
phenylephrine after seven weeks of administration of 
the drugs. In humans, Martin and Rabineau detected 
vasoconstriction of the retinal arterioles with timolol 
in serial examinations of monochromatic fundus 
photographs
It is usually the expectation that vasoconstriction 
will decrease flow. This has occurred with the use of 
adrenaline which has produced a reduction of blood flow 
to the iris and ciliary processes of rabbits and in 
monkeys  ^ in investigations using microsphere 
techniques. With beta blockers often no changes in 
blood flow have been detected. For example, a cross 
over study using a single instillation of timolol.
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betaxolol, and levobunolol in normal subjects failed to 
find any changes in perimacular haemodynamics 
(measured by blue field entoptic simulation) in normal 
subjects compared to a placebo condition 
Similarly, Green using radioactively labelled 
microspheres to examine topical therapy on rabbit eyes 
found no effect on blood flow with timolol (or with 
noradrenaline, ecthiopate iodide or pilocarpine)
Studies employing tonography have shown no effect of 
timolol on pulsatile ocular blood flow in normal 
individuals and in glaucoma patients and
Grunwald has detected no effect of carteolol on blood 
velocity, volumetric flow rate or venous diameter in 
the retinal circulation using laser Doppler velocimetry 
. Another study using the latter method however 
detected an 11% increase in the maximum velocity of red 
blood cells in the retina and 13.2% of estimated blood 
flow in timolol treated eyes and a similar effect 
has been found in patients with ocular hypertension 
If agents which lower intraocular pressure such as beta 
blockers cause vasoconstriction, this may be a response 
to lowered intraocular pressure and not a direct effect 
of the drug on the blood vessels. Vasoconstriction may 
occur to compensate for the increased perfusion 
pressure resulting from lowered intraocular pressure, 
thereby stabilising the blood flow. Studies employing 
techniques which can estimate the blood pressure in the 
ocular vessels have not always detected such changes in
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perfusion pressure. For example, using compression 
ophthalmodynamometry, although mean blood pressure in 
the ophthalmic artery was increased in timolol treated 
eyes compared to the "placebo treated" contralateral 
eye, multiple other parameters, such as diastolic and 
systolic blood pressure and serial measurements of 
blood pressure in the ophthalmic artery were unchanged 
. Pullinat in a parallel comparison of normal 
individuals using oculo-oscillo-dynamography found no 
change in retinal or ciliary perfusion pressures with 
timolol, betaxolol, pilocarpine and acetazolamide 
despite reductions in intraocular pressure 220^ 
Carteolol even showed a significant reduction in 
perfusion pressure in this study.
The topical application of the alpha agonist aprocloni- 
dine which might be expected to cause vasoconstriction 
has produced no acute effects on macular blood flow on 
blue field simulation in normal subjects after single 
dose topical administration
Intravenous a-^cetazolamide has been shown to cause 
vasodilation and increased retinal blood velocities 
(laser Doppler velocimetry) in normal volunteers ^23^
A carbonic anhydrase inhibitor, this agent causes an 
increase in tissue pC02 which may have induced 
vasodilation of the retinal vessels. In combination 
with the increased perfusion pressure from reduced lOP 
and the measurement of increased blood velocities it
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would appear highly likely that increased blood flow 
occurs with the drug. This may be usefully exploited 
to increase blood flow in conditions such as central 
retinal artery occlusion.
The effects of other agents have been investigated 
primarily in experimental circumstances using animals 
models. For example, dopamine antagonists have been 
shown to increase pulsatile blood flow in the eyes of 
rabbits whilst reducing intraocular pressure . In 
the same study dopamine and bromocriptine had no effect 
on flow. Anticholesterase inhibitors have reduced the 
flow detected in the anterior uvea in rabbits 
(microspheres m e t h o d ) Further investigations of 
the effects of drugs may be stimulated by recent 
investigations of the effects on the ocular circula­
tions of endothelin-1 and nitric oxide which are 
derived from vascular endothelial cells, the former
causing vasoconstriction and the latter vasodilation 
77,78^
Although considerable efforts have been made to examine 
the potential effects of drugs on ocular blood flow the 
clinical relevance of the findings is as yet unclear, 
particularly with topical medications such as beta 
blockers. Studies should be examined carefully for 
methodology before the conclusions are accepted.
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1.6 BLOOD FLOW AND OCULAR DISEASE.
Ocular and systemic diseases have been investigated 
using various techniques for examination of ocular 
blood flow but few are applied in the clinical setting. 
There are however diseases in which the measurement of 
blood flow might aid diagnosis and management.
In diabetic retinopathy retinal blood flow may be 
reduced and the normal autoregulatory capacity 
deficient 88,256^ Small induced diabetes in dogs and 
noted that retinal blood flow was significantly reduced 
after 5 months, using a radionuclide labelled 
microsphere technique ^56^ Grunwald using laser 
Doppler velocimetry, investigated diabetic patients 
with poorly controlled blood glucose and, in comparison 
to normals, found that the autoregulatory response to 
oxygen breathing (ie., decreased retinal blood flow) 
was less in diabetic patients A mean 15% increase
in retinal blood flow during hyperglycaemia compared 
to normoglycaemia (after administration of insulin) was 
found in poorly controlled type 2 diabetic patients 
examined by laser Doppler velocimetry . The 
autoregulatory response to oxygen breathing was reduced 
during hyperglycaemia in these patients, A reduction 
in mean retinal venous diameter, red blood cell 
velocity and volumetric blood flow (from laser Doppler 
velocimetry) has been detected after panretinal 
photocoagulation with a return of the autoregulatory
21
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response to oxygen breathing Reduced choroidal
blood flow in diabetic patients has been suggested by 
the observation of a mean pulsatile ophthalmic artery 
blood flow (from ophthalmodynamometry) of only 0.15 
ml/min it therefore appears that blood flow in
the eye may be reduced in patients with diabetic 
retinopathy particularly in the retinal circulation.
Those with poor control may have a relative increase in 
blood flow which is then reduced by tightening glucose 
management, whether clinically applicable methods of 
blood flow assessment can be used in monitoring the 
progress of diabetic retinopathy and responses to 
treatment remains to be seen.
Ocular hemodynamics are altered in patients with
glaucoma and ocular hypertension but the methods of
&studies must be examined to ensure that topical 
medications have been stopped (because of their 
potential effects on blood flow) with adequate washout 
periods employed. Of course, if the patient is off 
treatment, blood flow changes may merely reflect the 
presence of raised intraocular pressure and not primary 
vascular abnormalities. With these caveats in mind, 
studies of patients with chronic open-angle glaucoma 
have found prolonged dye transit times on fluorescein 
videoangiography 264,303 reduced ophthalmic artery
velocities by duplex Doppler ultrasound 235^ More 
severe loss of visual function in glaucoma has been
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associated with reduced white blood cell velocities in 
the macula (and presumably reduced macular blood flow) 
using blue field simulation 262^ The alterations in 
blood flow were most likely to have resulted from the 
intraocular pressure drop from the operation but the 
measurements may also have been influenced by the fact 
that most of the patients were on topical medications 
such as beta blockers pre-operatively but not post- 
operatively.
To avoid the problem of raised intraocular pressure 
Trew compared the results of ophthalmodynamometry in 
patients with ocular hypertension to patients with 
primary open angle glaucoma 276^ The patients with 
glaucoma had a lower mean pulsatile ocular blood flow 
Obviously patients with normal tension glaucoma 
do not have the confounding influence of raised 
intraocular pressure. Reduced pulsatile blood flow 
from ophthalmodynamometry has also been detected in 
such patients 3.21^  Whether the reduced blood flow in 
glaucoma is contributing to the pathogenesis of the 
disease or is secondary to the loss of nerve fibres in 
the disease remains as yet undetermined ^22^
Cranial arteritis (often a clinically hazardous 
condition to manage) can cause profound haemodynamic 
changes in the orbit. Intraocular pulse pressure 
amplitude (the measure from which ophthalmodynamometry 
estimations of pulsatile blood flow are obtained) has 
been compared in patients with giant cell arteritis and
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patients with nonarteritic anterior ischaemic optic 
neuropathy or nonarteritic central retinal artery 
occlusion . The arteritic patients showed a mean 
pulse amplitude which was only 37% of the mean value in 
the nonarteritic group (estimated values of pulsatile 
ocular blood flow of less than O.Gml/min in the 
arteritic group). In another study using a pneumoto­
nometer the mean ocular pulse amplitude was reduced in 
patients with ischaemic optic neuropathy and temporal 
arteritis but not in those with neuropathy alone or 
temporal arteritis alone In this group, patients
with ischaemic optic neuropathy and central retinal 
artery occlusion associated with temporal arteritis, 
also showed a reduced pulse amplitude in their 
contralateral eyes. Many of these patients' recordings 
increased after treatment with prednisolone therapy.
In temporal arteritis the severity of the disease 
appears to be associated with more severe changes in 
blood flow therefore monitoring of blood flow should 
aid diagnosis and the determination of the response to 
therapy.
In central retinal vein occlusion blood flow has been 
shown to be reduced by fluorescein angiographic 
techniques 24 6,258^ Stenosis of the carotid arteries 
sometimes reduces the ocular blood flow although 
studies have revealed differing results 152,188,247^ 
Reduced pulsatile ocular blood flow has also been found
24
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in cataractous patients, the relevance of which is 
unknown
1.7 CONCLUSION
The measurement of blood flow in the eye is a complex 
and often confusing issue. No technique has reached 
the status of gold standard and all have disadvantages 
not least because of their measurement usually of only 
one of the multiple parameters involved in blood flow. 
Their collective application over many studies however 
has revealed patterns of haemodynamic change in normal 
physiology and in ocular diseases. As the technology 
and its application continues to improve, the 
shortfalls of current methods are gradually met. In 
the future, more of these methods may be available to 
the physician in the clinical setting.
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2 Chapter 2
INTRODUCTION TO COLOUR DOPPLER IMAGING OF THE EYE.
2.1 Summary.
The technique of colour Doppler imaging is introduced 
and previously reported studies employing the method 
are described in this chapter.
2.2 Colour Doppler imaging. Previous Studies
Christian Andreas Doppler (1803-1853) was the first to 
describe the principle of using sound waves to measure 
the velocity of an object. The principle using 
ultrasound energy was first applied to the investiga­
tion of human diseases in 1957 and is now established 
in routine clinical practice 245^ Although the 
investigation has previously largely been confined to 
the examination of the larger vessels in the body such 
as the carotid arteries and the heart, recent 
technological innovations and advances have allowed the 
inspection of other vascular systems.
At first, continuous wave Doppler ultrasound was used 
which had the disadvantage of recording signals from 
all of the vessels in the path of the ultrasound beam. 
With the development of B mode and duplex Doppler 
ultrasound, vessels at specific depths can be examined 
if their anatomical positions are known. Furthermore 
colour mapping of flow in colour Doppler imaging (GDI) 
has greatly facilitated the identification of blood
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flow, particularly in vasculatures which are below the 
resolution of B mode scanning. This technique has 
aided the examination of structures of variable or 
complex vasculature, such as the neonatal brain 
197,198^ testes and abdominal organs because
flow in specific blood vessels can be identified on a 
visual display unit (VDU) screen. As yet GDI is 
qualitative and quantification requires the application 
of spectral analysis of the Doppler signals followed by 
angle correction calculations for blood velocity 
measurements.
Erickson was the first to describe the qualitative 
appearances of GDI in some normal orbits and in a few 
orbital disorders . More recently, blood velocities 
in the vasculature of the eye and orbit in normal 
healthy populations have been described using colour
Doppler imaging 158 (the fellow eyes of patients with
choroidal melanomas) and duplex scanning .
As the technology advances so the sensitivity of the 
machinery increases, currently most of the scanners 
available commercially detect flow rates as low as 1-3 
cm/s 270,302^ Lower flow rates than this may be missed 
giving the examiner the false impression that a vessel 
is occluded. This error is increased when examining 
blood vessels of small diameter such as in the orbit 
but can be reduced by keeping the Doppler beam parallel 
to the direction of flow in the vessel. To provide
I
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measures of the degree of pulsatility in the velocities 
measured by Doppler two indices have been used: 
resistive index and pulsatility index . The
pulsatility of the blood flow can then be interpreted 
to provide estimates of the peripheral resistance to 
flow in the circulation.
Imaging by ultrasound has been regarded as safe and 
non-invasive but as the resolution of modern ultrasound 
equipment increases so does the ultrasound energy being 
applied to the tissue. In colour Doppler imaging the 
highest Ispta intensities occur during spectral 
analysis of the Doppler frequency shifts. Ispta I
levels for the Acuson 128 during pulsed Doppler of 44 
mW/cm^ are below the maximum recommended levels advised
by the British Medical Ultrasound Society (lOOmW/cm^) 
and the Food and Drug Administration of the USA 
(68mW/cm ). Considerably higher ultrasound intensities
'I?are required to induce damage to the choroid and lens 
of rabbits, approximately 100 W/cm^. The occurrence of 
damage also depends upon the duration of the exposure 
to the ultrasound 165-167^ m  general the colour
coding of blood velocity can be used to speed the
localisation of a site of interest thereby shortening Is1the exposure time.
The results of previous control populations using 
Doppler ultrasound to measure the orbital blood 
velocities are shown in table 2.1. The ophthalmic 
artery, central retinal artery and vein, posterior
:ir
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Table 2.1
Technique (n) OA CRA CRV(Instrument) (cm/sec)
Lieb GDI 40 31.4 10.3 2.9(QAD 1) (4.2) (2.1) (0.25)
Guthoff Duplex 72 31.6 9.5 5.7(ATL Ultramark) (9.0) (3.1) (1.25)
Table 2.1. Mean peak systolic blood velocity (and SD) 
in the major vessels in the orbit from two studies of 
Doppler velocimetry in normal eyes (n - number of subjects, OA = ophthalmic artery, CRA = central retinal 
artery and CRV = central retinal vein).
ciliary arteries, vortex veins and inferior and 
superior ophthalmic veins can all be detected (the 
normal arterial anatomy is shown in figure 2.1). The 
exact reproducibility of the recordings from these 
sites has not been fully determined. Measurements from 
the central retinal artery and vein and the ophthalmic 
artery appear to be reliable having been detectable in 
almost all normal orbits in the major series reported, 
so far 90,158^ The anteroposterior orientation of 
these blood vessels 99,103 the orbit greatly aids 
accurate Doppler recordings because the calculation of 
blood velocities from the Doppler frequencies from a 
vessel are dependant upon the angle of incidence of the 
ultrasound beam to the direction of travel of the 
vessel (figure 2.2). Although blood velocity in the 
posterior ciliary arteries can be recorded the results 
show a wide range of values perhaps because of the 
tortuosity of these vessels investigation of
patients with known occlusion of the posterior ciliary 
or central retinal arteries may help determine the 
influence of these vessels on the Doppler recordings in 
this area.
As yet, changes in these Doppler measurements with age 
and posture have not been investigated. Elevation of 
the intraocular pressure (lOPj above 40mmHg caused a 
reduction in the measurements of blood velocity by 
duplex scanning in the central retinal artery . This
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Figure 2.1 The normal arterial anatomy of a right orbit is 
illustrated showing the antero-posterior orientation of the blood vessels. The usual positions for the interrogation of the blood 
vessels by Doppler are indicated by A (ophthalmic artery), B (central retinal artery and vein), C (temporal posterior ciliary arteries) and D (nasal posterior ciliary arteries).
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Figure 2.1. The variation in the calculation of blood velocities from the Doppler frequency shifts which can be induced by inhde- 
quata correction for the angle of travel of the ultrasound beam 
to the direction of blood flow. Considerable error is produced at angles above 45".
is in accordance with the results of other investigative 
techniques of blood flow which have indicated that 
autoregulation of the retina fails above this level of 
lOP 229. The Doppler imaging technique by the 
application of a probe to the eyelid may raise the TOP 
thereby altering the blood flow to the eye. An 
investigation is required to determine the magnitude of 
lOP rises during ultrasound examination so that its 
possible effect on blood flow can be assessed.
The technique has already been applied to the 
investigation of some ocular disorders. In 11 patients 
with severe carotid stenosis and ocular ischaemic 
syndrome, peak systolic velocity was significantly 
reduced to a mean of 3.5 cm/s in the central retinal 
artery and to 3.9 cm/s in the posterior ciliary 
arteries in the ophthalmic artery of these
patients reversal of flow was observed in 12 of the 16 
eyes examined, A case of 100% internal carotid artery 
occlusion in a 24 year old man showed hypoperfusion of 
the central retinal artery and nasal posterior ciliary 
arteries on fluorescein angiography which
correlated with undetectable flow in these vessels by 
GDI. The peak systolic velocity in the ophthalmic 
artery of only 9.1 cm/s was interpreted as signifying 
that there was partial occlusion in the ophthalmic 
artery of this patient. Blood flow returned to the 
ocular vessels after 3 weeks without any treatment of 
the carotid stenosis.
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Reduced ophthalmic artery velocities in glaucoma have 
been found by duplex Doppler ultrasound 235 colour
Doppler imaging . After treatment by trabeculectomy 
increased blood velocities and evidence of reduced 
peripheral resistance to flow have been detected in the 
central retinal artery and posterior ciliary arteries 
by colour Doppler imaging 277^ The alterations in 
blood flow were most likely to have resulted from the 
intraocular pressure drop from the operation but the 
measurements may also have been influenced by the fact 
that most of the patients were on topical medications 
such as beta blockers pre-operatively but not post- 
operatively. A study of patients with normal tension 
glaucoma found increased vascular resistance in the 
ophthalmic arteries as compared to age-matched healthy 
control subjects The increased resistance was
normalised when pC02 levels were elevated in the 
patients suggesting the presence of reversible 
vasospasm in these patients with normal tension 
glaucoma.
Examination of a case of superior ophthalmic vein 
thrombosis showed absence of flow in the dilated 
superior ophthalmic vein and flow in dilated collateral 
venous channels but the significance of this is 
unknown because the normal pattern of flow in the 
superior ophthalmic vein has not yet been defined.
Three series of patients with intra-ocular tumours
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examined by colour Doppler or a combination of colour 
Doppler and Duplex examination techniques have been 
published 91,161,3 05^ ^ tumour circulation was detected 
in almost all of the cases of choroidal malignant 
melanoma which have been described (figure 2.3). A few 
patients in whom no tumour circulation was detectable 
had raised intra-ocular pressures from secondary 
glaucoma and may have had secondary tumour necrosis 
from cessation of the tumour blood supply. The 
examination of Doppler frequency shifts of choroidal 
melanomas after radiotherapy has determined that the 
blood flow velocity rises in the first few days and 
then reduces significantly from predosage levels 
Nineteen of the 20 cases described by Wolff-Kormann had 
reduced blood velocity as shown by GDI before tumour 
regression was detected by conventional ultrasonography 
205, In one patient in whom increased velocity was 
noted after treatment tumour recurrence subsequently 
developed.
Other intraocular tumours such as choroidal haemangio- 
mas and métastasés have also shown evidence of tumour 
vessels when examined by GDI 161,305^ Haemangiomas 
have reportedly higher velocities than melanomas. 
Although a case of posterior hyperplastic primary 
vitreous showed blood flow in a vessel within its 
centre 296^ other lesions which may mimic malignant 
tumours, such as age related macular degeneration, 
choroidal osteoma and choroidal naevi have shown no
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Figure 2.3. The tumour vascular supply is detectable in this color Doppler image of a malignant melanoma. It may be difficult to determine the direction of travel of the vessel and so Doppler 
frequency shifts have often been quoted in studies of tumours 
without converting these to velocities.
Figure 2.4. The dilated superior ophthalmic vein is apparent in 
the superior orbit of a patient with carotico-cavernous fistula 
showing an unusual arterial type of waveform on spectral analy­
sis .
detectable blood flow 151,305^
Patients with carotico-cavernous sinus fistula show 
dilated orbital veins particularly the superior 
ophthalmic vein with a change from continuous venous 
flow to pulsatile arterial flow 13 f 52,55 ^ an example is 
shown in figure 2.4. The direction of flow is usually 
reversed and in the vortex veins may be bidirectional 
^2. In one of the described cases the flow velocities 
returned to a venous pattern after embolisation of the 
fistula .
Reversal of flow in the superior ophthalmic vein has 
also been described in a case of thrombophlebitis of 
the cavernous sinus and in two cases of orbital apex 
tumour 23, CDI has also been used to examine an 
orbital arterio-venous malformation in which low 
resistance arterial flow was seen , orbital varices 
in which flow can be detected in the varix during the 
Valsalva manoeuvre as the vessel fills and empties 
13,160  ^ and a few cases of orbital tumours 220^
The description of a case of gaze induced amaurosis 
fugax secondary to an intraconal orbital mass further 
illustrates the potential of CDI to elucidate the 
pathogenesis of vascular disease processes 236^ The 
peak systolic flow velocity in the central retinal 
artery was reduced in this patient from 11.6 cm/s to
5.0 cm/s during abduction of the eye when amaurosis 
fugax occurred signifying a partial occlusion of this
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vessel during eye movements. As yet the gaze induced 
changes in the blood velocity measurements are not 
known for the normal population.
There is great potential for the use of CDI for 
investigating the effects of pharmacological agents on 
blood flow to the eye because it is a noninvasive 
method accommodating repeated examinations. Our study 
investigating the use of topical timolol 0.5% detected 
a significant reduction in the resistive index in the 
administered and fellow eyes, indicating a reduction in 
the resistance to flow. This appeared to be independ­
ent of the effect of the drug on lOP, systemic pulse 
and blood pressure and may have been due to an effect 
of the drug on the retinal blood vessels themselves, 
perhaps indicating that contrary to current opinion 
sympathetic receptors may be present on these vessels. 
Colour Doppler imaging of patients after administration 
of aproclonidine have shown a reduction in end 
diastolic velocities from the posterior ciliary 
circulation suggesting reduced peripheral resistance to 
flow 279^
The Doppler principle has been used primarily for the 
investigation of blood flow but there are other 
applications in ophthalmology. For example, an initial 
study has been performed to use the technique to 
determine the velocity of the contractions of the 
extraocular muscles during saccades 27, These saccadic 
velocities were reduced after the injection of
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Botulinum toxin into the muscle. Duplex scanning was 
used by the same investigators for the measurement of 
the mobility of the vitreous 206 
CDI provides a rapid and convenient method of 
identification of blood vessels in the eye and orbit. 
Spectral analysis of the Doppler signals allows the 
characteristics of the pulsatility of the blood flow in 
these vessels to be investigated. So far, studies have 
looked at the blood flow in vascular occlusions and 
intraocular tumours primarily, as well as describing 
miscellaneous orbital conditions. Further use of the 
technique can only be made if certain basic information 
is obtained such as reproducibility. Currently, 
interpretation of the results of studies is difficult 
because basic investigations have not been performed. 
The next chapter describes studies in this area.
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3 Chapter 3
ASSESSMENT OF COLOUR DOPPLER IMAGING IN A NORMAL 
POPULATION.
3.1 Summary
A control population was examined to determine the 
blood vessels in the orbit from which measurements of 
blood velocity could be obtained. Although multiple 
blood vessels could be imaged only the results from the 
ophthalmic artery and central retinal artery and vein 
were reproducible. Normal ranges were defined for 
these vessels. Age, systolic blood pressure and 
smoking habit were found to influence the results 
obtained. The inter-relationship of the velocities 
showed that there was, in particular, a relationship 
between the velocities in the central retinal artery 
and vein.
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3.2 Introduction.
The application of any new examination technique 
requires the investigation of various parameters in a 
population of normal individuals to allow experience to 
be gained, normal ranges to be determined and the 
inherent variability of the technique assessed. This 
section of the study was performed to investigate the 
technique of colour Doppler ultrasound imaging as a 
means of measuring blood velocity in the eye and orbit. 
The group was examined to identify the blood vessels 
from which blood velocities could be obtained and the 
reproducibility of the velocity measurements measured.
A group of volunteers was imaged to produce normal 
ranges for the Doppler results and to identify 
correlations of the results with age, systemic blood 
pressure, smoking habit and the presence of systemic 
vascular diseases. The effect of postural changes was 
examined and the effect on intraocular pressure from 
the application of the ultrasound transducer investi­
gated.
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3.3 Method of Colour Doppler Imaging.
An Acuson 128 (Mountain View, California) colour 
Doppler ultrasound imager with a 7.5 MHz linear array 
surface transducer was used (figure 3.1). The machine 
is controlled via a computer keyboard with an integral 
rollerball and real time images displayed on a visual 
display unit. The machine settings are varied for 
optimal imaging whilst at the same time restricting the 
ultrasound energy being applied to the tissue. An 
"application" setting for "eyes" was used at a stimulus 
power of ”0.09 dB. The ultrasound exposure duration 
was kept as short as possible, in particular, pulse 
Doppler imaging was limited to a maximum of 10 secs of
continuous duration.
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JFigure 3.1. The Acuson 128 machinery is shown.
3,3.1 Management of the Patient or Volunteer During 
CDI.
The patient lay in the supine position for three 
minutes before commencing scanning. In this way the 
systemic blood pressure and pulse rate were allowed to 
reach a resting level. The procedure was explained to 
the patient and the name and date of birth of the 
patient and date of examination recorded for identifi­
cation of the scan during later analysis. The subject 
was asked to close the eyelids, avoid eye movements and 
direct their gaze towards the ceiling of the room. The 
ultrasound transducer was applied with contact jelly to 
the eyelid whilst the hand of the examiner rested upon 
the patient's inferior orbital margin thereby 
minimising the pressure on the globe. The 7.5 MHz 
transducer was applied in the horizontal axis, 
therefore all images presented in the figures are in a 
horizontal transverse plane.
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3.3.2 The imaging was performed in four stages :
A. B MODE IMAGING.
B mode ultrasound was used to produce a two dimensional 
image of the eye and orbit allowing identification of 
the structures of the region. The vitreous cavity was 
identified by its hyporeflective (dark) appearance and 
the orbital fat by its hyperreflective (white) 
appearance. The curvature of the posterior pole of the 
eye can therefore be identified where the fat and the 
vitreous cavity meet. Within the orbital fat the optic 
nerve was detected as a hyporeflective band extending 
posteriorly from just nasal to the posterior pole of 
the eye.
B. COLOUR IMAGING.
After identification of the structures of the eye and 
orbit the ultrasound setting was changed to provide a 
colour coded image. During this part of the procedure 
the ultrasound signal from the transducer was divided 
into two portions. The first continued to produce a B 
scan image on the visual display unit (VDU) but at a 
lower temporal frequency (the image changes less often 
making "real time" observation of the tissues less 
sensitive). The second portion of ultrasound signal 
was employed to detect Doppler frequency shifts which 
were represented as coloured pixels on the B scan image 
on the VDU and situated at the appropriate anatomical
40
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location. A blue green red orange yellow scale set to 
detect Doppler frequency shifts from -0.06 to 0,06 dB 
was used. With the eye immobile, frequency shifts were 
produced from the movement (flow) of red blood cells in 
the blood vessels. In this way the blood vessels could 
be located and their direction of flow determined, the 
red spectrum indicating movement towards and blue away 
from the probe. Changes in the velocity of the flow 
(pulsation) were detectable because the VDU image was 
constantly renewed. The vasculature was identifiable 
by its anatomical location on the B scan according to 
the anatomical descriptions of Hayreh 99,103 ^ the 
direction of blood flow and ultimately by the pulsatile 
flow characteristics in the vessel.
C. OBTAINING A VELOCITY WAVEFORM.
After identification of the vessel of interest by its 
anatomical location and appearance on the scan, a 
cursor on the VDU (controlled by the rollerball on the 
keyboard) was used to aim a pulsed Doppler ultrasound 
beam at the vessel. Higher intensity ultrasound with a 
sample gate of 1.5mm x 1.5mm, was employed. The 
ultrasound frequency shifts were converted by 
computerised mathematical analysis using Fast Fourier 
Transformation into a spectral waveform of the blood 
velocities against time. If the direction of the blood 
flow was visible on the colour image, the conversion of
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the frequency shifts into velocity values (cm/s) was 
adjusted for the angle of incidence of the Doppler beam 
to the direction of flow (angle correction). The pulse 
waveforms showed a spectrum of blood cell velocities 
which were displayed on a graph of velocity against 
time. Velocity towards the probe was shown above the x 
axis and away from the probe below the x axis. The 
upper border (or lower border for flow away from the 
probe) of the waveform represented the maximum velocity 
recordable in the vessel at that time (peak velocity). 
The area beneath the curve represented the other 
velocities from slower moving blood cells. An 
illustration of a common carotid waveform is shown in 
figure 3.2 and illustrates the typical features of 
spectral analysis of arterial blood velocities.
D. BLOOD VELOCITY MEASUREMENT.
Once a series of waveforms was obtained these were 
"frozen" on the VDU and recorded on VHS magnetic 
videotape. Velocities were measured by directing a 
cursor on the screen (using the rollerball) to the 
appropriate part of the waveform. In order to minimise 
the effect of respiratory function on the velocities 
three consecutive pulse waveforms were measured, ie., 
over the duration of one respiration at 2 0 breaths per 
minute. If three consecutive pulses were unobtainable 
the blood vessel was categorised as unrecordable,
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Figure 3.2. A colour Doppler image of the blood velocities in the carotid circulations and the spectral waveform obtained from 
the common carotid.
Three arterial measurements were taken:
Peak Systolic Velocity (PSV) - The maximum velocity in 
the blood vessel in the systolic phase of the blood 
flow.
End Diastolic Velocity (EDV) - The maximum velocity at
the end of the diastolic phase of the blood flow.
Resistive index - Calculated from the formula:
PSV - EDV 
Resistive index = --- ----- ----—
PSV
This ratio is an indicator of the shape of the 
frequency time display waveform and can be used to 
avoid the error that the angle of travel of blood flow 
might induce upon absolute measurements of velocity.
An increase in the resistance to flow distal to the 
site of measurement causes an increase in the resistive 
index, whereas, a constriction of the vessel proximal 
to the site of measurement decreases the index.
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Three venous measurements were obtained:
Maximum Peak Velocity (Vmax) - The maximum velocity 
during one cardiac cycle.
Minimum Peak Velocity (Vmin) - The minimum peak 
velocity during one cardiac cycle.
Venous Pulsatility Index (VPI) - Calculated from the 
formula :
Vmax - Vmin
Venous Pulsatility Index = ------------------Vmax
The nomenclature "Vmax" and "Vmin" were employed for 
the venous velocities because these peak velocities did 
not necessarily occur during the systolic or diastolic 
phases of the arterial cycle. Similarly, although the 
resistive index formula (which was described by 
Pourcelot for arterial Doppler recordings) was used
for the venous waveforms as a measure of the 
"pulsation" of blood flow in the vein, the nomenclature 
"venous pulsatility index" was employed.
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3.3.3 SELECTION OP THE CONTROL POPULATION.
Ninety five volunteers were examined to provide control 
data and consisted of staff of the Ophthalmology or 
Radiology department at the Western Infirmary Hospital, 
Glasgow and relatives of the patients attending the 
central retinal vein occlusion study or the ophthalmol­
ogy out patient department. The volunteers were asked 
for a history of general medical and ocular conditions, 
drug usage and smoking habit. Subjects with a history 
of previous ophthalmological disorders were excluded. 
Systemic blood pressure was measured using a digital 
sphygmomanometer and intraocular pressure was recorded 
with a Goldman or Perkins applanation tonometer. One 
orbit only of each volunteer was examined (right or 
left eyes were chosen by random number sequences).
DATA STORAGE AND ANALYSIS.
All data were stored on specially designed databases 
using FoxPro II software and analysed using CSS 
Statistica software on an IBM compatible personal 
computer. Graphs were produced using CSS Statistica or 
Harvard Graphics.
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3.3.4 REPRODUCIBILITY OF COLOUR DOPPLER IMAGING.
In fifteen healthy volunteers attempts were made to 
detect and record blood velocities from the following 
vessels in the orbit:
Ophthalmic Artery 
Central Retinal Artery 
Central Retinal Vein 
Temporal Posterior Ciliary Arteries 
Nasal Posterior Ciliary Arteries 
Temporal Vortex Vein 
Nasal Vortex Vein 
Superior Ophthalmic Vein.
Spectral analysis of the vessels was obtained on two 
occasions by one observer to allow the assessment of 
intraobserver reproducibility. In addition, the 
ophthalmic artery, central retinal artery and vein were 
examined by another observer, allowing the investiga­
tion of interobserver reproducibility. This observer 
was masked from the results obtained by the previous 
observer. This part of the study required repeated 
ultrasound examinations over a period of 1 hour. To 
restrict the dosage of ultrasound energy being applied 
to the tissue for reasons of safety, the posterior 
ciliary arteries, superior ophthalmic vein and vortex 
veins were not examined in the interobserver compari­
son. Systemic blood pressure and pulse were recorded 
before each examination by digital sphygmomanometer.
4 6 I
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The order of the examinations was randomly varied.
Each observer measured mean PSV, EDV and resistive 
index from three consecutive waveforms from the 
arteries and Vmax, Vmin and venous pulsatility index 
from the veins.
3.3.5 STATISTICAL ANALYSIS AND INTERPRETATION OF THE 
RESULTS.
The results were statistically analysed by obtaining 
the mean difference between the Doppler results 
obtained during the intraobserver and interobserver 
examinations. These were presented as the mean 
difference and the standard deviation of the mean 
difference (SD) . The mean difference provides a 
measure of whether there is a consistent error in the 
results obtained between two examinations. If the 
value was negative the second examination has provided 
lower results and if positive higher results have been 
obtained. Doubling the SD of the mean difference has 
been used as a measure of the inherent variability 
between the examinations, eg., a SD of the mean 
difference of 10 for results with mean value of 100 
would indicate a variation of 2 0%. The least variation 
is present when the mean difference and the SD both 
equal zero. Systemic blood pressure and pulse were 
similarly assessed to determine any difference in these
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systemic parameters during the examinations.
3.3.6 PRODUCTION OF NORMAL RANGES
Normal ranges were calculated by adding and subtracting 
2 SD from the mean values for the Doppler results of 
the ophthalmic artery and central retinal artery and 
vein (the upper and lower confidence limits were also 
given for comparison with subsequent means from 
populations of patients with ocular disease). Fifteen 
volunteers with a past history of systemic disease such 
as hypertension, maturity onset diabetes or arteriopa- 
thy were excluded from the data for the production of 
these normal ranges. In twenty individuals the blood 
velocities in the ophthalmic artery were measured at 
the orbital apex and in the nasal orbit to determine 
any difference in the results from these two sites. In 
the remainder of the control population the ophthalmic 
artery was examined only in the nasal orbit.
3.3.7 CORRELATIONS WITH OTHER FACTORS.
The influence of age, right or left eye, sex, systolic 
and diastolic blood pressure, cigarette smoking and the 
presence of vascular disease were examined by Spearman 
rank correlation, multiple linear regression analysis 
or analysis of covariance where appropriate. R and p 
values for rank correlation and p values for analysis 
of covariance are shown. For multiple linear
48
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regression results were described as significant at p 
less than 0.05.
The difference between the Doppler results from the 
three vessels was determined using Wilcoxon matched 
pairs testing. Secondly, the relationship of the 
velocity values to each other was examined by observing 
scattergrams and employing Spearman rank correlation.
3.3.8 THE LEARNING CURVE.
Since the cases were numbered sequentially with those 
examined early in the course of the study given low 
case numbers it was possible to gain an idea of the 
learning curve for the technique from the scatter of 
the Doppler values against the case number of the 
volunteer.
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3,3.9 DETERMINATION OP THE EFFECTS OF POSTURE ON THE
a r t e r i a l b l o o d v e l o c i t i e s .
INTRODUCTION.
Postural changes are known to occur in the blood flow 
to the eye in the choroid whereas autoregulation 
maintains a steady flow in the retina. For this 
reason, it was important to determine whether postural 
changes would alter the velocity results and decide 
upon a position in which future scans would be 
performed. The results could also provide a way of 
assessing the autoregulatory capacity of the vascula­
ture for its use in future studies of diseases in which 
this may be lost, eg., diabetic retinopathy.
SUBJECTS AND METHOD.
Twenty of the volunteers, 12 males, 8 females, age 
range 20 to 60 years (mean 34.6), were examined in 
three postural positions. Initially, each subject was 
asked to lie supine for five minutes. The systemic 
blood pressure and pulse rate were then noted. Blood 
velocities were recorded from the ophthalmic artery and 
the central retinal artery at the optic nerve either 
from the left or right eye, according to a predeter­
mined random number sequence. Each subject was then 
asked to sit upright and all recordings were repeated 
two minutes later. The subject was asked to stand for 
two minutes, and all recordings were repeated once
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3.4 RESULTS
3.4.1 THE CONTROL POPULATION.
Ninety three volunteers were examined mean age 47.0 
years (SD 1.82, range 20-83 years), 56 males and 37 
females. Doppler values for all of the volunteers are 
shown in table 3.1,
THE IDENTIFICATION OF ORBITAL BLOOD VESSELS.
It was found that the Bscan image of the optic nerve 
provided the most useful landmark for the identifica­
tion of the anatomical location of the blood vessels 
for a number of reasons. The blood vessels listed 
below were identifiable and provided velocity 
recordings :
- The ophthalmic artery was situated either above or 
below the optic nerve in the posterior orbit before 
passing forward in the nasal orbit in a horizontal 
plane slightly superior to that of the optic nerve, 
(figure 3.3). The velocity waveform from the artery 
possessed a profile similar to the internal carotid 
with a high PSV spike followed by a rapid drop in the 
velocity to a low EDV. A dichrotic notch from the 
closure of the aortic valve was usually present and a 
window indicating relatively uniform blood flow 
occasionally seen (figure 3.4). The results of blood
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Table 3.1
The results from 9 5 volunteers,
n Range mean SD Confidence limits
upper lower
AGE 95 20-83 47 1.82
Ophthalmic Artery
PSV 95 11.0-65.0
EDV 1.9-2 3.0
RI 55.7-89.7
Central Retinal Artery
PSV 95 4.6-18.6EDV 1.3-6.3
RI 56.0-89.0
Central Retinal Vein
35.0 11.2 37.3 33.58.6 3 . 8 9.4 7.874.0 8.2 75.8 72.4
10.2 2.8 10 . 8 9 . 63.1 1.1 3 . 3 2.869.3 7.7 70.9 67.7
Vmax 76 3.0-11.0 5.7 1.4 6.1 5.4
Vmin 2.0-7.7 3.8 0.8 4.0 3.6
RI 13.5-60.0 32.4 9.7 34.6 30.1
Table 3.1. The means (SD), confidence limits and range 
of values are shown for the ophthalmologically healthy 
volunteers for the ophthalmic artery and central 
retinal artery and vein.
Figure 3.3. A normal color Doppler image of the left orbit showing the blood flow in the ophthalmic artery indicated by the coloured pixels (arrow).
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Figure 3.4. The blood velocity waveforms produced by spectral 
analysis of Doppler signals from the eye and orbit of a young healthy subject showing from top to bottom the ophthalmic artery 
(OA), the central retinal artery (CRA) and vein (CRV), a posteri­or ciliary artery (PCA) and the superior ophthalmic vein (SOV) and a vortex vein (W) . The arrows indicate the portions of the waveform which correspond to peak systolic velocity (PSV) and end 
diastolic velocity (EDV) in the ophthalmic artery.
velocity measurements from the ophthalmic artery at the 
orbital apex and the nasal orbit were similar.
- The central retinal artery and vein were detected 
within the optic nerve in its retrolaminar portion for 
a length of approximately 10mm. They were adjacent to 
each other (figure 3.5) and were seen as a blue and red 
band of coloured pixels on the VDU within the optic 
nerve at an average of 15.1° to the anteroposterior 
meridian. The central retinal arteries provided a 
velocity profile which was relatively smoothed out in 
comparison to the ophthalmic artery and the posterior 
ciliary arteries (figure 3.4).
- The posterior ciliary arteries commenced as trunks 
approximately 10-20mm behind the globe before forming 
multiple branches surrounding the optic nerve in its 
retrobulbar portion. The waveform produced in these 
vessels provided velocity values which were similar to 
the central retinal artery but with a sharper PSV spike 
(figure 3.4). These vessels were examined on the nasal 
and temporal sides of the nerve (figure 3.5).
The superior ophthalmic vein (usually a larger sized 
vessel than the other veins) took an oblique course 
superior to the optic nerve in the centre of the 
retrobulbar orbit (figure 3.6). The flow pattern in 
this vessel and direction of flow was variable, 
sometimes the flow was constant or phasic with the 
respiration of the individual (figure 3.4) and in one 
case demonstrated a flow pattern similar to that of the
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Figure 3.5. A normal color Doppler image of the right orbit 
showing the blood flow in the central retinal artery and vein 
(CRAV) and the posterior ciliary arteries (PCA).
dr
Figure 3.6. The superior ophthalmic vein (SOV) is shown in the superior orbit above the optic nerve. The direction of flow in 
this vessel may be anteriorly or posteriorly in normal individu­als .
Figure 3.7. The color Doppler image of a vortex vein (W) as it 
exits the globe of the eye. These vessels provide variable results and may be difficult to detect in normal individuals.
jugular vein.
The vortex veins were located in a horizontal plane 
either above or below that of the optic nerve as they 
exited the sclera just posterior to the equator of the 
eye (figure 3.7) and demonstrated flow of a constant 
velocity (figure 3,4).
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3.4.2 REPRODUCIBILITY 
INTRODUCTION.
Fifteen volunteers were examined by colour Doppler 
imaging to inspect the reproducibility of the method 
for two examinations by the same ultrasonographer 
(examinations 1 and 2 intraobserver variability) and 
between examinations by two ultrasonographers 
(examinations 1 and 3, interobserver variability). 
Systemic blood pressure and pulse were monitored 
throughout.
SYSTEMIC BLOOD PRESSURE AND PULSE RATE.
Systolic and diastolic blood pressures and pulse rate 
were similar between examinations 1 and 2, but the 
diastolic blood pressure was significantly lower 
between observations 2 and 3 (paired t test p=0.01, 
table 3.2). Analysis showed that as the disparity 
between the diastolic blood pressure in observations 2
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Table 3.2
1 2 3
(Mean and SD)
SBP 122 121 122
(mmHg) (12) (20) (11)
DBP 73 69 77
(mmHg) (8) (8) (7)
Pulse 68 69 71
(/min) (12) (13) (15)
Table 3.2. Systemic pulse and blood
reproducibility analysis showing a rise in diastolic 
blood pressure in the interobserver examination, 1 and 3 (DBP = diastolic blood pressure, SBP = systolic blood 
pressure).
and 3 increased, the disparity between the resistive 
indices in the ophthalmic artery also increased 
(Spearman Rank correlation, r = 0.49, p = 0.03). All 
other comparisons of the difference in blood pressure 
or pulse and velocimetry did not show any correlation. 
In one individual a large variation in systolic blood 
pressure from 13 2 mmHg to 17 2 mmHg was associated with 
a rise in the central retinal artery PSV of 3.3 cm/sec 
and EDV of 2,0 cm/sec and a rise in the nasal posterior 
ciliary artery PSV of 8.4 cm/sec and EDV of 12.7 cm/sec 
in the intraobserver comparison and the results from 
this individual were removed from the analysis. In 
addition, during the interobserver comparison the 
velocity results from one individual were particularly 
dissimilar from the rest of the group and were 
therefore removed.
ORBITAL ARTERIES.
Reproducibility of the Doppler results from the orbital 
arteries are shown as the mean difference in the values 
between examinations and its standard deviation, table 
3.3. The measurements from the ophthalmic artery and 
central retinal artery between observations were 
similar.
Notably, the mean differences in the results from the 
posterior ciliary arteries (intraobserver analysis 
only) are higher and more variable, and the relatively 
larger standard deviations of these means indicate that
54
Table 3.3
mean velocity 
(n) cm/sec
(SD)
1+2 1+3
mean differences 
cm/sec
(SD)1-2 1-3
t Tests
1-2 1-3
Ophthalmic Artery
PSV14 39.7 7 . 3 39 . 2 7 . 8 0.5 2 . 1 2 , 6 3 . 2 ns ns
EDV
14
10.9 
3 . 2
10.2
3.0
0.7
1.2
0.5 
2 . 6
ns ns
RI14
72.7
5.0
74 . 0 
4 . 8 -0.33 . 5
— 1.6
4.6
ns ns
Central Retinal 
PSV 11.5 
14 2.0
Artery 10 . 9 
1.9
0.4
1.4
0.8 
2 . 1 ns ns
EDV
14
4 . 0 
1.0
3 . 6 
0.9
0 . 2 
0.8
0.8
0.9
ns ns
RI14 65. 6 6.4 67 . 1 5.7 -0.4 4 . 2 -3 . 4 4.2 ns ns
Nasal
PSV
14
Posterior 
12 .1 
3 . 3
Ciliary Artery 
0.9 
3 . 6
ns
EDV
14
5.4 
2 . 5
-1.1
1.2
ns
RI
14
60.4
7.0
1.0 
8 . 2
ns
Temporal Posterior Ciliary Artery 
PSV 12.3 0.1 
14 4.2 4.5
ns
EDV
14
4 . 9 
2 . 0
-0. 1
1.9
ns
RI
14
60.0
6.4
6.8
6.0
ns
ns
Table 3.3 The intraobserver (comparisons between 1 and 2) and interobserver (comparisons between 1 and 3, and 
2 and 3) reproducibility for velocimetry results from 
the orbital arteries. It is notable that the mean 
difference in the posterior ciliary results are more 
variable, and the relatively larger SDs of these means 
indicate a greater variation between two examinations than for the ophthalmic artery and central retinal 
artery.
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a greater variation exists between any two examinations 
than for the ophthalmic artery and central retinal 
artery. The resistive indices showed less variation 
than the velocity measurements but were still higher 
than in the other arteries.
ORBITAL VEINS.
The results of reproducibility of the orbital veins are 
shown on table 3.4. The mean differences between 
measurements from the central retinal vein are much 
smaller than the other veins and comparable to the 
results from the ophthalmic and central retinal 
arteries. The superior ophthalmic vein and the vortex 
veins often showed significant differences between the 
results from the examinations. In addition, these 
veins were undetectable in many of the orbits examined, 
eg., the superior ophthalmic vein was undetectable in 
either of the examinations in two cases, in the nasal 
vortex vein in 6 cases and in the temporal vortex vein 
in 5 cases. In 2 further patients the nasal vortex 
veins were only detectable in one of the observations 
and in 3 of the patients the temporal vortex veins were 
only detectable once.
The coefficients of variation of repeated measures are 
shown for the results of the study of reproducibility 
of colour Doppler recordings (figure 3.8). Coeffi­
cients of variation were higher for the results of PSV
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Table
(n)
3.4
mean velocity 
cm/sec
(SD)
1+2 1+3
mean
(SD)
1-2
differences 
cm/sec
1-3
t Tests 
1-2 1-3
Central Retinal Vein 
Vmax 5.9 5.9 
14 1.2 1.3
0.1
0.8
0.3
1.2
ns ns
Vmin
14
4.1 4.1 
0.8 0.9 -0.20.5
0.0
0.9
ns ns
VPI14 29.9 30.0 5.4 8.2 1.02.7
-0.16.8 ns ns
Superior Ophthalmic Vein 
Vmax 9.5 (4.0-15)
12 3.4
Nasal
Vmax8
Vortex Vein 13.4 (8-21) 
5.0
%
Temporal Vortex Vein 
Vmax 8.4 (5-10)
7 2.1
Table 3.4. The intraobserver (comparisons between 1 and 2) and interobserver (comparisons between 1 and 3, and 2 and 3) reproducibility for the orbital veins.
The mean differences (and SDs) of measurements from the 
central retinal vein are small indicating good 
reproducibility. There are significant differences in 
the mean intraobserver measurements of the superior 
ophthalmic vein and the vortex veins. In addition, out 
of the 14 orbits examined, blood flow was undetectable 
on both occasions in the superior ophthalmic vein in 2 
cases, in the nasal vortex vein in 6 cases and in the 
temporal vortex vein in 5 cases. In 5 cases the vortex 
veins were detectable on one examination only.
Acuson 128
Reproducibility
Coefficient of Variance of Repeated Measures (%) 40
CRV
PSV EDV RI
Figure 3,3. The coefficients of variation of repeated measures 
are shown for the various measurements and blood vessels in the 
intraobserver comparison.
Ophthalmic artery (OA)
Central retinal artery (CRA)Central retinal vein (CRV)
Nasal posterior ciliary arteries (PCN)Temporal posterior ciliary arteries (PCT)
Peak systolic velocity (PSV)End diastolic velocity (EDV)
Resistive index (RI).
a
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and EDV than for resistive index. The coefficients of 
variation are much higher from the posterior ciliary 
arteries than the ophthalmic artery, central retinal 
artery and vein.
3.4.3 NORMAL RANGES.
The normal ranges are shown in table 3.5. Age adjusted 
normal ranges did not influence these results 
appreciably. Only values for the venous pulsatility 
index in the central retinal vein (which demonstrated 
the largest r value by Spearman rank correlation for 
age, r=0.49) produced normal ranges which were notably 
different, ie., 13.5% to 41.5% for those less than 50 
years and 16.6% to 55.0% for patients of 50 years of 
age or more.
3.4.4INFLUENCE OF SYSTEMIC PARAMETERS.
These effects are summarised on table 3.6.
AGE
Ophthalmic artery velocities showed a negative 
correlation age (both PSV an EDV, r=-0.31, p=0.003, 
figure 3.9). Resistive index in the central retinal 
artery and pulsatility index in the vein showed a 
positive correlation (r==0.21, p=0.04 and r=0.54, 
p<0.00001, figure 3.10).
Multiple regression analysis (including the variables
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Table 3.5 
Normal Ranges
Normal Range 
(Age 20-83 years)
(cm/sec)
Ophthalmic Artery
PSV 12.4-58.1
EDV 1.1-17.8
RI 56.8-90.4
Central Retinal Artery
PSV 5.0-15.4
EDV 1.1-5.1
RI 53.5-83.9
Upper and Lower 
Confidence Limits 
of the Mean (p=0.95) 
(cm\sec)
33.0-38.1
8.0-9.8 
71.8-75.5
9.6-10.8 
2,9-3.4
67.0-70.4
Central Retinal Vein
Vmax 2.7-8.7
Vmin 2.2-5.6
VPI 12.8-48.8
6.1-5.3 
3.7-4.1 28.4-33.1
:
Table 3.5. The normal ranges and confidence limits of 
blood velocities are provided for the ophthalmic artery 
and the central retinal artery and vein for 80 system 
ically and ophthalmologically healthy volunteers.
Table 3.6
The Variation of Velocity Measurements with Systemic 
Features.
Age
Age
Ophthalmic Artery
PSV
EDV
RI
Central Retinal Artery
PSV
EDV
RI +
Central Retinal Vein
SBP
+
DBP
+
Smoking
+
+
Vmax
VminVPI +
Table 3.6. The effects of the various systemic para 
meters are shown with + and - indicating a positive or negative correlation respectively.
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Ophthalmic Artery Velocity v Age
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figure 3.9 The blood velocities in the ophthalmic artery {peak 
systolic blood velocity, P S V ,  and end diastolic blood velocity, 
E D V )  had a negative correlation with age (r=-0.31, linear regres­
sion lines are shown).
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Figure 3.10. The resistive index in the central retinal artery and venous pulsatility index in the vein demonstrated a positive 
correlation with age (r=0.21 and r=Q.54 respectively, linear re­
gression lines are shown).
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systemic blood pressure and smoking habit) confirmed the 
negative correlation of age with the velocities in the 
ophthalmic artery and the positive correlation with the 
resistive index in the central retinal artery and 
pulsatility index in the vein.
SEX
There were no differences found for the velocity 
results for males or females (multiple linear 
regression including age, systemic blood pressure and 
smoking habit).
SYSTEMIC BLOOD PRESSURE.
Systolic and diastolic blood pressure increased with 
age (both r=0.49 and p<0,0001). Multiple linear 
regression analysis (age, blood pressure, smoking 
habit) showed that the PSV in both of the arteries was 
positively correlated with systolic blood pressure 
(ophthalmic artery b=0.56 and central retinal artery 
b=0.39, figure 3.11). No change was found for 
diastolic blood pressure.
CIGARETTE SMOKING HABITS.
A history of smoking habit was ellicited from ninety 
individuals, of these two pipe or cigar smokers were 
excluded leaving 19 smokers, 60 non smokers and 9 
exsmokers for comparison by ANCOVA with the covariants
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PSV in the Arteries
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Figure 3.11, The effect of raised systemic blood pressure on the 
peak systolic blood velocities (PSVs) in the ophthalmic and 
central retinal artery are indicated demonstrating negative 
correlations (r=*0.56 and r«0.39 respectively, linear regression lines are shown).
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Figure 3.12. The values for mean peak systolic velocity (SE and 
SD) in the ophthalmic artery of smokers and non smokers are 
illustrated. A reduction in the peak systolic velocity can be seen in those volunteers who smoke.
;
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age and systemic blood pressure. Mean ophthalmic artery 
PSV was lower in smokers 29.5 cm/s (SD 10.4) than non 
smokers 3 6.5 cm/sec (SD 11.2, p=0.03, figure 3.12) and 
therefore the resistive index in the ophthalmic artery 
was also lower in the smokers 69.7% (SD 6.0) than 
nonsmokers 75.6% (SD 8.4, p=0.003). Ex smokers had 
similar results to the nonsmokers for example in the 
ophthalmic artery a mean PSV of 3 6.9 cm/sec (SD 13,0) 
and a mean resistive index of 72.1% (SD 7.1). The 
other Doppler measurements demonstrated no differences 
after statistical analysis.
ARTERIOPATHY AND HYPERTENSION.
There was no difference in the Doppler measurements 
from healthy individuals and a small group of 5 elderly 
patients with a history of arteriopathic disease 
(myocardial infarction, angina or cerebrovascular 
accident) or with a group of 8 patients on observation 
or treatment for hypertension. Two patients suffered 
from maturity onset diabetes with no retinopathy, one 
diet controlled the other on oral hypoglycaemics.
NB: Any comparisons with the patients with central 
retinal vein occlusion include the whole group of 
volunteers because of the high incidence of systemic 
disease in these patients.
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RIGHT OR LEFT EYES.
No significant differences were found in the Doppler 
results from right or left eyes.
3.4.5 THE INTER-RELATIONSHIP OF THE VELOCITY MEASURE­
MENTS ,
The Doppler measurements were compared with each other 
to determine whether there was any relationship between 
the flow in the ophthalmic artery, central retinal 
artery and vein. First of all the differences between 
the blood velocities in the three vessels were 
determined by Wilcoxon matched pairs test.
Not surprisingly PSV in the ophthalmic artery was 
significantly higher than in the central retinal artery 
which was significantly higher than the Vmax in the 
central retinal vein (all p<0.0001). Although the 
ophthalmic artery had a significantly higher EDV than 
the artery and the Vmin of the vein, Vmin in the vein 
was higher than EDV in the central retinal artery. The 
resistive indices were higher in the ophthalmic artery 
than in the central retinal artery (p<0.0001).
Secondly the relationship of the Doppler results were 
defined by use of Spearman Rank correlation.
PSV and EDV or Vmax and Vmin in the same vessel were 
positively correlated (ophthalmic artery r=0.55, 
central retinal artery r=0.65, central retinal vein 
r=0.81, all p<0.0001). Ophthalmic artery PSV showed no
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correlation with the velocities in the central retinal 
artery or vein but as the EDV in the ophthalmic artery 
increased so did the velocities in the central retinal 
artery (r-0.24, p=0.03 and r-0.33, p=0.004).
Velocities in the central retinal vein positively 
correlated with the velocities in the artery (table 
3.7). Also the venous pulsatility index positively 
correlated with the resistive index in the artery. 
Central retinal artery EDV (r=-0.31, p=0.005) 
negatively correlated with the resistive index in the 
ophthalmic artery. Resistive index in the central 
retinal artery and ophthalmic artery were positively 
correlated (r=0.31, p-0.006).
The formula for the calculation of resistive index and 
venous pulsatility index can be written as:
Resistive Index (%) ~ 100 x (1 - (EDV/PSV))
Venous Pulsatility Index (%) = 100 x (1 - 
(Vmin/Vmax))
Therefore the indices are increased by an increase in 
PSV or Vmax or a decrease in EDV or Vmin. The results 
were therefore examined to determine which velocities 
appeared to influence the resistive indices most. In 
the ophthalmic and retinal arteries resistive index 
negatively correlated with EDV (r= -0.51, p=0.000002 
and r=-0.61, p<0.000001 respectively) whereas the 
venous pulsatility index positively correlated with 
Vmax (r-0.47, p=0.0002).
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Table 3.7Interrelationship of the Velocity Measurements in the 
Central Retinal Vein and Artery.
Central Retinal
Vein
Vmax
Vmin
Central Retinal Artery 
PSV EDV
(r and p values)
VPI
0.33(0 .01)
0.28(0.04)
ns
ns
0.29(0.03)
ns
RI
ns
ns
0.34
(0.008)
Table 3.7. The r values (and p) for Spearman rank correlation are provided for the measurements from the 
central retinal artery and vein in the control 
population. The venous velocities increase with the 
arterial velocities and as the pulsation increases in 
the artery (resistive index, RI) the pulsation also 
increases in the vein (venous pulsatility index, VPI).
3.4.6 THE LEARNING CURVE.
The scatter of points on scattergrams did not correlate 
with case number. In addition, multiple linear 
regression analysis including the variables age, 
smoking
habit ajii systemic blood pressure showed that there was 
no correlation of the Doppler measurements with the 
case number.
3.4.7 THE DETERMINATION OF THE EFFECTS OF POSTURE ON 
THE BLOOD VELOCITIES.
No effect of a change in posture was seen in velocime- 
try readings at any of the sites measured despite rises 
in diastolic blood pressure and pulse when changing 
from a supine or sitting position to standing (table 
3.8, rises in diastolic blood pressure and pulse rate 
were significant at p<0.01 and p<0.05 respectively). 
There was however a trend for a reduction in ophthalmic 
artery blood velocities.
61
    _ :
Table 3.8
Pulse
(beats/min)
SBP
(mmHg)
DBP
(mmHg)
PSV(ms”l) EDV(%)
RI
Supine 70.6 118.0 71.7 33.7 7.5 77.3
Sitting 72 . 6 113 . 5 72.9 30.0 5.7 81.6
Standing 78.6* 114 . 0 79.8# 27.3 5.5 79.8
Table 3.8. The results of changes in posture are shown 
for mean puise rate, systemic systolic (SBP) and 
diastolic blood pressure (DBP) with a significant rise 
in both DBP and pulse rate (* p<0.05 and # p<0.01).Also shown are the results of blood velocities and 
resistive indices in the ophthalmic artery of 20 
volunteers showing a trend for a reduction in the velocities which was not significant.
3.5 DISCUSSION
There is a need for a technique for the measurement of 
blood flow in the orbit and eye which can be performed 
easily and reliably and which can be used to investi­
gate the multiple vascular disorders of this region.
In this context colour Doppler imaging was assessed in 
a control population. It was apparent that multiple 
blood vessels could be detected in the orbit and 
spectral waveforms of their velocities obtained. In 
fifteen volunteers an attempt was made to examine all 
of the major blood vessels in the orbit to determine 
the reproducibility of the results. The following 
blood vessels were detectable and provided velocity 
measurements :
Ophthalmic Artery 
Central Retinal Artery 
Central Retinal Vein
Posterior Ciliary Arteries, Nasal and Temporal 
Superior Ophthalmic Vein 
Vortex Veins, Nasal and Temporal 
Only the ophthalmic artery and the central retinal 
artery and vein produced results which were reproduci­
ble. The posterior ciliary arteries provided wide 
variations up to 75% in velocity values, although with 
the calculation of resistive index this variation 
reduced to 2 0%. The superior ophthalmic vein and 
vortex veins were undetectable in some individuals.
The velocity results obtained from the ophthalmic
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artery and central retinal artery and vein were 
considered reproducible and therefore were recorded in 
the remainder of the control population.
In general, the higher the velocity values the better 
was the reproducibility. The interobserver variation 
was as low as 10% for the PSV in the ophthalmic artery 
(with the highest velocities) and as high as 35% for 
EDV in the central retinal artery (the lowest 
velocities). In the case of the latter the velocity 
values were close to the resolution of the instrumenta­
tion and therefore undetected flow in the blood vessel 
may have been contributing to the poorer reproducibili­
ty. Resistive index provided more reproducible results 
because the errors in absolute velocity measurements 
induced by incorrect angle correction were reduced by 
the calculation of the ratio.
As expected interobserver variation was higher than 
intraobserver variation but the results from the two 
examinations by the two ultrasonographers were 
statistically similar. The results indicate that 
serial examinations in the same individual are best 
performed by the same ultrasonographer and that a 
difference in the velocity measurements of greater than 
10-35% (depending on the blood vessel examined) 
indicate a 95 % chance of the change being true.
There was a large interindividual variation (amongst 
the 95 volunteers) in the velocity results especially
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at the lower velocity values. This variation reflects 
the fact that minor changes in blood vessel calibre can 
produce profound effects on the blood velocity. The 
normal ranges are wide, therefore, a disease will have 
to cause a severe change in blood velocity to produce 
a detectable result in an individual. An examination 
of occlusive diseases is required to determine whether 
changes in blood velocity can be detected. Another 
cause of variation in the results was the age of the 
volunteer but age corrected normal ranges were only 
applicable to the venous pulsatility index. The 
results were unaffected by the individuals sex or 
whether the eye was on the right or left, or by a 
history of arteriopathy (in a small group of volun­
teers) .
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3.5.1THE BLOOD VESSELS.
INTRODUCTION.
In this part of the discussion the results of CDI of 
the control population are examined describing each 
blood vessel in turn. The effects of age, systemic 
parameters and posture are interpreted to allow an 
assessment of the properties of the blood flow in each 
vessel and to allow the reader to form a view of the 
relative usefulness of the examination of each blood 
vessel.
OPHTHALMIC ARTERY.
The ophthalmic artery was detectable in its course 
through the posterior orbit and in the nasal orbit.
The velocity results from these two sites were 
statistically similar but a smaller range of values was 
found in the nasal orbit in which visualisation of the 
vessel and its direct course allowed angle correction 
to be applied more accurately. The ophthalmic artery 
is variable in its course in the posterior orbit, 
passing either above or below the optic nerve head and 
may have a dual supply from the internal carotid and 
middle meningeal artery, which anastomoses distal to 
this site For this reason after the initial
examination measurements were taken from the nasal 
orbit. It may be argued, however, that readings from 
this site are of reduced relevance to the study of
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ocular blood flow because the posterior ciliary and 
central retinal arteries have already branched off the 
ophthalmic artery before it reaches the medial orbit. 
The results from the ophthalmic artery were highly 
reproducible with approximately 10% variation in 
results from the same observer for PSV and resistive 
index and 22% for EDV. In the examination of the 
control cohort of 95 volunteers the ophthalmic artery 
velocities reduced with advancing age, perhaps an 
indication of the reduction in peripheral perfusion in 
the elderly. This was despite an increase in the 
incidence of systemic hypertension in the elderly group 
(PSV in the ophthalmic artery was positively correlated 
with systemic systolic blood pressure). Interestingly 
the PSV was lower in the patients who smoked than in 
those patients who were nonsmokers. The resistive 
index in this vessel was also lower in the smokers.
This may have resulted from an effect of nicotine on 
the vessels constricting the peripheral vessels thereby 
reducing the peripheral blood flow, however this would 
also be expected to increase the peripheral resistance 
and therefore the resistive index. The difficulty in 
the interpretation of these results arises from the 
complexity of the effects of cigarette smoking on the 
vasculature which include arteriopathy and the effects 
of carbon monoxide (a cerebral vasodilator) and 
nicotine.
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Change in posture to the supine position was expected 
to produce an increase in the velocities in the artery 
but although there was a trend for an increase in the 
velocities these did not reach significance. Canning 
and Restori using Duplex Doppler scanning in an 
undisclosed number of subjects found that there was an 
increase in the diastolic blood velocity in the supine 
position . All future studies were performed with 
the subject in the supine position which was also the 
most convenient position for examination.
Central Retinal Artery and Vein.
The central retinal artery and vein are adjacent to 
each other in the optic nerve and therefore the 
measurements from these can be taken simultaneously. 
The vessels possess their straightest course in their 
intraneural portion allowing the application of angle 
correction with ease. As a result the reproducibility 
was good with variation between observations of 23-24% 
for the velocities (35% for EDV in the artery) from 
these vessels and 13-18% for the resistive indices.
The resistive index increased with age probably 
signifying increased resistance to flow in the retinal 
arterioles in the elderly. Although the PSV increased 
with the systolic blood pressure in a similar fashion 
to the ophthalmic artery, postural changes induced no 
change in the velocities in the artery signifying the 
autoregulatory capacity of the retinal circulation.
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Cigarette smoking also had no effect on this vessel.
In the retinal vein an unusual pattern of pulsatile 
flow was seen. The venous pulsatile index was measured 
in the vein to provide a quantification of its 
pulsation. The values for this index do not provide a 
measure of the peripheral resistance of this vessel and 
should not be interpreted in such a way. Nor are they 
a measure of the resistance to flow upstream of the 
intraneural vein because the intraocular flow within 
the eye is reported as nonpulsatile 231^ instead the 
results probably provide an indicator of the increase 
in the velocity of flow that is induced in the vein by 
the artery. This can be seen from the increase in the 
pulsatility index in the vein with age which follows 
the resistive index in the artery and by the positive 
correlation between the two indices from these vessels. 
The calculation of venous pulsatile index was increased 
primarily by an increase in the Vmax which may reflect 
the increase in velocity in the vessel caused by the 
proximity of the central retinal artery. This is in 
contrast to the arteries for which a reduction of the 
EDV caused an increase in the index and was a sign of 
the rapid reduction in blood velocity induced by high 
peripheral resistance.
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Posterior Ciliary Arteries.
Investigators have reported that the posterior 
ciliaries are detectable by CDI 52,158 duplex
Doppler Results from these arteries have been
reported in the literature in one control population 
and in disease groups but reproducibility data has not 
previously been provided. A hint of the poor 
reproducibility of the recordings from these blood 
vessels is evident from the extremely wide range of 
values obtained previously (1.4 - 22.7 cm/s) 158^ in 
this study, the reproducibility of the recordings from 
these vessels was poorer than the other orbital 
arteries. This is not surprising considering that they 
commence as a variable number of trunks (4-6) and then 
branch into 10-20 short posterior ciliary arteries . 
The vessels are extremely tortuous and can often be 
detected during CDI as blood flow away from the globe 
indicating that they occasionally turn back upon 
themselves. Accurate angle correction in these 
circumstances is impossible resulting in poorer 
reproducibility. Although for the resistive index the 
variation was reduced measurements from these blood 
vessels are of limited value and their examination is 
best reserved to the observation of whether blood flow 
within them is present or absent.
Superior Ophthalmic Vein
Much has been made of the changes in the flow in the
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superior ophthalmic vein in orbital diseases. For 
example reversal of flow has been assigned to diseases 
such as carticocavernous fistula, tumours of the 
orbital apex and cavernous sinus thrombosis 
This investigation has determined that the blood in 
this vessel is not always detectable in the orbit, the 
vein may momentarily become undetectable. An arterial 
pattern of flow however does not occur normally and can 
be used to diagnose caroticocavernous fistula.
Vortex Veins
Four vortex veins are present one for each quadrant of 
the eye. An attempt was made to examine one on the 
temporal and one on the nasal side of the orbit but 
frequently it was difficult to detect these vessels.
The Inter Relationship of the Velocities in the Blood 
Vessels.
Not surprisingly the PSV or Vmax in a blood vessel 
positively correlated with the EDV or Vmin. The 
velocities in the central retinal artery positively 
correlated with the EDV in the ophthalmic artery but 
showed no correlation with the PSV in the ophthalmic 
artery. In turn the velocities and pulsatility index 
calculations from the central retinal vein positively 
correlated with the velocities and resistive index in 
the central retinal artery.
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It was interesting to try to determine the influence of 
the velocity values on the calculation of resistive 
index. In the arteries the resistive index positively 
correlated with EDV. This reflects the influence of 
peripheral perfusion on the resistive index. If the 
peripheral resistance is high the velocity of the blood 
reaches a maximum in the systolic phase of the cardiac 
cycle as the blood is pumped out of the left ventricle 
of the heart but falls rapidly to a low velocity in 
diastole, in contrast the velocity remains high during 
diastole if the resistance is low. The values for 
pulsatility index in the vein were dependent on the 
value of Vmax, probably reflecting the influence of the 
central retinal artery on the vein, that is if the 
pumping action of the artery was large, the pulsation 
in the blood velocity induced upon the constant blood 
velocity of the vein was increased.
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4 Chapter 4
DETERMINATION OP THE INTRAOCULAR PRESSURE (lOP) RISE 
PRODUCED BY ULTRASOUND EXAMINATION.
4.1 Summary
The application of an ultrasound transducer may induce 
intraocular presssure rises which may alter the blood 
flow in the eye. To investigate this potential source 
of error the intraocular pressure was monitored in an 
enucleated pig's eye during ultrasound examination.
The elevations in pressure were small but variable 
depending on the ultrasonographer.
4.2 Introduction.
Blood flow in the retina is autoregulated up to intra­
ocular pressure of 3 0 mmHg. Larger elevations in the 
lOP result in a reduction of blood flow. The 
ultrasound technique requires the application of a 
transducer to the closed eyelid of the patient.
Although attempts are made to minimise the pressure 
being applied to the globe by resting the examiner's 
hand on the subject's orbital rim, intraocular pressure 
rises may occur. An experimental model was therefore 
designed to allow intraocular pressure (lOP) measure­
ments during Bscan ultrasound and four different 
ultrasonographers were tested on repeated occasions to 
determine the degree of pressure elevation during the
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exmination and to see if there was any variation 
between operators or any effect of fatigue.
4.3 Method
A fresh pig's eye was supported in the orbital cavity 
of a human skull with an isosonic material and covered 
with a thin sheet of latex rubber (Supplied by Acuson 
ltd). Four ultrasonographers each performed five B 
scan ultrasound examinations of the globe and were 
asked to image the lens and posterior pole of the eye. 
A 5 to 10 second break was allowed between scans. A 
pressure transducer (Statham Strain Gauge Pressure 
Transducer) was inserted into the anterior chamber of 
the pig's eye to provide a continuous reading of the 
lOP during the examinations (Devices Instruments Ltd.). 
The ultrasonographers were masked from the results of 
the lOP measurements during imaging.
The mean lOPs for each examination were determined to 
allow assessment of the lOP elevations caused by 
consecutive examinations and by the different 
ultrasonographers.
4.4 RESULTS
The mean intraocular pressure increases during the five 
examinations by the four ultrasonographers are shown in 
figure 4.1. The mean lOP rises induced by each examin-
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Table 4.1
Ultrasonographer.
(mmHg)
mean lOP rise (mmHg) Range
1 10.2 0 - 2 4
2 1.4 0 - 8
3 6.0 4 - 11
4 3.3 0 - 11
Table 4.1. The mean intraocular pressure xisa and 
range of lOP rises induced in a pig's eye during Bscan 
ultrasonography by four ultrasonographers are shown. 
‘Considerable variation between the operators is appar­
ent .
Ultrasonographer 1
lOP mmK*
0
I 2 4
O on**cullv* Exjunln«tloo«.
Ultrasonographer 2
Con«»cutlv« ex*in)n»lloo*.
Ultrasonographer 3
Con««cutlv* Examination#.
Ultrasonographer 4
tOf* mmM*
20
443t
Contaoutiv# Examination#,
Figure 4.1. The intraocular pressure variations induced in an 
enucleated pig's eye during ulrasonography are shown for four ultrasonographers. The results from five consecutive examina­tions by each operator are provided.
.....
er showed considerable variation (table 4.1). 
Ultrasonographer 2 and 4 induced the lowest intraocular 
pressure rises and have performed all of the colour 
Doppler imaging in the studies of control populations 
and disease processes described in this paper.
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Discussion.
External pressure from the ultrasound transducer may 
potentially result in an increase in the intraocular 
pressure during examination. It is important during 
Doppler imaging to minimise this external pressure so 
as to reduce any effect on blood flow. We have 
determined that there is considerable variation in the 
intraocular pressure rises induced by different 
ultrasonographers. With the exception of two 
operators; the elevation in lOP was limited to a 
maximum of 11 mmHg and the mean rises were small. 
Previous animal experimentation has shown that the 
retinal blood flow remains stable during moderate rises 
in intraocular pressure 2,72 in humans Riva et al
(1986) using laser Doppler velocimetry showed that 
blood velocity in the retinal circulation is effective­
ly autoregulated up to intraocular pressures of 3 2 mmHg 
. It would appear, therefore, that the small intra­
ocular pressure rises produced during the ultrasound 
examination are unlikely to influence blood flow 
velocity measurements.
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5 Chapter 5
EXAMINATION OF PATIENTS WITH ARTERIAL OCCLUSION OF THE 
BLOOD VESSELS OF THE OPTIC NERVE HEAD.
5.1 Summary
Multiple arteries were apparent at the optic nerve head 
providing colour indices of flow in this region on 
colour Doppler imaging. These could presumably be 
identified as posterior ciliary arteries and the 
central retinal artery by their anatomical relationship 
to the optic nerve but to substantiate their identity 
patients with known occlusion of these vessels were 
examined. The central retinal artery was found to 
provide colour indices in the optic nerve shadow whilst 
the posterior ciliary arteries produced peripapillary 
indices. The results further illustrated the 
difficulty in accurately measuring from the posterior 
ciliary arteries.
5.2 Introduction.
It was apparent that CDI of the arterial vasculature of 
the optic nerve head region involved multiple vessels. 
The central retinal artery is anatomically located 
within the optic nerve with 10 to 2 0 posterior ciliary 
arteries surrounding the optic nerve. Although it was 
assumed that these vessels could be identified either 
by anatomical location or by the identification of
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blood flow in the region on CDI, confirmation of the 
identity of these vessels was required. Therefore, to 
investigate the contribution of the posterior ciliary 
and central retinal arteries to the measurements from 
this region patients with known occlusion of these 
vessels were imaged. Patients with central retinal 
artery occlusion and anterior ischaemic optic 
neuropathy (occlusion of the posterior ciliary 
arteries) were examined in the acute stage of the 
process, ie., within twenty four hours of the onset of 
symptoms. The blood velocity characteristics of these 
occlusive disorders was further investigated by 
performing serial examinations and also by imaging 
patients with at least a 3 weeks interval from their 
onset of the occlusion, the results from which are 
presented more fully elsewhere 200^
5.3 Patients and Methods
Fourteen patients were examined who had suffered either 
acute anterior ischaemic optic neuropathy (AION, seven 
patients) or central retinal artery occlusion (CRAO, 
seven patients). CDI was performed by an observer who 
was masked from the clinical diagnosis of the patients. 
All patients were fully informed and consented to the 
procedure. Velocity recordings were obtained from the 
ophthalmic artery and its continuation in the medial
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orbit and from the optic nerve head. Only if three 
consecutive pulse waveforms could be obtained from a 
site showing color indices was this site deemed a 
reliable source for velocimetry.
The patients had a detailed history taken for the 
clinical features of giant cell arteritis. Systemic 
blood pressure, erythrocyte sedimentation rate (ESR) 
were recorded. Temporal artery biopsies were performed 
on all patients with anterior ischaemic optic 
neuropathy and three patients with central retinal 
artery occlusion who exhibited raised ESRs or clinical 
features consistent with the diagnosis of cranial 
arteritis.
Fundus fluorescein angiography using a wide angle 
Canon Fundus camera was performed within 2 4 hours of 
Doppler ultrasonography on all cases with acute 
arterial occlusion (see section 9.3). The fluorescein 
angiograms were assessed by an independent observer, 
masked to the patients' identities, clinical diagnoses 
or velocimetric recordings. Color Doppler examinations 
were repeated in six patients with evidence of arterial 
nonperfusion to determine the time-course of reperfu­
sion.
Four patients with acute CRAO were examined by 
Doppler velocimetry within 24 hours of the onset of 
visual loss. A further three patients were examined 
who had suffered from CRAO at least three weeks 
earlier.
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similarly, four patients with AION of arteritic 
(three patients) or non-arteritic types (one patient) 
were examined within 24 hours and three were examined 
whose vascular occlusions had occurred more than three 
weeks previously.
5.4 RESULTS.
None of the patients with CRAO had a positive temporal 
artery biopsy. In three patients with acute central 
retinal artery occlusion no blood flow was detectable 
in the central optic nerve. Peripapillary colour 
indices of flow were present (table 5.1, figure 5.1). 
Although occasional pulse velocimetry readings were 
obtainable from these sites no reproducible measure­
ments (three consecutive pulse waveforms) could be 
obtained. Fluorescein angiography in these patients 
confirmed the diagnosis and revealed an intact 
posterior ciliary circulation as evidenced by normal 
choroidal and optic nerve head perfusion (table 5.2). 
Doppler studies in three patients with acute anterior 
ischaemic optic neuropathy showed no detectable 
peripapillary colour indices but did show evidence of a 
central vessel at the optic nerve head (table 5.1, 
figure 5.2). Velocimetry measurements were obtained 
from the optic nerve head in all of these patients.
All three had positive temporal artery biopsies.
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Figure 5.1. The color Doppler image is provided for a patient with central retinal artery occlusion on whom no flow was detect­
able within the optic nerve (arrow).
Figure 5.2. The color Doppler image is provided for a patient with anterior ischaemic optic neuropathy in whom no perineural flow was detectable (arrow).
Table 5.1
Case Diagnosis Optic Nerve Tmvf Choroid/Retina(secs) (secs)
1 CRAO Normal 38.1 0.0
2 CRAO Normal 11. 2 3.5
3 CRAO Normal 35.8 5.4
4 AION No inferior fill. 6.5 0.0
5 AION No inferior fill. 6.6 -4.6
6 AION No inferior fill, 
delay superiorly. 8 . 2 -6.8
Table 5.1. The results of fluorescein angiography of 
eyes with abnormal position 3 (optic nerve head) scans 
for patients with central retinal artery occlusion (CRAO) and anterior ischaemic optic neuropathy (AION). Results are shown of the masked assessment of optic 
nerve head perfusion, time to maximal venous filling 
of dye (tmvf) and time to choroidal perfusion relative 
to the first appearance of dye in retinal arterioles (a 
negative result indicates choroidal filling after 
retinal arteriolar filling).
Table 5.2
Case Diagnosis Central Retinal Artery PosteriorPSV EDV 
cm/sec
RI
%
Ciliary
Arteries
1 CRAO NIL NIL NIL YES
2 CRAO NIL NIL NIL YES
3 CRAO NIL NIL NIL YES
4 AION 7.4 3 . 0 59 NO
5 AION 4 . 6 1.4 69 NO
6 AION 5. 6 1.4 75 NO
Table 5.2. The results of colour Doppler imaging of 
eyes with abnormal (optic nerve head) scans for patients with central retinal artery occlusion (CRAO) 
and anterior ischaemic optic neuropathy (AION). 
Peripapillary colour indices of flow were either 
detectable (YES) or undetectable (NO).
Fluorescein angiographic evidence of normal dye transit 
times confirmed the presence of normal central retinal 
artery perfusion in these patients. Delayed choroidal 
filling and absent optic nerve head perfusion provided 
evidence for reduced posterior ciliary artery 
circulation (table 5,1).
The Doppler results at the optic nerve head were normal 
in all six patients whose vascular occlusion had 
occurred more than three weeks earlier. A normal 
recording was also obtained from one patient with acute 
CRAO and one with acute AXON (temporal artery biopsy 
showed no evidence of cranial arteritis in this 
patient). Fluorescein angiography demonstrated that 
perfusion of the retinal and posterior ciliary arterial 
circulations had been restored in these patients (table 
5.1) .
Blood velocities were detectable in the ophthalmic 
artery of all patients but was retrograde in one 
patient with CROA.
5.5 Discussion.
Doppler velocity readings were absent at the optic 
nerve head in cases of acute CRAO in which hypoperfu­
sion of the retinal circulation was present on 
fluorescein angiography evidenced by markedly prolonged 
arterio-venous dye transit times. These cases showed 
absence of color indices of flow in the central portion
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of the optic nerve. Peripapillary color indices were 
visible from blood flow in the posterior ciliary 
arteries but did not provide reliable velocimetry 
readings. Carotid artery disease is not uncommon in 
patients with CRAO and its presence in these
patients might have caused a reduction of perfusion of 
the posterior ciliary circulation thereby explaining 
our findings. Indeed a patient with internal carotid 
occlusion has been reported in which absent perfusion 
on CDI of the nasal posterior ciliary arteries and 
central retinal artery was interpreted as a partial 
occlusion of the ophthalmic artery in this case
the velocity of blood flow was also reduced in the 
ophthalmic artery. The determination of normal blood 
velocity in the ophthalmic artery in six out of seven 
of our patients with CRAO suggested the presence of a 
normal blood supply to the orbit from the internal 
carotid circulation. The remaining patient demonstrat­
ed perfusion of the ophthalmic artery which was 
probably via the external carotid circulation. The 
failure of CDI to provide reliable measurements from 
the posterior ciliary arteries in these patients 
therefore provides further evidence that these vessels 
provide unreliable velocity results and their 
assessment should be restricted to the determination of 
the presence or absence of flow.
Three of the patients with acute AION showed a single
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central blood vessel in the region of the optic nerve 
head but did not show evidence of blood flow within the 
multiple peripapillary blood vessels with CDI. All of 
these patients were suffering from giant cell 
arteritis. Absent or reduced blood flow in the 
posterior ciliary arteries was confirmed by the 
demonstration of incomplete optic nerve head perfusion 
on fluorescein angiography. Velocity readings at the 
optic nerve head were measurable from the centrally 
placed artery, the central retinal artery.
Those cases of AION examined in this study produced 
interesting results. Of the four patients examined 
within 24 hours of occlusion, three with arteritic 
AION showed loss of the indices of flow in the 
posterior ciliary arteries. The remaining patient with 
a non-arteritic AION showed detectable peripapillary 
blood flow. Hayreh has argued for the occurrence of a 
temporary occlusion in the non-arteritic form of AION 
which may explain why normal flow was detected in this 
individual Alternatively, there may have been
only partial occlusion of the posterior ciliary 
circulation.
In one patient with giant cell arteritis loss of flow 
in the whole orbit was seen at a later stage in the 
disease process and demonstrates the more extensive 
nature of the arteritic process. This was associated, 
in this case, with a deterioration in the course of the 
disease despite what was deemed to have been appropri-
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ate therapy. This more global reduction in orbital 
blood velocity in the arteritic form of the disease may 
provide a useful discriminator from the non-arteritic 
type of AION. It may also explain why there is reduced 
ocular blood flow seen with ocular pneumo-plethysmogra­
phy in the arteritic form of AION but not the non- 
arteritic form Whether colour Doppler ultrasound
will be of use in the investigation of cranial 
arteritis needs further study. Although it has been 
applied to the examination of the temporal arteries to 
detect retrograde flow before biopsy 289^ it has not to 
our knowledge been used to aid diagnosis.
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6 Chapter 6
AN UNDERSTANDING OF THE RETINAL CIRCULATION PROVIDED BY 
AN ANOMALOUS RETINAL VEIN
6.1 Summary
The velocities obtained from the central retinal vein 
demonstrated an unusual pulsatile waveform which may 
have occurred from the close approximation of the vein 
to the central retinal artery in the nerve or from 
intraocular pressure variations in the eye. A patient 
was examined by CDI in whom one hemiretinal vein passed 
outwith the nerve and the other within the nerve. Only
in the latter was a pulsatile waveform observed 
suggesting that the location of the vein within the 
nerve is required for the production of pulsatile flow 
in the vein.
6.2 Introduction
In the study of the control population the blood 
velocities in the central retinal vein in the optic 
nerve have been found to have an unusual pulsatile 
pattern of flow which is in synchrony with the arterial 
pulse (figure 3.4) and which is not seen in other 
veins. This pattern of blood flow may occur because 
the intraocular venules are compressed by the 
fluctuations in pressure within the eye which occur 
with the systemic pulse. Alternatively, the reason may
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be the close approximation of the vein to the central 
retinal artery in the distal optic nerve where both 
vessels are enclosed within a common adventitial 
sheath. A colour Doppler examination from a patient 
with an unusual retinal venous anatomy facilitated the 
identification of the source of the pulsatile 
velocities in the vein.
6.3 Case Report
A 61 year old man was noticed on fundoscopy to have a 
superior hemiretinal vein which directly entered the 
choroid adjacent to the upper edge of the optic disc 
(figure 6.1). The inferior hemiretinal vein followed 
the usual path and entered into the central optic disc 
with the artery.
Colour Doppler imaging was used to detect the blood 
velocity signals from the continuation of the inferior 
hemiretinal vein within the optic nerve adjacent to the 
central retinal artery. Spectral analysis of these 
signals provided a pulsatile velocity waveform which 
was in synchrony with the pulsations in the central 
retinal artery and which was similar to the waveforms 
from the central retinal vein of normal controls with a 
maximum velocity of 8 cm/sec and a minimum velocity of 
5 cm/sec. The Doppler signal attributable to the 
superior hemiretinal vein was detected in the
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Figure 6.1. The retinal venous pattern is shown with the superior 
hemiretinal vein appearing to enter into the choroid adjacent to the optic nerve (arrow). The inferior hemiretinal vein enters into the central optic disc with the arteries.
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Figure 6.2. The colour Doppler image of the right orbit showing the superior hemiretinal vein (extraneural) and the spectral 
analysis of the blood velocities in this vessel which demon­strates a nonpulsatile waveform.
perineural area at the level of lamina cribrosa and 
continued down the side of the optic nerve to join the 
inferior hemiretinal vein as it exited the nerve 
approximately 10mm posterior to the globe (figure 6.2). 
The waveform in this vessel exhibited a constant peak 
velocity of 7 cm/sec and did not manifest the normal 
central retinal venous pulsatile waveform.
6.4 Discussion.
This case demonstrates that an extraneural retinal vein 
has a constant flow rate, whilst an intraneural retinal 
vein exhibits a pulsatile flow rate in phase with the 
cardiac cycle. If the fluctuations in the intraocular 
pressure were responsible for the pulsations in the 
vein both the intraneural vein and the extraneural vein 
would have been expected to possess pulsatile flow. 
Since only the intraneural vein had pulsatile flow this 
must have been induced by the anatomical location of 
the vein within the nerve. The central retinal artery 
and vein in the optic nerve share a space within a 
common adventitial sheath . This sheath which has a 
relatively broad diameter and is collagenous, is 
relatively indistensible. The dilation of the artery 
within this confined space during systole must result 
in compression of the vein. We speculate that this may 
have the effect of "pumping" blood into the distensible 
distal vein as it leaves the optic nerve thereby 
resulting in the pulsatile blood flow rate which has
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been observed.
7 Chapter 7
THE RELATIONSHIP BETWEEN BLOOD VISCOSITY AND OCULAR 
BLOOD FLOW.
7.1 Summary
In a cohort of volunteers who underwent CDI examination 
of their orbital vessels various systemic measures of 
blood viscosity were obtained. The results demonstrat­
ed that there were correlations between the viscosities 
and the measures of peripheral resistance in the blood 
vessels as estimated by resistive index calculations.
It would appear that in the normal population increased 
viscosity is compensated for by a reduction of 
peripheral resistance perhaps by peripheral vasodila­
tion.
7.2 Introduction.
The Hagen Poisueille law indicates that the flow of a 
fluid in a tube is reduced when the viscosity of the 
fluid increases. It is likely therefore that ocular 
blood flow will be affected if the blood viscosity is 
altered 2 05_ Indeed in an experimental model using the 
pig, retinal blood flow was found to reduce as the 
blood viscosity increased ^ .
Blood viscosity is particularly important in the venous
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system where slower blood flow causes a relative in­
crease in viscosity resulting in a susceptibility to 
stasis 168,169,203^ This in turn may result in 
thrombus formation further reducing the blood flow. 
Indeed blood viscosity has been implicated in the
pathogenesis of retinal venous occlusion of the eye 
60,173 _
Viscosity is calculated from the shear stress (force 
being applied to a fluid) and the velocity of the 
fluid.
Shear Stress Viscosity - ------------------------------v2 - vl (Velocity Difference)
Blood plasma demonstrates Newtonian properties of 
viscosity in that the blood velocity is directly 
proportional to the shear stress applied. Plasma 
viscosity is measured using a capillary viscometer 
which measures only at one shear stress. Whole blood 
shows non-Newtonian characteristics, ie., the viscosity 
increases at low shear stresses. Cylindrical or 
conical viscometers are often used which allow 
measurement of whole blood viscosity at different shear 
stresses but if such measurement is to be taken at only 
one shear stress a capillary viscometer can be used. 
Whole blood shows an additional increase in viscosity 
at very low shear stresses. This change in viscosity 
is described as "pseudoplastic" because plastics have 
the property of becoming solid at low shear stresses. 
Plasma viscosity is increased by elevated plasma
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protein levels, globulins having the greatest effect, 
followed by albumin and then fibrinogen 203^ and whole 
blood viscosity rises with elevated haematocrit, 
fibrinogen, plasma viscosity, erythrocyte aggregation 
or by reduced erythrocyte deformability. In turn, 
erythrocyte aggregation increases with elevated plasma 
levels of IgM, IgA and alpha 2 macroglobulin. 
Abnormalities of rheology have previously been detected 
in a variety retinal vascular and ocular disorders 
(table 7.1). In this study the relationship between 
systemic viscosity and orbital blood velocities from 
Doppler imaging in normal individuals was investigated.
7.3 METHOD
Twenty four of the volunteers from the control 
population examined in the colour Doppler experiments 
had blood rheology examined on the same day as their 
colour Doppler imaging. Venous blood was sampled from 
an antecubital vein with a 21 gauge butterfly needle 
after minimal use of a tourniquet. Blood was 
anticoagulated with dipotassium edetate (K2 EDTA, 
1.5mg/ml) for viscosity examination which was performed 
within four hours of sampling. Whole blood viscosity 
and plasma viscosity were measured at high shear rates 
(more than 3 00/sec) in a capillary viscometer (Coulter- 
Harkness) at 37 degrees C. Haematocrit (Hawksley
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7.1. Ocular Disorders and Rheology.
Retinal Vein Occlusion.
See table 11.1.
Diabetic Retinopathy.
Blood v i s c o s i t y  has b e e n  found to be h i g h e r  in p a t i e n t s  w i t h  
diabetic retinopathy compared with controls i ' and m a ybe due to increased erythrocyte aggregation 244,274 reduced 
erythrocyte d e f o r m a b i l i t y  or reduced leucocyte filterabili- 
ty 288^ Increased s e v erity of retinopathy has been associ a t e d
nopa t h y  d e m o n s t r a t e s  i n c r e a s e d  v i s c o s i t y  d u r i n g  h y p o x i a  in a similar manner to sickle cell disease 226^
Sickle cell retinopathy.No differences in viscosity or erythrocyte filterability between 
p a tients wi t h  s ickle c a l l - h a e m o g i o b i n  C and h o m o z y g o u s  s i c k l e  
^ l ^ l ^ ^ ^ i s e a s e  w i t h  a n d  w i t h o u t  p r o l i f e r a t i v e  r e t i n o p a t h y
V a s c ulitis.Plasma viscosity measurements provide an alternative to erythro- 
^■^te s e d i m e n t a t i o n  rate in the diagnosis of c r a n i a l  a r t e r i t i s
Immunosuppressive therapy (including plasmapheresis in one p a ­
tient) reduced the plasma viscosity and r e t inopathy in two p a ­tients with retinal vasculitis 22 _
Central retinal artery occlusion ,
Six patients had increased plasma viscosity, fibrinogen, erythro­
cyte aggregation and reduced erythrocyte d e f o r mability c o m pared  
to normal values
Malignant hypertension.
No difference in rheological variables in malignant hypertension 
compared with nonmalignant hypertensives were found. Inhibitors 
of pl a s m i n ,  fast a n t i p l a s m i n  and a l p h a 2 m a c r o g l o b u l i n ,  w e r e  
increased suggesting reduced fibrinolytic activity ^1^.
AIDS.High fibrinogen levels are detected in patients with cotton wool 
spots 21, A p a t i e n t  w i t h  vas c u l i t i s  re s p o n d s  to therapy, see
above 32
Bales Disease.
A retrospective study determines that plasma viscosity, erythro­
cyte r i g i d i t y  a n d  e r y t h r o c y t e  a g g r e g a t i o n  are s i g n i f i c a n t l y  
increased in the acute stage of the disease and reduces as d i s ­
ease activity reduces ,
Glaucoma
Increased whole blood and plasma viscosity was d e t ected in one controlled study of patients with low tension glaucoma ^^2 
not in another study Patients with primary open angle glau­
coma but not those with ocular hypertension were found to have 
raised mean blood viscosity compared to controls .
Age related macular degeneration.No difference in rh e o l o g y  was observed in 35 patients w i t h  age 
related macular degeneration compared with 35 controls  ^ .
microhaematocrit, 13000 g for 5 minutes) and red cell 
aggregation (photometric aggregometer, Myrenne GmbH, 
Roetgen, Germany) were also recorded and haematocrit 
corrected and relative blood viscosity calculated :
CBV = PV X ( EXP (log WBV/PV x 45/HCT) )
RBV = CBV/PV
CBV = Haematocrit Corrected Blood Viscosity
RBV = Relative Blood Viscosity
PV = Plasma Viscosity
WBV = Whole Blood Viscosity
HCT = Haematocrit
The haematocrit has a profound effect upon the 
measurement of whole blood viscosity. Therefore 
haematocrit corrected blood viscosity was calculated to 
provide a measure of the blood viscosity from 
factors other than haematocrit. In turn the relative 
blood viscosity was used to determine the relative 
contribution of plasma viscosity and cellular 
deformability or aggregation on the viscosity.
7.4 RESULTS
Table 7.2 shows the mean viscosity values for the 
volunteers. Multivariate linear regression analysis
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Table 7.2 mean SD
Whole Blood Viscosity 3.4 0.7
(mPas)
Plasma Viscosity 1.3 0.1(mPas)
Haematocrit 43.3 4.3
(%)
Red Cell Aggregation 4.8 0.9
Corrected Blood Viscosity 3.4 0.5(mPas)
Relative Blood Viscosity 2.6 0.3
Table 7.2. The results of the examination of the 
various viscosity parameters in the comparison with the 
blood velocities in the orbital vessels.
was employed with the variable "age" of the patient 
because this had been found to affect the Doppler 
velocities (see section 3.4.4). Systolic blood 
pressure was also included when analysing the 
ophthalmic artery velocities. Whole blood viscosity 
and haematocrit were negatively correlated witK. 
resistive index in the ophthalmic artery (both b=-0.55, 
figure 7.1 and 7.2). Haematocrit corrected and 
relative blood viscosities were significantly 
negatively correlated with the venous pulsatility index 
in the vein (b=-0.43 and b= -0.34 respectively, figure 
7.3 and 7.4). No correlations were found between the 
viscosities and the velocity measurements from the 
central retinal arteries.
7.5 DISCUSSION
In this study, haematocrit corrected and relative blood 
viscosity were negatively correlated with the venous 
pulsatility index in the central retinal vein. Using 
the venous pulsatility index as a measure of pulsatili­
ty, increased relative blood viscosity (indicating 
reduced cellular deformability or increased red cell 
aggregation) appears to reduce the pulsations in the 
vein. Whether this effect on pulsatility of the flow 
in the vein is detrimental to the flow of blood in the 
central retinal vein and thus increases the risk of
91
i\i Lci y  ivi
and Whole Blood Viscosity
(D
• fm4CQ
<DP:^
1.5 2.5 3 3.5 4 4.5
Viscosity (mPas)
5 5.5
Figure 7.1. The resistive index in the ophthalmic artery n e g a ­
tively correlates w i t h  w h ole blood v i scosity (linear regression 
lines are shown with 95% confidence l i m i t s ) .
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Figure 7.2. The resis t i v e  index in the o phthalmic artery n e g a ­
tively correlated w i t h  the haematocrit (linear regression lines 
are shown with 95% confidence l i m i t s ) .
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Figure 7.3. The venous pulsatility index in the central retinal 
v e i n  n e g a t i v e l y  c o r r e l a t e d  w i t h  h a e m a t o c r i t  c o r r e c t e d  b l o o d  
viscosity (linear regression lines are shown with 95% confidence 
l i m i t s ) .
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Figure 7.4. The venous pulsatility index in the central retinal 
vein negatively correlated with elevated relative blood viscosity 
(linear regression lines are shown with 95% confidence limits).
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stasis or occlusion remains to be seen.
In this study, the viscosity results did not influence 
the values for blood velocity in the orbital arteries 
perhaps because of compensation for elevated viscosity 
by vasodilation but the resistive index from the 
ophthalmic artery demonstrated a negative correlation 
with the haematocrit and whole blood viscosity. The 
resistive index can be reduced by both increased 
resistance to flow upstream of the measurement site and 
also by decreased resistance to flow downstream. Since 
haematocrit is the most important determinant of blood 
viscosity in arteries of greater diameter than 3 00 
microns (the ophthalmic artery has a diameter of 
approximately 3 00 microns) but becomes relatively 
unimportant in smaller arteries and arterioles, the 
changes in the values may have arisen from increased 
resistance to flow in the carotid circulation. An 
alternative interpretation is that the blood viscosity 
has induced peripheral vasodilation thereby reducing 
peripheral resistance to flow and maintaining the blood 
velocities.
These findings indicate that there is a relationship 
between ocular blood flow and viscosity. Studies of 
this relationship in patients with central retinal vein 
occlusion are described in chapter 11.
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8 Chapter 8
INTRODUCTION TO CENTRAL RETINAL VEIN OCCLUSION
8.1 Summary
A critical review is provided of the literature on the 
subject of central retinal vein occlusion (CRVO). The 
results of pertinent investigations are discussed to 
allow an appreciation of the aims of the studies of 
blood velocity and viscosity in future chapters.
8.2 Introduction.
Central retinal vein occlusion is a common vascular 
disorder of the eye which results in a rapid onset of 
loss of vision and ultimately may lead to a blind, 
painful eye. The condition is characterised by 
dilation of the retinal veins and widespread retinal 
haemorrhages with, in many instances, a swollen optic 
disc (figures 8.1 and 8.2, table 8.1). The vitreous is 
more often detached in the ischaemic form of the 
disease and the incidence of vitreomacular attachment 
is said to be higher in those patients who develop 
cystoid macular oedema ^25^
Since the first description in 187 0, there has been 
much debate concerning the pathogenesis (table 8.2)
. Even today there is still uncertainty whether the 
disorder is primarily due to occlusion of the central 
retinal vein or occlusion of the central retinal ar-
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Figure 8.1. A fundus photograph of the retinal appearance of a nonischaemic CRVO.
Figure 8.2. A fundus photograph of the retinal appearance of an ischaemic CRVO.
Table 8.1 Clinical Features.
Moore, 1924; Braendstrup, 1950 21,200^
Most common in the 7th decade.
Males equal females.
Left eyes more than right.
Sudden loss of vision, occasionally gradual onset.
Dim or misty vision described.
Most present in within 3 months of onset.
Visual acuity can be moderately or markedly reduced, usually becoming progressively worse.
Intraocular pressure is lower in the affected eye.
Ophthalmoscopic Features 
Retinal oedema 
Dilated and tortuous veins.
Profuse retinal haemorrhages (superficial and deep)
Microaneurysms
Cotton wool spots
Disc hyperaemia and swelling
Late Features
Disappearance of retinal haemorrhages and cotton wool 
spots.
Macular degenerative changes
Neovascularisation of the disc, retina or iris.
i
Table 8.2
Historical Review of Central Retinal Vein Occlusion.
Liebreich, 1855 D e s c r i b e s  the c l i n i c a l  a p p e a r a n c e  of C R V O  as 
retinal apoplexy
Leber, 1377 Describes CRVO as haemorrhagic retinitis
Michel, 1878) T he first p u b l i s h e d  r e p o r t  of t he p a t h o l o g i c a l  
findings in CRVO. 2 cases were described one with proliferation 
of the intima and the other ascribed to thrombus formation in the 
vein
Coats, 1904 Describes 4 cases pathologically, 3 thought to be 
due to thrombi and one to endothelial proliferation. He believed 
on review of the cases described so far that angiosclerosis was a 
significant association with CRVO (and noted an association with 
mitral stenosis). Plates show a c r e s c e n t i c  s h a p e d  vein. The eyes were rubeotic ^
Harms, 1905; Leber, 1915; Klien, 1944 Believe that stagnation of 
the central retinal artery blood flow causes secondarv thrombosis and obstruction of the central retinal vein 95, 134 , 156 _
Verhoeff, 1906 Revi e w s  39 cases p r e v i o u s l y  d e s c r i b e d  in the 
literature, concluding that only 2 have pathological evidence of 
thrombosis and that these cases may have r e s ulted from sepsis. 
He c o n s i d e r s  the b l o c k a g e  to be due to i n t i m a i  t h i c k e n i n g  and 
degeneration wi t h  a resultant formation of a "collateral" vein 
^^^ough the v e i n  w a l l  in the fashion of a d i s s e c t i n g  a n e u r y s m
Coats, 1913 D i s c u s s i o n  on retinal v a s c u l a r  d i s e a s e  o u t l i n i n g  
similar topics of argument which exist today, eg., the roles of 
thrombosis w i t h i n  the vein and h y p o p e r f u s i o n  of the a r t e r i a l 
circulation, life expectancy after CRVO, the role of inflammation 
or systemic diseases
Verhoeff, 1913 Describes the change of endothelial cell prolif­
eration and "dissecting aneurysm" of the vein in eyes with open 
angle glaucoma, therefore, c o n c l u d i n g  that t h ese effects are 
solely due to raised iop and not a result or cause of CRVO 236_
Moore, 1922 Measures iop in CRVO and notes that the affected eye has a reduced iop in comparison to the fellow eye ^99^
Moore, 1924 Describes the typical features of the condition in a 
series of 6 2 patients. Describes young patients with influenza and C R V O
Verhoeff, 1907 Suggest that collateral circulations are important 
in the p r o t ection of the retina from damage in CRVO, opto-
ciliary veins, cilioretinal veins, choriovaginal veins
Harms, 1905; Moore, 1924; Klien, 1944; Cradle, 1937 Believe that 
conge'^^t^^ Y^^c^^^r anomalies play a role in the pathogenesis of
Cradle, 1937 Suggests that the vein leaves the nerve too early. 
Uses X r a y  t h e r a p y  in 9 p a t i e n t s  w i t h  no eff e c t  on the r e t i n a l  appearance of CRVO
Klien, 1944 Examines pathologically 21 cases of CRVO removed for 
glaucoma and shows that in patients with systemic disease most 
endothelial cell p r o l i f e r a t i o n  occurred in the anterior or pre- 
laminar portion of the vein secondary to a mechanical retrolami- 
nar narrowing, whereas in the elderly and those without systemic 
^^|ease proliferation occurred primarily in the posterior lamina
V e r h o e f f  1940 A case of t u b e r c l e  of th^e c e n t r a l  reti n a l  ve i n  
associated with haemorrhagic retinopathy 287^
Braendstrup, 1950 Large series describing the clinical features 
of t h e .d i s o r d e r , Cases of CRVO in infections of the paranasal 
sinuses, cavernous sinus thrombosis, facial ervsipelis, opht h a l ­
mic herpes zoster, polycythaemia and leukaemia .
Bruker, 1945 Cases of CRVO secondary to direct trauma
Mancall, 1951 A review of the pathological literature wi t h  the 
c o n t e n t i o n  t h a t  in e l d e r l y  p a t i e n t s  the o c c l u s i o n  is d u e  to 
endothelial cell proliferation and in those with systemic inflam­
matory or infective disease it is due to thrombophlebitis
Larsson, 1950 The first description of a series of patients with 
CRVO treated with anticoagulation. An u n c o n t r o l l e d  study of 59 
cases treated w i t h  dicoumarin and heparin showing results s u g ­gesting that such treatment is ineffective 154^
Vannas 19 6 5 A review of the literature and description of a large 
s eries of p a t i e n t s  w i t h  C R V O  t r e a t e d  by  a n t i c o a g u l a t i o n .  A 
nonrandomised controlled study of 17 9 patients using heparin and 
p r o t h r o m b i n  d e p r e s s a n t s .  Mo s t  series h a v e  s h o w n  no d e f i n i t e  benefit 282^
Dobree, 1957 Detects CRVO in 4.5% of 200 eyes w i t h  primary open 
angle g l aucoma and in 4% of 150 eyes with arteriosclerosis. A 
difference was noted from the results of branch v e i n  o c clusion 
which was found.in 1% of glaucoma patients and 7,3% of patients 
with arteriosclerosis 29.
Vannas 1960 Per f o r m s  a t o n o g r a p h i c  stu d y  of the i n c i d e n c e  of 
primary open angle glaucoma in CRVO finding the condition in 42% of patients 283.
Baton. 1964 Describes the fluorescein angiographic apoearance of CRVO 208,
Henkes, 1953 T he first large series on e l e c t r o r e t i n o g r a p h y  in 
CRVO with 5 3 cases in which the statement is made that ERG should 
^g^used to differentiate "partial" and "complete" vein occlusion
G r een 1981 A p a t h o l o g i c a l  study of 39 eyes, 4 atypical cases 
e x a m i n e d  in the acu t e  stage w i t h o u t  the p r e s e n c e  of r u b e o s i s  
i ridis. He claims to detect thrombosis in the vein or endotheli­al proliferation
Kohner 1974 In a controlled study, uses streptokinase in patients 
with CRVO but although a beneficial effect is detected for the 
recovery of vision, in three patients vitreous haemorrhage ensues 
a few days a f t e r  treatment. The c o n c l u s i o n  is dra w n  that the agent should not be used 12'.
Laatikainen 1977 A c ontrolled study of panretinal p h o t o c o a g u l a ­
ti o n  s h ows a b e n e f i c i a l  e f f e c t  in r e d u c i n g  the f r e q u e n c y  of rubeosis iridis but does not increase visual recovery l^l.
Ring 1976 ; Trope 1983. In controlled studies detect raised whole 
blood v i s c o s i t y  in acut= and chronic CRVO with ischaemic cases particularly affected 227,278_
Hayreh 1973 In experiments on monkeys, he attempts to produce the 
picture of CRVO by  o c c l u d i n g  the central retinal artery and or 
vein. He states that the closest reti^nal appearance is produced by temporary occlusion of the artery 108^
Fujino 196 9 Produces the retinal appearance of CRVO by injecting 
ggoprene into the central retinal vein at the optic nerve head
tery. Study of these circulations is therefore required 
to determine their contribution to the pathogenesis of 
CRVO.
8.3 EPIDEMIOLOGY
CRVO is the commonest vascular disorder to affect the 
retina after diabetic retinopathy, occurring bilateral­
ly in 6-16% 50,215,222,239 ^ Some investigators have 
claimed an increased incidence in males whilst
others have found no difference for the sexes 
Although predominantly a condition which affects the 
middle aged and elderly (9 0% of patients are aged more 
than 50 years old , younger patients with CRVO have 
been described '^ l ? 59 , 65, 222 , 291 j^ ore often males than 
females . Racial differences have been alluded to by 
Dodson and Kritzinger (1985) who have observed a low 
incidence of CRVO in Asians and West Indians In
their study of 221 patients with CRVO only 14 were from 
these races despite 14% of the population in the 
geographical area belonging to these groups. Similarly 
in patients under the age of 50 years old a low 
incidence of races other than Caucasian was detected in 
a study of a highly selective cohort of patients .
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8.4 CLASSIFICATION
Classification aids the efficient clinical management 
of CRVO by allowing a planned treatment and follow up 
strategy, however there is disagreement concerning the 
terminology that should be used. Hayreh has coined the 
phrases "Venous Stasis Retinopathy" for the milder
type of the disease and "Haemorrhagic Retinopathy" for 
the more severely affected eyes. The terms "ischaemic" 
and "non-ischaemic" CRVO have similarly been employed 
and "indeterminate" has been used for those cases 
which do not fit easily into the previous categories 
Finally Gass (1987) has described "impending, 
mild, moderate and severe" CRVO Walsh et al
(1977) further classified a mixed group of retinal 
vein occlusions into primary retinal vein occlusion 
when there was no systemic disease and secondary 
retinal vein occlusion in which systemic disease was 
present 290^
In most circumstances "venous stasis retinopathy" is 
synonymous with "non-ischaemic" CRVO and "haemorrhagic 
retinopathy" is synonymous with "ischaemic" CRVO. In 
the studies described the terms "non-ischaemic" and 
"ischaemic" CRVO are employed as it is believed that 
these are less misleading than Hayreh's nomenclature. 
"Venous stasis retinopathy" may be confused with the 
stasis retinopathy from carotid artery disease for 
which the same name has been used and "Haemorrhagic
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retinopathy" leads the clinician to believe that 
extensive retinal haemorrhages must be present but this 
is not always so.
Classification is primarily performed by examining 
fundus fluorescein angiograms for the presence of 
retinal capillary non perfusion. When present a case 
is deemed to be ischaemic with between 22% and 3 6%
222 Qg cases being so classified. Cases of CRVO 
examined in the acute phase may be mistakenly 
classified as non-ischaemic because capillary 
nonperfusion may not be fully developed until three 
months after onset of occlusion 146,177,254^ This 
explains some of the high "conversion" rates (9-20%) 
from non-ischaemic to ischaemic CRVO that have been 
reported in some studies 100,196,222,307^
8.5AETI0L0GY
The condition is associated with common systemic 
vascular disorders such as hypertension and diabetes 
(tables 8.3 and 8.4). Abnormal glucose tolerance 
tests, increased plasma levels of gammaglobulins, 
triglyceride and cholesterol may be found 3,47,238^
CRVO shares many aetiological factors with arterio­
sclerotic disease and, indeed, systemic ischaemic 
disease is found frequently in these patients 3,50,142^ 
However, dissimilarities with arterio-sclerosis exist.
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Table 8,3
Prevalence of Systemic Abnormalities in CRVO. 
Hypertension. 38-61% of patients 3,37,138,189
Diabetes. 13-15% 3,138^
Abnormal glucose tolerance test.
34% of 79 patients with retinal vein occlusion, 
64 with CRVO and 17.5% in another study of4 0 patients with CRVO
Increased plasma gammaglobulin.28%, increased IgA levels in 17% 1®^.
Cryofibrinogenemia, 12% 139^
Increased plasma lipids (hypercholesterolemia or hypertriglyceridemia) 32-57% 40,138,189_
Arteriosclerosis. 21% of 56 patients
Increased mean plasma C reactive protein.
A group of 3 7 hypertensive patients with cen­
tral retinal vein occlusion compared to 
49 normotensive patients with CRVO.
Increased Plasma antiphospholipid antibodies.
Particularly lupus anticoagulant, elevated in
isolated cases^of central retinal vein occlu- Sion 133,219,295_
Table 8.4
SYSTEMIC RISK FACTORS (%)
n Diabetes High Blood High ESR Arterio-
Mellitus Pressure Cholesterol Sclerosis
Dodson 1982
40 15 37.4 22.5
Kohner 1983 not all tests were performed on allpatients.
191 18.2 43.9 30.4 45.5
Appiah 1989^
117 13.7 47 7.8 23 22
Cole 1989
47 - 61.7 28.8
Elman 1990
160 13.1 45 - - 58
Kotval 1990
87 28.0 67 11
Table 8.4 The percentage of patients with CRVO in whom 
various systemic disorders have been found.
’ip
eg., a significant correlation with cigarette smoking 
has yet to be found. Ellis et al (1964) found that 51%
of vein occlusion patients smoked as compared with 40% piII
of controls, a result which was not found to be
Ûsignificantly different . The number of patients in 
this study (56 patients with CRVO) may have been too 
small to show significance for this difference but it 
is of interest that all 28 patients in the same study 
with central retinal artery occlusion were smokers.
An increase in mortality is expected in patients 
suffering arterial occlusion but this has not been 
reliably found in CRVO 4*7,48,50, 18 3^  Furthermore it is
?'luncertain whether an increase in cardio-vascular or
0cerebro- vascular mishaps affects these patients.
Priluck et al (1980) studied the long term follow-up of j|
42 young patients under 40 years old with vein 
occlusion and showed a 12% mortality at a mean 15 years 
follow up but provided no comparison with a matched 
population sample 218^
If a comparison is made with arterial occlusion of the
ocular vasculature then differences in aetiology are
again found. Central retinal artery occlusion is
associated with an increased incidence of carotid
artery disease but no such an association has been
found for CRVO 312^ Reduced mean optic disc area, a
risk factor for occlusion of the posterior ciliary
arteries, has also not been found in eyes with CRVO 
30,182,263
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A number of investigators have argued for an inflamma­
tory aetiology for the disease. In one study, evidence 
of inflammation was found in 48% of 29 postmortem eyes, 
either in the thrombus, the venular wall or the 
perivenular area CRVO may complicate systemic and
ocular inflammatory diseases (table 8.5) and raised 
plasma C reactive protein may indicate an inflammatory 
aetiology ,
Primary open angle glaucoma or ocular hypertension has 
been detected in 4% to 43% of patients with CRVO 
3,37,224,260,283^ Furthermore, tonography has revealed 
a reduced aqueous outflow facility in 42% of 71 
patients in one study of patients with CRVO 383^ 
Hitchings and Spaeth (1976) looked for evidence of 
previous CRVO or hemiretinal vein occlusion (HRVO), 
ie., the presence of disc collateral vessels or 
arteriovenous shunts in patients attending a glaucoma
service, and detected an prevalence of 4% 114 CRVO
causes an initial drop in intraocular pressure which 
recovers within a few weeks 106,283 even so an
increased mean intraocular pressure was found by Frucht 
(1985) in 24 patients compared to controls .
One study has suggested that the presence of open angle 
glaucoma signifies a poorer outcome from CRVO for the 
development of iris neovascularisation and visual 
recovery 38 3^  However, the group of patients with 
glaucoma in this study were older than the other pa-
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Table 8.5Case Associations with Inflammatory Disease
Î
5 
5f.
Moyamoya disease 355. |
Systemic lupus erythematosis ^53 
Tuberculosis
32
Optic neuritis 
Aids, 3 patients ^9,271
I
Acute multifocal placoid pigment epitheliopathy
I
É
,Table 8.5. The diseases involving the immune system ||
which have been associated with CRVO.
.
M
I
æ
tients which may have affected their prognosis. Dryden
(19 65) in an examination of postmortem eyes with CRVO
found histological evidence of open angle glaucoma in
32% of his 31 cases . Unfortunately, he does not
give the reason for enucleation nor what the criteria
for histopathological diagnosis of CRVO were. Large
rises in intraocular pressure with changes in posture
in patients with CRVO 131,298 reflect the increased
incidence of open angle glaucoma which itself causes an
increase in postural intraocular pressure variations 
276.
The high incidence of raised intraocular pressure has 
led to the belief amongst some investigators that CRVO 
possesses a different aetiology to branch retinal vein 
occlusion in which only 6% to 13% of patients have 
raised intraocular pressure 3,49,64. addition,
hypermetropia and high blood pressure are commoner in 
cases of branch retinal vein occlusion whereas raised 
erythrocyte sedimentation rate is commoner in CRVO ^. 
The role of intraocular pressure in the aetiology of 
central retinal vein occlusion has recently been 
questioned because a similar incidence of
underlying medical conditions has been reported in 
patients with and without raised intraocular pressure 
. In the same study recurrent CRVO was as common 
whether intraocular pressure was raised or not. 
Aetiological factors have also been investigated in 
young patients with CRVO (table 8.6) . Walters and
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Table 8.6 Young Patients.
Quinlan 1990 Retrospective study of 24 patients less than 50 years of age 322.
42% Hypertension
13% Collagen vascular disorders
Dodson 1985 40 patients less than 50 years35% Hyperlipidemia
60% Medical conditions check
Fong 1991 Selective cohort of 103 patients with CRVO 
under the age of 50 years (details of these patients were primarily obtained by mailing questionnaires to retinal specialists)
25% Hypertension
6.8% Primary open angle glaucoma 
6% Hyperlipidemia 6% Heart disease.
Walters 1990 Retrospective study of 17 patients under 
40 years of age (but with a large portion of missing data)291.
No evidence of an inflammatory 
aetiology was detected.
Table 8.6 The findings of studies examining CRVO in 
younger patients.
.
:K-
a group of 7 young patients less than 3 6 years old and
8.6 PATHOGENESIS
It is postulated that raised intraocular pressure 
causes external compression of the central retinal vein 
as it passes through the lamina cribrosa resulting in 
turbulent blood flow distal to the constriction and 
subsequent thrombus formation. The thrombus has been 
difficult to detect histologically, partly because 
pathological studies have been performed on cases of 
rubeotic glaucoma in which the veins are often 
recanalised 1^5. Klein found damaged endothelium and 
proliferation of endothelial cells in enucleated eyes
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Spalton (1990) , in a retrospective study of 40 patients I-:#,
ÿless than 4 0 years of age, reported good general health 
and also a good visual prognosis 391. Most of their 
patients suffered from non-ischaemic CRVO. Another 
group of 7 patients aged less than 45 years with 
ischaemic CRVO frequently had systemic diseases and a 
poor visual outcome . Platelet coagulant hyperactiv-
■
ity, associated with mitral valve prolapse has been f;
found in 4 out of 15 young patients Chew looked at 1
:found that there were diurnal variations in intraocular
:pressure of 8.8 mmHg in the affected eye with CRVO and 
9.3 mmHg in the fellow eye compared to a diurnal 
fluctuation of 3.7 mmHg in normal controls . I
    .  _ .....
.fi:
rubeotic eyes . This small group of 4 patients was 
examined within 24 hours of occlusion and found to 
have thrombus in the vein close to the lamina cribrosa.
cases of CRVO: one patient aged eight months had Reye's 
syndrome, one patient had massive intracranial
of such patients, sometimes with the presence of 
intramural thrombus ^3 5. was not until Green et al
(1991) examined 29 affected eyes and found that thrombi 
were found in the venous lumen of a few cases of non-
None of these cases can be described however as typical
J
haemorrhage and papilloedema, another had acute 
myelogenous leukaemia and the remaining patient had
died of myocardial infarction with no clinical evidence 
of CRVO. The rubeotic cases in the same study showed 
recanalised thrombus or vascular endothelial prolifera­
tion. Thrombus was situated at the lamina cribrosa
,with extension posteriorly in 24 eyes and anteriorly in 
5 eyes. Multiple small venous channels were often 
present in those with a short duration from onset of 
the occlusion whereas those of long duration showed the 
presence of a single venous channel.
Hayreh et al (1978) amongst others have argued that 
central retinal artery occlusion is an essential 
component in the pathogenesis of CRVO believing that 
the haemorrhagic form of CRVO is probably due to a 
combination of arterial and venous occlusion. Evidence 
for the hypothesis is provided by experimental studies 
on monkeys in which occlusion of the central retinal
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vein and temporary occlusion of the central retinal 
artery at their emergence from the optic nerve produced 
a clinical appearance in the retina with some similar! 
ties to CRVO whereas occlusion of the central retinal 
vein alone at this site did not, (table 8.7) *^^ 3. This 
experimental model, however, produced features which 
are not usually seen in CRVO in humans (eg., internal 
limiting membrane detachment and rapid resolution of 
retinal changes). In addition, neovascularisation 
which is a primary complication of CRVO was not 
produced.
Such experimental blockage of the central retinal vein 
distal to the optic nerve head does not take into 
account collateral venous channels around the optic 
nerve and may explain why there has been failure of 
production of CRVO by blockage at this site. Fujino 
(1969) using the owl monkey injected neoprene into the 
vein to produce occlusion at the optic nerve head 
In this experiment he was able to produce a haemorrhag­
ic retinopathy with evidence of back pressure on the 
arterial circulation. In comparison a group of monkeys 
with occlusion of the central retinal vein at the 
emergence from the optic nerve in the orbit produced 
only a temporary and reversible increase in retinal 
venous congestion.
Experimental models can be criticised particularly, 
because the animal models used are always younger
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Table 8.7
EXPERIMENTAL CRVO Hayreh 1978
Central Retinal 
Vessel Occluded
Retinal Features
Vein
Vein and Artery (Permanent)
Ilm detachment, dilated engorged 
veins, mild retinal haemorrhaging, 
optic disc leakage.
Ilm detachment, mild retinal 
haemorrhaging, optic disc leakage, 
capillary closure.
Vein and Artery Ilm detachment, dilated engorged (Moderate Duration) veins, mild retinal haemorrhag­
ing.
Vein and Artery Ilm detachment, dilated engorged (Short Duration) veins, marked retinalhaemorrhaging, optic disc leakage, 
capillary closure.
■li
I
Fujino 1969
Vein at Optic Nerve Head Mild retinal haemorrhaging, sometimes venous distension, 
normal arterial filling on 
fluorescein angiography.
Vein at Emergencefrom Optic Nerve Marked retinal haemorrhaging,
engorged veins, delayed arterial 
filling, histologically capillary 
necrosis.
Table 8.7. The observations from experimental studies 
of central retinal vessel occlusion in monkeys.
(relatively) than the usual age of human patients with 
CRVO and therefore their vasculatures are dissimilar to 
the aged blood vessels in most patients. Our 
understanding of the arterial involvement may be 
improved by in vivo investigation of the arterial and 
venous circulation in humans with techniques such as 
colour Doppler ultrasound by allowing the examination 
of the velocity of blood flow in the central retinal 
artery and vein simultaneously.
Jorrizo et al (1987) argued that prolonged arteriove­
nous dye transit times on fluorescein angiography 
provide evidence of arterial occlusion ^^4 these
could be due to back pressure on the arterial 
circulation from the congested veins. Ophthalmodyna­
mometry has also been used to try to illustrate the 
presence of arterial insufficiency in CRVO 258,
Patients with an appearance similar to that of CRVO 
have been described with caroticocavernous sinus 
fistula 25,216,265. These cases provide evidence for 
increased back pressure in the venous circulation 
without arterial occlusion. One case described by 
Suzuki showed a venous stasis retinopathy appearance 
which progressed to haemorrhagic retinopathy suggesting 
the presence of ischaemia 2 65. Although the retinal 
changes seen in these cases are probably the result of 
increased venous pressure, secondary central retinal 
arterial occlusion or "steal" from the arterial 
circulation may also be present.
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McLeod (197 6) investigated eleven patients with 
combined occlusion of the cilio-retinal artery and 
central retinal vein. Retinal haemorrhages were less 
prominent in the area of the arterial infarct than in 
the surrounding retina ^91 which is contrary to the 
expectations of Hayreh which suggest that haemorrhage 
should have been present within the area of retina 
supplied by the occluded artery 190. ^ lower
perfusion pressure in the cilio-retinal artery compared 
with the central retinal artery may explain why these 
arteries become blocked in vein occlusion, possibly by 
back pressure from the venous circulation. Video 
fluorescein angiography has shown that pulsations are 
present in these arteries 24 6 suggesting that there is 
back pressure without occlusion.
Green et al (1981) demonstrated arterial occlusion in
24% of postmortem eyes 80 but the majority of these
eyes were rubeotic and may therefore have suffered 
arterial occlusion secondarily to raised intra-ocular 
pressure. The CRVO picture has also been described in 
Moyamoya disease which is considered to be a disease of 
intracranial arteries 255.
The relative roles of occlusion of the central retinal 
artery and vein in the production of the appearance of 
CRVO is therefore uncertain. Indeed the mechanism of 
the occlusion is still open to investigation.
.’
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clinical setting have been to identify underlying
8.7 CLINICAL INVESTIGATION OF CRVO
The primary roles of investigation of CRVO in the
systemic and ocular conditions which require treatment, 
and to classify the vein occlusion thereby determining 
the risk of neovascular glaucoma and the prognosis for
105
visual function. A number of tests has been used for 
this including clinical parameters such as visual 
acuity, ophthalmoscopy, relative afferent pupillary 
defect, visual field assessment and investigations such 
as electroretinography and fluorescein angiography,
Hayreh et al (199 0) in an extensive prospective study 
compared functional tests such as visual acuity, visual S
field, relative afferent pupillary defect and 
electroretinography against "morphological" tests of |.
ophthalmoscopy and fluorescein angiography ^^4.
Overall, they found that functional tests were better I;measures of ischaemia according to his classification ||
system. There is, however, a reservation in the 
methodology for this study. Their parameters for 
classifying a patient as having ischaemic central 
retinal vein occlusion involved the following: presence 
of ocular neovascularisation or the presence of 
extensive capillary non-perfusion on fluorescein 
angiography or three of the following four findings;
(i) relative afferent pupillary defect of more than or 
equal to 1.2 log units; (ii) the presence of 10 or more
Î
cotton wool spots; (ill) a visual acuity of count 
fingers at 1-2 feet; or (iv) a visual field with 
sensitivity of less than or equal to V4e on Goldmann 
testing. Therefore the tests in their classification 
system were the same tests which they intended to 
assess. Despite this, some interesting results were 
found, for example, some investigations were dependent 
on the time of examination, ie., how long after the 
onset of the occlusion, such as fluorescein angiography 
and ophthalmoscopy whereas other tests were less 
duration dependent such as relative afferent pupillary 
defect and ERG. Visual field assessment and visual 
acuity appeared not to be duration dependent until 
after one year. ERG was not used in their initial 
classification and therefore data for this test were 
probably the most accurate showing it to be a good 
predictor of ischaemia.
8.7.1 CLINICAL PARAMETERS
Visual acuity, a simple, straightforward and readily 
available test, shows some predictive power for the 
development of neovascular glaucoma 254,290 its
value is reduced because the presence of cystoid 
macular oedema a common complication of CRVO reduces 
visual acuity in many non-ischaemic cases. A  
quantitative assessment of relative afferent pupillary
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an eye that evolves into an ischaemic pattern.
8.7,2 FLUORESCEIN ANGIOGRAPHY
defect (RAPD) using neutral density filters 273 ^^ s^ 
been used to investigate 120 patients with CRVO 250. ^
pupillary defect of at least 1.2 log units was detected 
in all 11 patients who developed new vessel formation 
in this study. Also 90% of the patients classified as 
ischaemic had a RAPD of at least 1.2 log units, whereas 
none of the nonischaemic patients did. The test is 
particularly useful because the pupillary defect does 
not appear to change with the duration after onset of 
the central retinal vein occlusion but will increase in
A number of parameters on fluorescein angiography have 
.been used in the classification of CRVO, the most 
important of these being retinal capillary non­
perfusion which has been shown repeatedly to predict 
the development of rubeosis (figure 8.3)
149,150,175,177. Unfortunately, the identification and 
quantification of this sign is subjective and difficult 
to standardise. An assessment of its extent may be 
improved by 60 degrees wide angle photography and 
objectivity introduced by image analysis 3.77. serial
fluorescein angiograms have shown that capillary 
closure increases with time and so early examination 
may underestimate the final extent of the retinal 
ischaemia 377,254. This progressive loss of capil-
I:
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Figure 8.3. A fundus fluorescein angiograph of a patient with 
CRVO showing capillary nonperfusion (drop out).
laries with time has also been demonstrated histologi­
cally in experiments using monkeys 308.
Other fluorescein angiographic signs have been 
investigated such as the condition of the perifoveal 
capillary arcade, an intact arcade providing a good 
indicator for recovery of visual acuity. Cystoid 
macular oedema usually occurs if there are breaks in 
the continuity of this arcade but this complication may 
still occur with an intact arcade if severe venous 
leakage is present 350. Sinclair (1979) found that 84% 
of patients with cystoid macular oedema achieve visual 
acuity of 6/7.5 or better if their perifoveal arcade is 
intact 254.
Studies of the time required for transit of fluorescein 
dye from the arterial retinal circulation to the venous 
have revealed varied results. Zegarra et al (1974) 
found that there were equal arteriovenous transit times 
in patients with ischaemic and non-ischaemic CRVO 207. 
Whereas, Laatikainen (1976) using macular transit time 
in patients examined less than three months after 
onset, found that delay was more often present in those 
who developed neovascular glaucoma 350.
Widespread retinal haemorrhages may severely hamper 
detailed examination of the retinal vasculature by 
fluorescein angiography. Hayreh et al (1990) 
determined that one third of fluorescein angiograms 
(from 140 eyes of 128 patients) had been inadequately
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assessed because of the presence of such factors as 
retinal haemorrhage and opacities of the media 304. 
Sinclair and Gragoudas (1979) found that 11% of the 
fluorescein angiograms of 57 patients did not allow 
adequate assessment of the perifoveal arcade due to 
retinal haemorrhages 254. j-n addition, because of the 
largely subjective nature of fluorescein angiography, 
there is considerable intra-examiner disagreement in 
its assessment. Welch (1987) found a surprisingly high 
intra-observer error (from 8 observers) with only 67.8% 
agreement between two assessments of 2 6 angiograms by 
the same observer 295. using forced choice methodology 
only 35% of examiners made a correct classification of 
ischaemia on one observation. Even so, fluorescein 
angiography remains the most frequently quoted 
indicator of ischaemia.
8.7.3 ELECTRORETINOGRAPHY (ERG)
A number of investigators have found that ERG is a
useful test for detecting ischaemia, (table 8.8) 
22,104,105,123,126,201,241,290. predictive
potential for the detection of patients who develop 
iris neovascularisation is often superior to fluoresce­
in angiography but the most efficient testing strategy 
or portion of the ERG waveform to examine has yet to be 
determined (figure 8.4).
A common abnormality of the ERG in CRVO is a reduction
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Studies of Electroretinography.
Sabates 1983 strobe light 45 patients.
He d e t e r m i n e d  th a t  the b e s t  m e a s u r e  of the r i s k  of 
neovascular glaucoma was the b/a ratio. Mean b/a ratio was 1,67 
(all were above 1.0) for 27 patients with venous stasis r e t inopa­
thy and 0.70 for the 6 pat i e n t s  w i t h  h a e m o r r h a g i c  r e t i n o p a t h y  
(all less than or equal to 0.76). All 6 patients who d e v e l o p e d  
neovascular glaucoma had ratios of less than 1.0 (mean 0.84). A 
paradoxical increase in the b wave was seen in some of the p a ­
tients with venous stasis retinopathy, an effect which can also 
be seen in patients with hypertension or those using vasodilator drugs. A l t h o u g h  the b / a  r a t i o  c o u l d  be u s e d  to p r e d i c t  the 
development of neovascular glaucoms it did not predict the final visual acuity result.
|ve 1988 30 patients G a n s f i e l d  bowl, a gold foil e lectrode.Ï
26 patients with non-ischaemic CRVO and 4 with indeter­
minate CRVO, 7 patients w e n t  on to develop iris n e o v a s c u l a r i s a ­
tion at 6 months. The best predictor of this complication was 
mean b w a v e  i m p l i c i t  time (a time of > 4 7 , 17ms or an i n t e r  eye 
difference of > 7 . 39ms predicted iris neovascularisation f o r m a ­
tion), f o l l o w e d  b y  b/a rat i o  and then b wa v e  amplitude. 95% c o n f i d e n c e  limits of m e a n  b wave i m p l i c i t  time for eyes w h i c h  
subsequently d e veloped rubeosis did not overlap with those for 
eyes unaffected by rubeosis. Results for b/a ratio showed o v e r ­
lap at 99% c o n f i d e n c e  limits c o m p a r e d  to n o n r u b e o t i c  eyes and 
overlap at 95% confidence limits for the fellow eye comparison.
Johnson 1983 15 patients with CRVO for flashand flicker ERG with 
a h e m i s o h e r e  i l l u m i n a t i o n  and a B u r i a n  A l l e n  b i p o l a r  c o n t a c t  lens.
7 with current iris neovascularisation and 2 who subse­
quently developed iris neovascularisation
She used the Nak a - R u s h t o n  physiological compression formula to 
produce an analysis of flash waveforms. In this study a compute­
rised forced choice analysis was performed to assess the discrim­
inant value (presented as a percentage) of each of the parameters 
for the p r e d i c t i o n  of neovascularisation. The order of values 
was logK 88%, Rmax 82%, flicker implicit times 61% and b/a ratio 
27%. This was co m p a r e d  with the forced choice analysis of the 
detection rate by six retinal specialists studying fluorescein 
angiograms of patients w i t h  iris neovascu l a r i s a t i o n  in w h i c h  a 
detection rate of only 36% was obtained.
Hayreh 1989 149 eyes of 128 Gass photgstimulator and hemisphere bowl with a contact lens electrode,
He compared the results of .his patients classified as 
either ischaemic or nonischaemic. Combining data for the photop- 
ic and scotopic waveforms d etermined that the b wave amplitude 
had the b e s t  s e n s i t i v i t y  (80-90%) a nd s p e c i f i c i t y  ( 7 0-80%), 
followed by b/a ratio (sensitivity 60-70% and specificity 70%), 
then a wave amplitude (sensitivity 50-70% and specificity 60-70%) 
and finally implicit times (sensitivity 30-55% and s p e cificity 
70-80%), Further analysis of the patients with ischaemic CRVO 
showed that ERG was unable to predict the occurance of neovascu­larisation in these cases.
Breton 1989 21 patients G a n z f i e l d  bowl and d i s p o s a b l e  u n i p o l a r  
contact l e n s e s .
Mul t i p l e  discriminant analysis of a number of p a r a m e ­
ters including those from the Naka-Rushton equation. A 14% false 
positive rate for the prediction of iris neova s c u l a r i s a t i o n  was found using this method.
Morrell 1991 41 patients DTL fHbre corneal electrode (and a
Gass strobe for flash r e s p onses). 201
E x a m i n e d  p a t t e r n  ERGs and found that it was s i g n i f i ­
cantly reduced in a group of 8 patients who went on to develop 
rubeosis iridis. In this study , flicker implicit times were the 
best predictor for the development of rubeosis. Using an inter­
eye difference of more than S secs as the cut off, a false p o s i ­
tive rate of 2% and false negative rata of zero were found. This 
c o m p a r e d  w i t h  a false n e g a t i v e  rate of 62,5% for f l u o r e s c e i n  
ang i o g r a p h y .  The e x a m i n a t i o n  s t r a t e g y  e m p l o y e d  in this s t u d y  
required 1 to 1.5 hours of time to perform.
Gouras 1992 12 patients u s i n g  a B u r i a n  A l l e n  b i p o l a r  c o n t a c t  
^gns e l e c t r o d e  and a Gass strobe fit t e d  to a G a n s f i e l d  bowl)
D i fferent wavelengths of light at d ifferent levels of 
light adaption. The cone ERG was delayed but increased in ampli­
tude in c o m p a r i s o n  to the fellow aye e s p e c i a l l y  for the light 
adapted eye at long wavelengths of light (rad). This effect has 
been att r i b u t e d  to an inability of the cones in the retina a f ­
f e c t e d  b y  C R V O  to r e d u c e  t h e i r  r e s p o n s i v e n e s s  to l i g h t  w i t h  increased levels of liaht adaotion.
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Figure 8.4. The electroretinographic waveforms (scotopic series 
and Naka R u s h t o n  slope) from a p a t i e n t  w i t h  CR V O  of the right 
eye.
- .'awir KiL:;
in the b wave amplitude. This portion of the ERG 
waveform is produced by the Muller cells in the retina 
which are damaged by the ischaemia induced by CRVO.
The a wave which results from the retinal receptors, is 
relatively preserved because the outer retinal layers 
are supplied by the choroidal circulation. |;
The amplitude of both the a and b waveforms can be ■Ireduced from other factors such as medial opacities.
I
In order to reduce the influence of such factors a 
ratio of the b wave to the a wave is often used. The 
b/a ratio is small in CRVO because of reduction of the 
b wave and because the amplitude of the a wave which is 
normally reduced by destructive interference from the b 
wave may be increased in CRVO, "I
Many other measurements are available from the |
electroretinogram such as a and b wave implicit times 
or measurements from the physiological compression 
formula of Naka and Rushton.
Naka-Rushton Formula.
Rmax I^R = --     :il" +
R = Amplitude from a wave trough to Bwave peak.
Rmax - Maximum ERG amplitude
I = Stimulus intensity ;;|
K = Intensity to reach 1/2 Rmaxn = Slope of the function
LogK is used as an indicator of the level of light 
required to obtain a "normal" amplitude and is used as 
a measure of the loss in sensitivity of the cells.
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Rmax is used as a measure of the loss of cell numbers 1"
and the slope n is used as a measure of the homogeneity
I'lof the retinal sensitivity. The ERG may be used to 
measure photopic or scotopic responses, colour response ■'I
OT flicker response. Not surprisingly there is much i:Idebate as to the most useful parameters to measure in 
CRVO.
The fellow eye has been used for comparison in many of
■;the studies on ERG in CRVO. Sakue (1989) found that 18 
out of his 50 patients had abnormal ERGs in the fellow 
eye, 15 of these had supernormal ERGs (increased a
wave amplitudes) of 2 standard deviations above the SInormal controls and three had negative ERGs (reduced 
a/b ratio) 242^
.8.8 VISUAL OUTCOME
Non-ischaemic CRVO has a better outcome with less 
frequent development of neovascular glaucoma and with
good recovery of visual acuity ^00/ ischaemic cases 
have a poor prognosis for the recovery of vision 
149,222,307^ Zegarra et al (1979), in a prospective 
study of the natural course of CRVO in 26 eyes of 25 /
patients, found that the final visual acuity was 3/60 |
or worse in 87% of the ischaemic group (16 eyes) |
whereas the non-ischaemic group (10 eyes) had 6/18 
vision or better in 80% ^^ *7. Quinlan et al (1990) 
found retrospectively in 168 eyes of 160 patients that
111 'i
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93% of ischaemic CRVO (61 eyes) culminated in a final 
visual acuity of less than 6/60 as opposed to 50% of 
non-ischaemic CRVO (107 eyes) ^22^ The final vision 
in young patients with CRVO was 6/60 or worse in 32% 
and no light perception in 6% in a large selective 
cohort of patients .
9.9 NEOVASCULARISATION AND NEOVASCULAR GLAUCOMA
Approximately 21% of cases of CRVO develop rubeosis 
iridis usually by six or seven months after onset 
although it can occur as late as 24 months from 
presentation (table 8.9, figure 8.5) 196,254,307^
Neovascular glaucoma has been reported in 8-50% of CRVO 
107, 67„82% of ischaemic CRVO 107,176,307 only 1%
of those with non-ischaemic disease 107,222,307 ^ 
Magargal's "indeterminate" group (1989) which fall in 
between these other classifications developed 
neovascular glaucoma in 7% of his 29 cases 177, New 
vessels in the posterior segment,usually occur in only 
5-7% of eyes with CRVO but have been found in 3 0%
of 61 eyes with ischaemic CRVO in one study . In 
patients under 50 years of age rubeosis has been 
described in 19%, neovascular glaucoma in 8%, disc or 
retinal new vessels in 1% in a study of 103 cases . 
Although rubeosis of the iris may occur as late as 24 
months after onset the majority of cases, 71% of 35
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Table 8.9
n
NEOVASCULARISATION
Iris Angle Glaucoma Disc Retina (% of patients)
Kruger 1990Nonischaemic283 3 2 1Ischaemic78 58 47 33
Magargal 1981Nonischaemic70 1Ischaemic45 60
Priluck 1980 ^18 Nonischaemic 21 0Ischaemic21 14
Zegarra 1979Nonischaemic 10 0Ischaemic 26 - - 26
Laatikainen, 1977Nonischaemic 11 8Ischaemic13 18
All
3
87
0
5
0
0
0
45
0
0
0
18
0
26
Table 8.9. The percentage of patients with ischemic or nonischaemic CRVO who suffer from neovascularisation of the iris, angle, disc and retina, and neovascular glaucoma in various studies.
Î
photograph.’ neovascularisation is shown in a slit lamp
Figure 8.6. A fundus photograph of the chorioretinal changes associated with panretinal photocoagulation is shown.
patients in one study ^07^ occur within the first six 
months. The neovascularisation may affect the iris or 
the anterior chamber angle causing anterior synaechiae 
to appear. These changes can be graded to aid the 
assessment of therapeutic strategies ^07. Magargal 
(1982) ^77 performed a retrospective study of the 
natural history of CRVO without treatment which 
included 42 patients with untreated rubeosis and found 
that 76% of these patients went blind to no perception 
of light in the affected eye and 28% developed phthisis 
bulbi or required enucleation of the eye for pain (none 
of the cases was treated with panretinal photocoagula­
tion) ^77^ Ninety three percent of the patients' eyes 
which developed iris neovascularisation had more than 
50% retinal capillary nonperfusion on microcomputer 
assessment of fundus fluorescein angiography. In the 
same paper Magaral also decribed 22 eyes with ischaemic 
CRVO treated with panretinal photocoagulation none of 
which developed iris neovascularisation. Interpreting 
the results in a different way showed that the 
treatment of all patients with CRVO on the grounds of 
50% capillary drop out would have lead to a significant 
proportion being treated unnecessarily because, of 200 
patients with 50% capillary drop-out of more, only 60% 
subsequently went on to develop rubeosis. That is 50% 
capillary drop out had a high sensitivity but a low 
specificity for the prediction of those patients who 
would develop iris neovascularisation.
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Disc and retinal new vessels occur with central retinal 
vein occlusion in approximately 5-7% of cases in con 
trast to the development of new vessels in branch 
retinal vein occlusion in 2 3% ^87^ whereas, new 
vessels of the iris appear within the first six months, 
new vessels of the disc and retina take longer to 
appear usually one year after the occlusion occurs 202^ 
Histological studies demonstrate a lack of viable 
retinal vascular endothelial cells after CRVO. 
Theoretically, an angiogenic factor would be unable to 
act on the retinal vessels themselves, instead it 
diffuses into the anterior segment and causes new 
vessels on the iris . Murdoch et al (1991) have 
suggested that panretinal photocoagulation may convert 
an ischaemic retina into a partially ischaemic retina 
and thereby cause the production of new vessels of the 
disc or the retina ^02. He described five patients in 
whom new vessels of the posterior segment appeared 
after apparently successful treatment of rubeosis 
iridis by panretinal photocoagulation. May et al 
(1979) described 6 of 15 patients in whom posterior 
segment new vessels occurred after panretinal
photocoagulation 187 but 6 of 19 untreated patients
also developed posterior segment neovascularisation in 
the same study.
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9.10 TREATMENT OF CRVO
The mainstay of treatment of central retinal vein 
occlusion is panretinal photocoagulation (figure 8.6). 
Laatikainen et al (1977) in a prospective randomised 
trial determined that Xenon panretinal photocoagu­
lation reduces the incidence of neovascularisation and 
cystoid macular oedema but has no effect on visual 
acuity. These findings have been confirmed by May et 
al (1979) who found no neovascularisation of the iris 
or neovascular glaucoma after treatment and who also 
found no improvement in visual acuity ^^7, others 
have used panretinal photocoagulation in the treatment 
of neovascular glaucoma and rubeosis and have been able 
to show that the neovascularisation can be reversed 
175,186,202^ Magargal et al (1982) even stated that 
treatment was always successful unless another 
ischaemic event was encountered in the eye ^77^ May et 
al (1979) and Murdoch et al (1991) have both demon­
strated that neovascularisation of the retina or disc 
may occur despite panretinal photocoagulation 187,202^ 
Dodson et al (1985) detected an increase in blood 
pressure, alcohol abuse and lower plasma HDL levels in 
patients with recurrent central retinal vein occlusion 
and has claimed that medical treatment of these reduces 
the recurrence rate of central retinal vein occlusion 
from 10-15% to 1% . Anticoagulants and fibrinolytic
agent have been tried unsuccessfully to treat the
115
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condition 137,154,282^
Vitrectomy to remove vitreous haemorrhage secondary to 
retinal neovascularisation did not improve visual 
acuity significanlty in one study 257^ in one case of 
pseudotumour cerebri (complicated by central retinal 
vein occlusion and increased CSF pressure) a reduction 
in the severity of the retinal features was observed 
after optic nerve sheath decompression
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9 Chapter 9
CENTRAL RETINAL VEIN OCCLUSION, AN INVESTIGATION BY 
COLOUR DOPPLER IMAGING: BLOOD VELOCITY CHARACTERISTICS 
AND PREDICTION OF IRIS NEOVASCULARISATION.
9.1 Summary.
The purpose of the studies described in this chapter 
was to determine pulsatile blood velocities in the 
orbital vasculature in patients with central retinal 
vein occlusion (CRVO). The ophthalmic artery, central 
retinal artery and vein of 8 0 patients with CRVO were 
investigated by color Doppler imaging (CDI). The 
patients were examined by ophthalmoscopy, relative 
afferent pupillary measurement using crossed polarised 
filters, fundus fluorescein angiography and electrore- 
tinography in order to estimate the degree of retinal 
ischaemia. Blood flow velocities in the central 
retinal vein and artery of eyes with CRVO were 
significantly lower than in fellow eyes and controls. 
The measurements from the vein were most reduced and in 
some cases absent in those eyes with "ischaemic” CRVO. 
Velocities were also reduced in the central retinal 
artery of the affected eyes but no correlation with 
"ischaemia" was detected. The risk of iris neovascu­
larisation in patients examined within 3 months of 
onset of CRVO can be determined from the flow 
velocities (Vmin of less than 3.0 cm/sec) with a high 
degree of predictability (75% sensitivity and 86%
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specificity), Blood velocity was reduced in the retinal 
circulation of patients with CRVO and reduced even 
further in the "ischaemic" variant of CRVO, The 
results indicate that noninvasive color Doppler imaging 
could play a major part in the routine assessment of 
patients with CRVO within three months of onset.
9.2 Introduction
There are few reported haemodynamic investigations of 
the central retinal vein occlusion (CRVO) perhaps 
because optical methods of blood flow measurement are 
difficult to apply to a retina with extensive 
haemorrhage 150,246,258,307_ phe present study 
examined the ophthalmic artery and central retinal 
artery and vein in 8 0 patients with CRVO and involved a 
comparison of the results with the control population 
described in Chapter 3.
The risk of the development of intraocular neovascular- /
istion requires the classification of eyes affected by 
CRVO into ischaemic or nonischaemic variants 69,101^
Although a number of tests has been applied none has 
been satisfactory on its own and often a combination of 
investigations has been required 104,150,250^ The 
results of colour Doppler imaging were therefore 
analysed to determine whether this investigation could 
be used to detect eyes at risk of neovascularisation.
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9.3 Patients and Methods.
Patients and Classification.
85 eyes with central retinal vein occlusion of 80 
patients were examined. The results from 75 unaffected 
fellow eyes and the control population of 95 ophthalmo- 
logically healthy volunteers (see chapter 3) were used 
for comparison with the disease group. Patients’ eyes 
were excluded if there was evidence of previous ocular 
surgery or if the intraocular pressure was greater than 
30 mmHg and only the most recently affected eye of 
patients with bilateral CRVO was included in statisti­
cal analysis.
To allow a classification of retinal ischaemia the 
patients were also examined by ophthalmoscopy, relative 
afferent pupillary defect (RAPD) measurement, fundus 
fluorescein angiography and electroretinography. The 
RAPD was measured by attenuating the light received in 
the unaffected eye from a binocular indirect ophthalmo­
scope headlamp by rotating cross polarised filters 
(Stereo Optical) in an adaption of a previously 
described technique 2 37^ When the RAPD was neutralised 
the angle between polarisers was recorded as a measure 
of the severity of the defect. Electroretinography was 
performed using a Ganzfeld dome and disposable contact 
lens electrodes. Fluorescein angiograms were 
interpreted by observers masked to the other clinical
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and investigative results. Seventeen patients were 
examined by photographic fundus fluorescein angiography 
using a wide angle Canon Fundus camera and 55 patients 
by videoangiography using a Rodenstock scanning laser 
ophthalmoscope (described in chapter 10). Angiograms 
were not performed in one patient because of a risk of 
an allergic reaction, in one who refused and in four 
because of a prolonged interval since the onset of the 
CRVO. Videoangiography was interpreted by three 
ophthalmologists with experience of this technique and 
classification applied when at least two of the 
observers were in agreement. Three categories 
"nonischaemic", "partially ischaemic" and "ischaemic", 
were used according to the criteria shown in table 9.1, 
The patients were re-examined at a minimum of 12 months 
after the onset of the CRVO. Four patients were 
excluded because of a duration from onset of less than 
1 year and three patients were lost to follow up. Iris 
neovascularisation was detected on slit lamp biomicros­
copy and gonioscopy, and the presence of retinal 
neovascularisation noted.
Color Doppler ultrasound
An Acuson 128 with a 7.5 MHz probe was used to obtain 
velocimetry measurements as has been described in 
chapter 3. Velocity measurements from the posterior 
ciliary arteries were not made because the reproduc-
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Table 9.1
Classification of CRVO.
Ischaemic.
1. Fluorescein angiographie evidence of severe capillary dropout (>10 disc diameters)
OR if the fluorescein is unassessable:
2. Presence of iris neovascularisation.OR
3. At least two of the following
1. Reduction in the B/A wave amplitude 
of the ERG.
2. RAPD of at least 2 0 degrees (cross polarisers)
3. Visual acuity less than 6/60. 
Nonischaemic.
1. No capillary drop out on fluorescein angiography. AND
2. Absence of iris neovascularisation.
AND
3. Normal ERG. 
and
4. RAPD of less than 20 degrees.
Partially ischaemic.
Any case which cannot be fitted into the above 
categories.
ibility experiments had shown high coefficients of 
repeated measures for the velocity results. Informed 
consent was obtained from all volunteers and patients 
before examination which was performed by an examiner 
who was masked to the clinical results of the patient.
Statistical Analysis.
Data were stored on a database and analysed using 
statistical software on an IBM personal computer. Only 
those patients with unilateral disease and healthy 
fellow eyes were used in the comparison of CRVO with 
fellow eyes. Mann Whitney U test, Spearman Rank 
correlation and Wilcoxon matched pairs test were 
applied where appropriate. Two methods were employed 
to overcome the disparity between the age of the 
controls and the patients. Firstly the results from 
these two groups were analysed using analysis of 
covariance with the covariant "age" to allow an age 
adjusted comparison (the mean age of the controls was 
46.6 years, SD 18.2). Secondly, thirty six patients 
were age and sex matched to 3 6 patients for a case 
controlled comparison. Receiver operator characteris­
tic curves were employed to determine a cut-off value 
for Doppler velocities for the determination of the 
risk of iris neovascularisation.
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a9.4 Results.
The mean age of the patients was 67.2 years (SD 13.5, 
range 27-87), 41 males and 39 females. Eighty five 
eyes (37 right eyes, 48 left and 5 bilateral), of 80 
patients were examined. A flow diagram of the patients 
used for each part of the analyses is shown in figure 
9.1. Three patients were excluded with raised 
intraocular pressures above 3 0 mmHg at presentation.
The mean duration from the onset of the CRVO to the 
date of examination was 4.1 months (SD 4.8), median 2 
months, range 1 week to 2 years. In the case 
controlled comparison the mean age of the patients and 
controls was 60.0 years (SD 15.7 years, range 25 to 85 
years) with male female ratio in each group of 1:1.
Central retinal vein occlusion.
Table 9,2 shows the velocity results from the eyes with 
CRVO, their fellow unaffected eyes and the control 
population. Figures 9.2, 9.3 and 9.4 show that the 
majority of eyes with CRVO had lower velocities and 
venous pulsatility indices in the central retinal vein 
than their fellow unaffected eyes (65% of the values of 
Vmax, 55% of Vmin and 59% of venous pulsatility indices 
in CRVO eyes were lower than in the fellow unaffected 
eyes). Comparison of the eyes with CRVO with fellow 
eyes and the control population showed significantly 
lower velocities in the central retinal artery and vein
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Figure 9.1All Eyes with CRVO 
(85 Eyes)
Removal of eyes with lOPs of more than 
30 mmHg and the fellow eyes of patients 
with bilateral CRVO.
(77 Patients)
Comparison with 
the Controls
Comparison with 
Retinal Ischaemia
Removal of Patients with 
CRVO or Ocular Disease in the Fellow Eye. 
(69 Patients)
Comparison with 
Fellow Eyes
Patients examined less than 
3 months from onset of CRVO 
and with follow up for 1 year. 
(36 Patients)
Prediction of
Visual Acuity Recovery 
Removal of Patients who 
presented with Rubeosis or 
who received prophylactic 
panretinal photocoagulation.
(30 Patients)
Prediction of Iris 
Neovascularisation
Figure 9.1. A flow diagram showing the manipulation of 
the data during the analyses (number of eyes remaining after each step).
Table 9.2.
Ophthalmic
Artery Artery
Central Retinal 
Vein
PSV EDV PSV EDV Vmax Vmi](mean and SD, cm/sec)
CRVOS 36.8 8 . 3 9.1 2.3 4.3 3.1(80) 10.9 4.1 3 . 2 1.6 2.1 1.6
FELLOW EYES 36.8 8 . 4 10.50 2.9* 6.3* 4.1*(72) 10.0 4 .1 3 . 1 1. 1 2 . 1 1,1
CONTROLS 35.1 8 . 6 10.2# 3 .1+ 5.8* 3 . 8 +(95) 11.2 3 . 9 2.9 1.1 1.5 0.9
Table 9.2. The velocimetry results from the eyes with 
central retinal vein occlusion (CRVO) , their contralat­
eral healthy eyes (fellow eyes) and controls. There 
are significant reductions in the velocities in the 
central retinal vein and to a lesser extent in the 
central retinal artery of those eyes with CRVO compared 
to the fellow eyes and the controls (*p<0.0001, 
@p<0.001, #p<0.01, +p<0.03). No differences were found 
between the velocities in the ophthalmic artery or between the comparison of the fellow eyes with 
controls.
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Figure 9.2. A scattergram of Vmax in the central retinal vein of 
the eyes with CRVO and their unaffected fellow eyes. The points 
are p r e d o m i n a n t l y  s c attered below the line showing that for the 
majority of patients the velocities were lower in the affected  
eyes than the unaffected eyes, The key shows the number of cases 
represented by each point, eg., the large circle reoresents three cases at that point.
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Figure 9.3. A scattergram of Vmin in the central retinal vein of 
the eyas w i t h  CRVO and t h e i r  u n a f f e c t e d  fallow eyes w i t h  the 
p oints m o s t l y  s c a t t e r e d  b e l o w  the line d e m o n s t r a t i n g  that the 
majority the velocities were lower in the affected eyes than the 
u n a f f e c t e d  eyes. The key shows the number of cases represented 
by each point.
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Figure 9.4. A scattergram showing the venous pulsatility indices 
in the c e n t r a l  r e t i n a l  v e i n  of the eyes w i t h  C R V O  a nd t h e i r  
u n a f f e c t e d  fel l o w  eyes. T he s c a t t e r  of points b e l o w  the line 
illustrates that most of the results were lower the affected eyes 
than the u n a f f e c t e d  eyes. The k ey shows the n u m b e r  of cases 
represented by each point.
Age and Sex Matched 
Comparison
cm /sec
I
PSV EDV
Retinal Artery
Vmax Vmin
Retinal Vein
controls
CRVO
Figure 9.5. The results of the age and sex matched comparison in 
w h i c h  s i g n i f i c a n t l y  lower velocities were found in the central 
retinal a r t e r y  and vein of eyes with CRVO than controls (EDV in 
the r e t i n a l  artery, p=0.04, and V m a x  and Vm i n  in the c entral 
retinal vein, p<O.OQ01 and p=0.002 respectively).
__     1 ^ ^
in eyes with CRVO (table 9.2). In the age and sex 
matched comparison the venous velocities and the EDV in 
the central retinal artery were significantly lower 
(figure 9.5).
Venous pulsatility indices in the central retinal vein 
were significantly lower in the eyes with CRVO than in 
the fellow eyes and controls (both p=0.00001) despite a 
significantly higher resistive index in the central 
retinal artery of the eyes with CRVO (p=0.02, figure 
9,6). Only the venous pulsatility index in the central 
retinal vein was significantly lower in the age matched 
comparison of eyes with CRVO and controls (mean 25.0%, 
SD 18.4 and 36.5%, SD 9.7 respectively p<0.001). These 
results were also significantly different when the 
analysis was performed for those patients with 
nonischaemic CRVO only.
Association with retinal ischaemia.
Forty two eyes were classified as nonischaemic, 26 as 
ischaemic and 12 as partially ischaemic. Comparison of 
age, duration, systemic blood pressure, intraocular 
pressure, keratometry, axial length and refraction 
showed no significant difference between the eyes with 
different grades of retinal ischaemia (table 9.3). The 
values of Vmax and Vmin in the central retinal vein 
reduced as the degree of ischaemia increased and were 
significantly lower in the ischaemic eyes than in the
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Resistive Indices in CRVO
100
Fellow Eyes
CRVO
Retinal
Artery Retina!Vein
Figure 9.6. A histogram showing the higher mean resistive index 
in the central retinal artery and the lower mean venous pulsatil­
ity index in the central retinal vein in the eyes with CRVO than 
their contralateral healthy eyes.
Retinal Vein Velocities in CRVO
s
cm/sec
Vmax Vmin
Nonischemic 
Partially Ischemic 
Ischemic
Figure 9.7. A histogram showing the reduction in mean velocities 
in the central retinal vein as the degree of retinal ischaemia i ncreases.
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Table 9.3
Age
(years)
Duration(months)
SBP
(mmHg)
DBF
(mmHg)
lOP
(mmHg)
AXIAL LTH 
(mm)
KERATOMETRY(Dioptres)
REFRACTION
(Dioptres)
Nonischaemic
62 .1 
16.3
4 . 0
5.2
14520.0
84 9 . 6
16. 1
4.2
22.91.1
43 . 61.2
0.6 2 . 6
Partial 
Ischaemia 
(Mean and SD)
69.5
7.0
4 . 34.3
157
26.5
8116.5
17.5
5.1
22 . 3
1.4
43 . 21.3
1.1 4 . 0
Ischaemic
72.3
9.4
4 . 3 
4 .4
155
27.4
90
12.4
15.7 
4 . 6
22.21.2
44 .1 1.8
0.5
3.1
Table 9.3. General data are presented showing similarities between the patients with different 
classifications of ischaemia.
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nonischaemic eyes (p=0.01 and p=0.003 respectively, 
figure 9.7). This was also found after analysis of 
covariance for age which was used to compensate for an 
insignificant trend for increased age in the ischaemic 
CRVOs. Flow in the central retinal vein was undetect­
able in 11 eyes, all of which had suffered ischaemic or 
partially ischaemic occlusions.
Prediction of the Development of Iris Neovascularisa­
tion.
The results from patients examined within three months 
of onset were investigated to determine the capability 
of the tests to predict the development of iris 
neovascularisation. The results from five patients 
were excluded, three patients who presented with new 
vessels of the iris at the first visit, two who were 
subsequently treated with prophylactic panretinal 
photocoagulation and one who developed retinal new 
vessels. The
Vmin in the central retinal vein was significantly 
lower in the 8 patients who went on to develop iris 
neovascularisation than those who did not (mean 1.9 
cm/sec, SD 1.8, and mean 3.5 cm/sec, SD 0.7, respec­
tively, p==0.02). The one patient who developed retinal 
neovascularisation also had a low Vmin of 2.8 cm/sec. 
The presence of a Vmin of less than 3.0 cm/sec in the 
central retinal vein in these patients was found to 
provide a high predictive value for the development of
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iris neovascularisation with a sensitivity of 75% and a 
specificity of 86% (figure 9.8). This was superior to 
conventional tests in this group for which sensitivi­
ties and specificities are shown in the table 9.4. 
Furthermore four patients could not be assessed by RAPD 
measurement (two because of bilateral CRVO and two 
because of ocular disease in the fellow eye) and six 
patients by fundus fluorescein angiography (because of 
poor agreement between observers or poor visualisation 
of retinal detail) thereby reducing the applicability 
of these tests.
Prediction of Visual Acuity Recovery.
The results from patients examined within three months 
of onset of the disease (37 patients) were also used to 
determine the use of the various tests for the 
prediction of visual recovery. The visual acuity at 
presentation had the highest predictive value for the 
final visual acuity with a sensitivity of 85% and 
specificity of 75% for obtaining 6/24 visual acuity or 
better if the presenting visual acuity was 6/24 or 
better. This was primarily because 51% of the patients 
showed no change in their visual acuity over the year. 
In seven of the patients the visual acuities reduced 
over the year, five of these patients had values for 
Vmin in the central retinal vein which were less than 
3.0 cm/sec (figure 9.9). In addition, seven of the
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ROC Curve for the 
Prediction of Rubeosis 
Vmin
Sensitivity
0.8 -
0.6 -
0.2 -
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1-Specificity
F i g u r a  9.8. A r e c e i v e r  o p e r a t o r  c h a r a c t e r i s t i c  c u r v e  for the 
prediction of iris neovascularisation from values of Vmin in the 
central retinal vein.
Table 9.4
Unassessable
patients
Color Doppler Imaging 0
Electroretinography 0
RAPD Measurement 4
Fluorescein Angiography
6
Visual Acuity 
Ophthalmoscopy
Sensitivity Specificity (%)
75
67
71
60
50
25Cotton Wool Spots
(Presence v Absence)
Retinal Haemorrhages 3 3
(Mild V Moderate or Severe)
86
92
79
67
45
45
27
Table 9.4. Prediction of the Development of Rubeosis 
in patients with less than three months from the onset of the occlusion. The sensitivity and specificity 
values are shown and indicate that the presence of low 
velocity (Vmin) in the central retinal vein measured by 
Color Doppler Imaging provides the best prediction of 
iris neovascularisation. Some patients were unassessa­
ble by RAPD measurement or fluorescein angiography and were excluded from the calculations.
Prediction of 
Deterioration in VA
Patients Correctly Predicted (%)
100
GDI ERG RAPD FFA CWS Haems
Figure 9.3. A histogram showing the percentage of the patients 
who su f f e r e d  a loss of visual acuity and in wh o m  an "ABNORMAL" 
result was detected bv the various tests.
Prediction of 
Improvement in VA
Patients Correctly Predicted {%)
100
GDI ERG RAPD FFA CWS Haems
Figure 9.10. A histogram showing the percentage of the patients 
nose visual acuity improved and in w h o m  a "NORMAL" result was detected by the various tests.
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above this value (figure 9.10). These results were 
reflected in the calculation of venous pulsatility 
index in the vein which was higher in those patients 
who lost visual acuity than those who improved 
(p=0.04).
1
k;-..eight patients with improvement in their acuity had Vmin
The Fellow Unaffected Eye.
Analysis of covariance for age determined that the 
venous pulsatility index in the vein was significantly 
lower in the central retinal vein of the fellow eyes 
compared to the controls (p=0.007, figure 9.11) but 
this result was not significant in the age matched case 
controlled comparison. In an examination of the 
control population there was a positive correlation 
between the resistive index in the central retinal 
artery and that in the vein (r-0.34 p=0.0008). The 
correlation between the resistive indices was less in 
the fellow eyes of the CRVO patients (r=0.27, p=0.03) 
than in the controls. In the case controlled study the 
resistive index in the ophthalmic artery was signifi­
cantly higher in the fellow eyes compared with the 
controls (76.9 cm/sec, SD 7.0, and 73.5 cm/sec, SD 8.5 
respectively p=0.05). In addition an increase in this 
measure with age (r=0.27, p<0.05) was found in the 
patients but not the controls.
9.5Discussion
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an increase in the index with
In this study the blood velocities in patients with 
central retinal vein occlusion were examined by color 
Doppler imaging to determine the influence of the 
condition upon blood flow in the eye and to determine 
the applicability of GDI as a clinical tool for the 
investigation of CRVO. The results were analysed for 
the prediction of visual recovery and development of 
iris neovascularisation. In the latter particularly 
the system could be applied effectively with advantages 
over conventional tests. The results of the patients 
examined less than three months from onset of the 
occlusion were used because the blood velocities 
measured by colour Doppler imaging can reasonably be 
expected to change as the recanalisation of the vessels 
occurs. For the prediction of the development of iris 
neovascularisation the measurement of blood velocity in 
the central retinal vein in those examined within three 
months of onset of the occlusion provided higher 
sensitivities and specificities than the conventional 
tests (75% and 86% respectively for Vmin less than 3,0 
cm/sec). In addition one patient who developed retinal 
neovascularisation also had a low Vmin value (2.8 
cm/sec).
Unlike fundus fluorescein angiography the investigation 
is noninvasive and is unaffected by retinal haemorrhag­
ing or opacification of the media which often prevent
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adequate assessment of angiograms (8% of cases in this 
study and up to 33% in another study) Capillary
closure may not be detectable on fluorescein angiogra­
phy until three months after the onset of the occlusion 
which explains the poor predictability of this test in 
the patients with recent presentation (sensitivity 60% 
and specificity 67%). The usefulness of the fluoresce­
in angiography is further reduced because poor 
agreement frequently exists between assessments of 
ischaemia by the same observer The other tests
also have drawbacks, for example, relative afferent 
pupillary defect measurement can only be applied to 
cases of unilateral CRVO when the fellow eye is 
healthy, preventing its use in 15.3% of the cases in 
this study. Electroretinography produces a variety of 
predictive values, depending on the test strategy used 
but requires a prolonged examination procedure 
22,126,201,241^ therefore be used to determine
the outcome for patients with CRVO and is superior to 
conventional methods of investigation in the prediction 
of iris neovascularisation for patients examined within 
three months of onset of the disease.
The visual acuity at presentation in these patients 
provided the best indicator of the visual acuity at one 
year because the majority (51%) showed no change. 
However, a large proportion (87.5%) of the patients who 
showed an increase in their visual acuity had a Vmin in 
the central retinal vein of 3.0 cm/sec or greater and
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similarly most of those (71%) in whom the visual acuity 
decreased had Vmin less than 3.0 cm/sec.
The reduction in the blood velocities in the retinal 
circulation of eyes suffering from CRVO was greatest in 
the vein and was most marked in those patients with 
ischemia of the retina. Although there was a 
significant reduction in the velocities in the central 
retinal artery this was smaller than in the vein and 
did not vary with the degree of retinal ischemia. As 
yet the resolution of the color Doppler equipment is 
not sufficient to determine the diameter of vessels as 
small as these and therefore extrapolation of the 
Doppler results to the blood flow in the vessel must be 
performed with care. Any change of the cross 
sectional area of a vessel will profoundly affect the 
velocity of the blood if constant laminar blood flow is 
assumed. The central retinal artery and vein in the 
optic nerve are however surrounded by a thick 
collagenous adventitia reducing the chance of 
temporary collapse or dilation of these vessels. 
Calculation of the cross-sectional area of the vein 
from a diametric measurement of the vessel in any case 
would be frequently inaccurate because the vein's 
cross-sectional profile in the optic nerve varies from 
crescentic to oval ^69^ it is possible that the 
velocities in the central retinal vein reflect the 
changes in the retinal circulation more accurately than
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îthose from the muscular artery which may have dilated 
in response to relative ischemia of the retina or 
constricted in an attempt to maintain a constant 4";|
pressure in the capillaries.
Doppler examination of the central retinal artery and 
vein within the optic nerve provides some technical 
advantages because their straight course aids the 
reliability of Doppler measurements and allows angle 
correction to be applied (figure 9.12). In CRVO the 
pathological changes in the vessels occur in the region 
of the lamina cribrosa The blood velocities
were measured posterior to this site, therefore 
providing a measure of the changes in blood flow 
resulting from the constriction. It is tempting to 
suggest that the decrease in venous pulsatility index 
in the vein signifies an increase in the resistance to 
flow upstream of the measurement site, ie., from 
blockage or constriction of the vein at the lamina 
cribrosa. In the vein however this explanation is of 
doubtful validity because the intraocular retinal 
venous velocity described by laser Doppler velocimetry 
is nonpulsatile and in an anomalous hemiretinal
vein with an extraneural course non pulsatile flow is 
present (chapter 6). The pulsations in the venous flow 
in the vein in its intraneural course result probably 
because the artery increases the velocity in the vein
Î'because of its close proximity to the vein, ie., the 
artery expands during systole reducing the cross-
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Figure 9.12. Normal. The central retinal artery and vein in the 
optic nerve are indicated on the Bscan image by red and blue coloured pixels respectively (arrow).
Figure 9.13. Ischaemic CRVO. Only flow in the central retinal 
Bftery (red) can be detected no venous flow (blue) is seen (arrow).
' 'V4-i
sectional area of the vein thereby increasing the blood 
velocity. The reduction in the values for venous 
pulsatility index in the veins of the affected and 
contralateral unaffected eyes in CRVO shows that this 
effect has been lessened in these patients.
The observation of undetectable or reduced blood 
velocity in the central retinal vein of eyes with CRVO 
despite maintained blood velocity within the central 
retinal artery may be explained by blood bypassing the 
occluded central retinal vein via collateral venous 
channels. Indeed 2 0% of the patients demonstrated 
dilated collateral channels at the optic nerve head on 
fundoscopy. These channels are multiple, small in 
calibre and in most circumstances beyond the resolution 
of CDI. Alternatively, low flow may still have been 
present in the central retinal vein but was beyond the 
resolution of the machinery 270,302^ Blood velocities 
in the central retinal vein were further reduced or 
undetectable in those eyes with ischaemia of the retina 
(figure 9.13), indicating that the "occlusion" in these 
cases was more severe.
A lower venous pulsatility index was detected in the 
central retinal vein of the fellow unaffected eyes than 
in the controls. This may predispose the retinal 
circulations of these patients to stasis of blood flow 
explaining the risk of bilateral disease in 6- 16% 
50,222,239^ Since the changes in velocity in the vein
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are likely to be induced by the pulsation of the artery 
this may be a sign that the venous velocity in these 
patients is less able to change. Possibly this is 
caused by increased blood viscosity reducing the 
rapidity with which the blood can change its velocity 
227/278^ Alternatively, stiffening of the arterial or 
the venous wall from sclerotic degenerative changes 
could be reducing the expansion of the artery 
during systole and therefore the degree of alteration 
in velocity in the vein. Evidence of peripheral 
arterial disease on CDI was provided by the increased 
resistive index in the ophthalmic artery of the fellow 
eyes.
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In summary, CDI allowed simultaneous examination of the 
central retinal vein and artery in patients with CRVO. 
The pattern of blood velocity changes indicates a 
predominant disruption to the flow in the central 
retinal vein and to a lesser degree in the central 
retinal artery. The blood velocities in the vein can 
be used to help determine the likelihood of visual 
recovery. Finally the presence of a low velocity in 
the vein can be used to predict the development of iris 
neovascularisation and is superior in this aim than 
conventional tests. The results indicate that 
noninvasive color Doppler imaging could replace the 
invasive procedure of fundus fluorescein angiography as 
the routine method of assessing patients with CRVO with 
less than three months from onset of the occlusion.
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10 Chapter 10
A COMPARISON OF COLOUR DOPPLER IMAGING OF ORBITAL 
VESSELS AND OTHER METHODS OF BLOOD PLOW ASSESSMENT.
10.1 Summary.
A comparison of the haemodynamic measurements obtained 
by colour Doppler imaging and other methods of ocular 
blood flow measurements was made. The blood velocities 
from colour Doppler imaging of patients with central 
retinal vein occlusion were compared with the results 
of video fluorescein angiography, continuous tonography 
and ophthalmodynamometry. Patients with low or 
undetectable blood velocities in the central retinal 
vein had longer retinal dye transit times on video 
angiography. Tonographic readings showed a positive 
correlation with the velocities in the ophthalmic 
artery but ophthalmodynamometric results showed a 
negative correlation. The velocities from colour 
Doppler imaging of the central retinal vein may provide 
a more accurate indicator of the blood flow in the 
retina than the artery perhaps because the muscular 
artery actively undergoes changes in diameter in 
response to disease processes. The ophthalmic artery 
blood velocities provide an alternative to other 
methods for the assessment of blood flow in the 
ophthalmic artery.
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10.2 Introduction.
A comparison of colour Doppler imaging with other 
methods of blood flow assessment in the eye and orbit 
is required in order to enhance the interpretation of 
the velocity measurements. In this study, the 
relationships between fluorescein video
angiography, continuous tonometry and ophthalmodynamom­
etry, and colour Doppler imaging of the ophthalmic 
artery and the central retinal artery and vein was 
investigated in patients with central retinal vein 
occlusion. The results obtained by these different 
methods are compared and contrasted.
10.3 Patients and Methods
A cohort of 54 patients who had suffered central 
retinal vein occlusion, at most 6 months previously, 
underwent both colour Doppler imaging and fluorescein 
videoangiography of the affected eyes. The mean age of 
the patients was 68.8 years (SD 11.8 years) with 25 
males and 29 females. The mean systemic blood pressure 
was 151.3 mmHg (20.6 mmHg) and diastolic blood pressure 
was 80.3 mmHg (SD 11.5 mmHg). Sixteen of these 
patients also consented to continuous tonometry and 
ophthalmodynamometry and the results were compared to 
velocity results from colour Doppler imaging. Ethical 
committee approval had been granted and informed
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consent was obtained before each examination. The 
study conformed to the principles established in the 
Declaration of Helsinki.
Colour Doppler Imaging.
The examination method for colour Doppler imaging has 
been fully described previously in chapters.
Fluorescein Videoangiography.
A Rodenstock Scanning Laser Ophthalmoscope (SLO) was 
used to obtain fluorescein video-angiograms on 54 
patients with central retinal vein occlusion. The 
pupils were dilated with topical Tropicamide 0,5%. 
Recordings of the images were stored on Umatic magnetic 
video tape. In the first instance Helium neon laser 
was used to focus the laser upon the retina. The laser 
was then changed to Argon green and 3 mis of 2 0% 
sodium fluorescein was injected at rate of 1 ml/sec 
through an intravenous 2 3 gauge butterfly inserted into 
an antecubital vein. At the start of the injection the 
timer of the SLO was commenced and the video recording 
started. Images of the optic disc area using a 40 
degree field of view were taken whilst the dye entered 
the retinal circulation and until the dye had faded 
from the retinal veins. Six views of the peripheral 
retina were then recorded. Two measures of the flow of 
blood plasma in the retinal circulation were obtained
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by observing the appearance of fluorescein dye in the 
retinal vessels:
The Retinal Transit Time (RTT) - The time between the 
first appearance of dye in a hemiretinal artery at the 
optic disc margin and the first appearance of dye in 
the adjacent hemiretinal vein.
The Time to Maximal Venous Filling (TMVF) - The time 
between the first appearance of dye in the hemiretinal 
artery and the time when the maximal fluorescein 
concentration is seen in the adjacent hemiretinal vein. 
These two measures were estimated by an observer who 
was masked to the clinical and investigative results of 
the patients.
Tonography
Intraocular pressure variation during the systemic 
pulse was recorded in 3 2 eyes (16 affected by central 
retinal vein occlusion and 16 contralateral unaffected 
eyes) using a Digilab 3OR pneumotonometer. The 
amplitude of the intraocular pressure rise is dependent 
on the change in blood volume in the choroid and has 
been used as a measure of the pulsatile component of 
the ophthalmic artery blood flow 152,252^
Before each examination the tonometer was recalibrated 
using calibration apparatus which applies a known 
pressure onto a diaphragm. The tonometer was applied 
to the diaphragm and the marker needle of the recording 
paper adjusted accordingly. Benoxinate 0.4% was in­
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stilled into the eyes of each patient who was positioned 
supine. The tonometer was applied to the cornea and 
continuous TOP recordings obtained over three 
respiratory cycles. Recordings were obtained from both 
eyes of each patient.
Ophthalmodynamometry
The diastolic blood pressure was estimated in the 
ophthalmic artery using a Yablonski Fundus Lens 
Ophthalmodynamometer (Varian, Clinitex division) in 19 
eyes of 12 patients (ten with central retinal vein 
occlusion and nine contralateral unaffected eyes, one 
was excluded because of the presence of a longstanding 
retinal detachment). In four patients the examination 
was abandoned because of poor visualisation of the 
vessels or tolerance of the test. The pupils were 
dilated with topical Tropicamide 0.5% and the corneas 
anaesthetised with Benoxinate 0.4%. The patient was 
placed in the examination position on a slit lamp and 
the maximum force indicator on the ophthalmodynamometer 
was set to zero. Whilst viewing the hemiretinal 
arteries at the disc through the contact lens an 
increasing force was gradually applied to the lens by 
means of the sprung lever of the instrument until the 
arteries began to pulsate. The force was then 
released, the maximum force was recorded in grams by 
the maximum reading indicator needle on the dial. The
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procedure was repeated on three occasions for each eye 
and the results averaged. The results obtained by 
ophthalmodynamometry are considered to provide the 
diastolic blood pressure momentarily of the central 
retinal artery but after a few seconds of sustained 
pressure the readings are thought to be of ophthalmic 
artery blood pressure *71,185^ The results were 
therefore converted into the ophthalmic artery 
perfusion pressure by converting the values into 
diastolic blood pressure (3.1g/mmHg diastolic blood 
pressure) and subtracting the intraocular pressure: 
Diastolic Perfusion Pressure = (Force/3.1) - lOP
Statistical Methods
Nonparametric statistical tests were employed using 
Mann Whitney U test, Wilcoxon Matched pairs test and 
Spearman rank correlation where appropriate.
10.4 Results
Colour Doppler Imaging
The results from the patients used in the comparison 
with videoangiography are provided in table 10.1, and 
with ophthalmodynamometry and tonometry in table 10.2. 
Even in the small sample size used in the comparison of 
colour Doppler imaging with tonography and ophthalmody­
namometry there were significant differences between 
the velocities from the retinal vessels in the eyes
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Table 10.1
PSV EDV Resistive Index
(cm/sec) (%)
Eyes with CRVO
Ophthalmic Artery
39.0 (11.4) 9,2 (3.9) 76.6 (6.7)
Retinal Artery
9.2 (3.2) 2 . 3 (1.5) 74.5(12.1)Retinal Vein
3.9 (2.3) 2.9 (1.7) 24.4(13.3)
Table 10.1 The velocity results from colour Doppler 
imaging of the thirty eight patients used in the 
comparison with the videoangiography.
Table 10.2PSV EDV Resistive Index
(cm/sec) (%)
Eyes with CRVO
Ophthalmic Artery
37.3 (11.6) 9.5 (4.6) 75.0 (7.8)
Retinal Artery
9.7 (3.0) 2.2 (1.0)# 75.6(11.9)
Retinal Vein
3.7 (2.0)* 2.5 (1.6)* 29.0(24.1)
Fellow Unaffected Eye
Ophthalmic Artery
38.2 (12.1) 9.6 (4.9) 75.8 (5.9)
Retinal Artery
10.9 (3.0) 3.1 (0.9)# 70.8 (8.3)
Retinal Vein
6.4 (2.7)* 4.1 (1.2)* 32.0(14.2)
Table 10.2 The colour Doppler results are provided for 
the patients who were used in the comparison with 
ophthalmodynomometry and tonography. Despite the small sample size (n=16) there were significant differences 
between the results from the affected eyes and the 
fellow unaffected eyes for the venous velocities (* 
p=0.001) and for the EDV in the central retinal artery (# p=0.005) .
affected by the venous occlusion and their fellow 
unaffected eyes.
Fluorescein Angiography
Fifty four patients were examined but in 16 the 
examination of dye transit times was inadequate because 
of poor visualisation due to medial opacities, blinking 
or eye movements. Thirty eight eyes affected by 
central retinal vein occlusion of 38 patients had 
fluorescein videoangiograms from which the two 
subjective measures of the flow of dye through the 
retinal circulation, time to maximum venous filling and 
retinal transit time were elicited.
The mean retinal transit time was 5.9 seconds (SD 2.4) 
and the mean time to maximal venous filling was 15.7 
seconds (SD 4.8). No correlation was found between the 
Doppler results from the ophthalmic artery and central 
retinal artery and the results from the videoangiograms 
(using Spearman rank correlation). The Doppler results 
from the central retinal vein provided undetectable 
flow velocities from eight patients in whom blood flow 
may have been present. To allow comparison, the 
fluorescein results from those patients with Vmin 
velocities greater than 3.0 cm/sec were compared to the 
rest of the group (similarly 4.0 cm/sec was used as the 
cutoff for Vmax). The mean time to maximal venous 
filling for the 16 patients with a Vmin of more than
140
::CK.
3.0 cm/sec was significantly shorter than the mean 
result for the rest of the group (mean 13.4 secs, SD
4.4 and mean 16.6 secs, SD 3.8, respectively p=0.02). 
Also the mean macular transit time for the 19 patients 
with a Vmax of greater than 4.0 cm/sec was significant­
ly shorter than the mean for the rest of the group 
(mean 5.0 sec, SD 2.3 and 6.8 sec, SD 1.7, respectively 
p—0.02).
Tonography
Thirty two eyes from sixteen patients were examined by 
tonography. The mean intraocular pressure amplitudes 
in the eyes with central retinal vein occlusion and 
their fellow eyes were statistically similar (1.02 
mmHg, SD 0.8 and 0.83 mmHg, SD 0.6 respectively). 
Figures 10.1 and 10.2 illustrate that the amplitude of 
spontaneous intraocular pressure variation was found to 
positively correlate with the Doppler measurements of 
velocity in the ophthalmic artery (peak systolic 
velocity r=0.63, p=0.0004, figure 10.1, and end 
diastolic velocity r=0.54, p=0.004, figure 10.2). None 
of the other Doppler results showed any correlation 
with tonometry.
Ophthalmodynamometery
Nineteen eyes of 12 patients were successfully examined 
by ophthalmodynamometry which provided a measure of the 
diastolic perfusion pressure in the central retinal
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Fi g u r e  10.1. The peak s y s t o l i c  veloci t i e s  in the o p h t h a l m i c  
artery positively correlated with the intraocular pressure v a r i a ­
tions in the eye which are thought to result from the puls a t i l e 
component of the choroidal blood flow (r=0.53). A linear r e g r e s ­
sion line and 95% confidence levels are shown.
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Fig u r e  10.2. The end d i a s t o l i c  v e l o c i t i e s  in the o p h t h a l m i c  
a r t e r y  c o r r e l a t e d  w i t h  the i n t r a o c u l a r  p r e s s u r e  f l u c t u a t i o n s  
(r=0.54). A linear regression line and 95% confidence levels are 
s h e w n .
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artery and indirectly in the ophthalmic artery. 
Attempted examination of the other eyes failed because 
of poor tolerance of the test in two patients, cataract 
in four eyes and poor pupillary dilation in two eyes. 
The mean diastolic perfusion pressures in the eyes with 
central retinal vein occlusion and their fellow eyes 
were statistically similar (35.9 mmHg, SD 12.2 and 38.5 
mmHg, SD 8.2 respectively). The results from one 
patient were found to have a much reduced diastolic 
perfusion pressure (10 mmHg) with relatively high 
ophthalmic artery velocities (PSV 62 cm/sec and PEDV 16 
cm/sec) perhaps signifying a localised stenosis of the 
artery . This patient was removed from the Spearman 
rank correlation as an outlying point. Correlations 
were detected between the diastolic perfusion pressure 
and the EDV and resistive index in the ophthalmic 
artery (end diastolic velocity r=-0.54, p=0.02 and 
resistive index r=0.47, p-0.05, figure 10.3).
10.5 Discussion
There is no direct method for the measurement of blood 
flow in the orbit and so many indirect methods have 
often been devised. In this study three established 
techniques for the estimation of different parameters 
of blood flow in this region were compared to the blood 
velocity measurements obtained by colour Doppler imag-
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Figura 10.3. The diastolic velocities in the o phthalmic artery 
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line and 95% confidence levels are shown.
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ing. Correlations were found between the Doppler 
measurements and the other measures of the haemodynam- 
ics in the ophthalmic and retinal circulations obtained 
by ophthalmodynamometry, continuous tonometry and 
fluorescein angiography.
The mainstay of clinical vascular investigation of the 
human retinal circulation is fluorescein angiography.
In this study, the time required for the dye to pass 
through the circulation was recorded as a measure of 
how rapidly the dye passes from the arterioles to the 
venules of the retina and is presumably related to the 
rapidity of blood flow in this circulation. Comparison 
of the Doppler results and the videoangiographic 
results by linear correlation was not possible when 
examining the blood velocities in the vein because of 
the significant number of patients with undetectable 
blood velocities. However there were significantly 
longer dye transit times for those patients with low 
Vmax or Vmin results than those with higher results.
In this simplified comparison with its obvious 
inadequacies there appears to be some relationship 
between the rapidity of the dye transit and the 
velocities in the vein. In contrast the velocities in 
the central retinal artery showed no correlation with 
the fluorescein dye transit times. This finding could 
be due the occurence of a secondary change in the 
diameter of the central retinal artery as was suggested 
in chapter 9, which altered the measured velocity of
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artery blood flow showed no correlation with the 
retinal blood velocities.
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the blood thereby explaining the poor correlation with 
angiography. The thin walled amuscular vein cannot 
actively change its diameter. Therefore the velocity of 
the blood in this vessel may provide a better indicator 
of changes in the perfusion of the retina.
A variety of methods have been devised for the 
estimation of the pulsatile component of total ocular 
blood flow from the variations that occur in intraocu­
lar pressure with the systemic pulse using tonography
152.252 ^ number of assumptions have been made
113.252 volume changes are thought to result
II
primarily from the expansion of the choroidal 
vasculature during the ingress of blood with the 
systemic pulse 112,252^ The choroidal circulation 
takes the majority of the ocular supply from the
ophthalmic artery, therefore the lOP amplitudes have 
been used to measure the pulsatile component of the 
ophthalmic artery blood flow to the eye. In this study 
the amplitude of the intraocular pressure rises 
measured by tonography demonstrated a positive 
correlation with the velocities measured by Doppler in 
the ophthalmic artery. Since the retinal circulation 
takes only a small proportion of the ocular blood flow 
from the ophthalmic artery, approximately 2-5% it
is not surprising that this measure of ophthalmic
Î
i
Finally ophthalmodynamometry was used to measure the 
diastolic ophthalmic arterial blood pressure using a 
contact lens technique. The results are contrary to 
the expectation that as the perfusion pressure 
increases the blood flow and therefore the blood 
velocity increases. In this study the velocity in the 
ophthalmic artery negatively correlated with the 
perfusion pressure during diastole. This may be due to 
the inherent inaccuracies of both techniques or is a 
warning that we cannot assume that increased blood 
velocity means increased blood flow. For example, 
undetected changes in the diameter of the blood vessels 
may have result in increased blood velocities despite a 
reduction in perfusion. The positive correlation 
between the resistive index in the ophthalmic artery 
and the perfusion pressure suggests increased 
peripheral resistance to flow which may have caused 
systemic hypertension in these patients. This may have 
increased the perfusion pressure despite a reduction in 
the blood flow to the tissue. Whatever the explanation 
the finding illustrates the complexity of the 
relationship of haemodynamic parameters in the human.
In summary, the velocities in the ophthalmic artery 
correlated positively with the intraocular pressure 
variations induced in the eye by the pulsatile blood 
flow in the ophthalmic artery. In contrast the 
perfusion pressure was negatively correlated with the 
ophthalmic artery velocities. The blood velocities
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from the central retinal vein varied with the passage 
of fluorescein dye through the retina but those from 
the artery did not.
I
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11 Chapter 11
BLOOD VISCOSITY AND COAGULATION IN CENTRAL RETINAL VEIN 
OCCLUSION: A POPULATION CONTROLLED STUDY.
11.1 Summary
The role of blood viscosity and coagulation has been 
investigated in the past in studies consisting of 
patients with central retinal vein occlusion (CRVO) and 
branch vein occlusion and with conflicting results.
This may have been in part due the presence of 
differing aetiological factors in these two types of 
vein occlusion. In this study viscosity and coagula­
tion were re-examined in 69 patients with CRVO only and 
compared to the results from an age-matched, population 
based control group. Viscosity variables were higher 
in CRVO than controls (in particular relative blood 
viscosity) suggesting (in the presence of similar red 
cell aggregation) that reduced red cell deformability 
was associated with the occurence of CRVO. Patients 
who developed the complication of iris neovascularisa- 
tion had relatively low antithrombin III, factor VII 
and tissue plasminogen activator indicating both a 
tendency to thrombus formation and a reduction in 
fibrinolytic activity. In most patients with CRVO 
there may be an increased risk of CRVO because of 
raised blood viscosity and in some patients particular­
ly those who developed complications abnormalities of 
haemostasis may be present. A proposal is made that
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stasis of flow occurs in these patients with thrombus 
formation only in at risk individuals who go on to 
develop iris neovascularisation.
11.2 Introduction
Blood viscosity is an important determinant of blood 
flow and may be a contributory factor in the production 
of a number of vascular diseases of the eye, A 
clinical association between central retinal vein 
occlusion (CRVO) and raised blood viscosity exists 
because the systemic hyperviscosity syndromes often 
present with retinal features which are similar to CRVO 
such as venous engorgement, retinal haemorrhages, disc 
hyperaemia and macular oedema
8,38,62,139,193,236,243,261^ Indeed in some cases the
retinal appearance cannot be distinguished from CRVO 
7,272^ The retinopathy only occurs when the blood 
viscosity is high and resolves when therapy reduces
the viscosity 81,174^ Another link with CRVO and 
viscosity has been provided by the association between 
the systemic conditions commonly found in central 
retinal vein occlusion, e.g., systemic hypertension, 
and abnormal rheology
There have been a number of studies examining the role 
of blood viscosity and haemostasis in patients with 
retinal vein occlusion, most of which have included
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mixed groups of patients with branch retinal vein 
occlusion and CRVO (table 11.1 and 11.2) 
40,210,213,227,278,297^ These two conditions probably
have different pathogenetic mechanisms, for example, a 
raised erythrocyte sedimentation rate (a measure of 
increased red cell aggregation) is common in patients 
with CRVO but not those with branch retinal vein 
occlusion 212^ Previous investigations may therefore :
have under or over estimated the significance of their 
findings to CRVO.
Haematocrit, haematocrit corrected whole blood I
viscosity and plasma viscosity have all been signifi- I
%cantly increased in patients with retinal vein 
occlusions both during and after the acute stage
in comparison to controls. Higher whole blood 
viscosity has also been described in ischaemic vein 
occlusions than nonischaemic. Even when patients with 
hypertension, a history of oral contraceptive
administration, diabetes or heavy smoking, were 
excluded similar findings were detected Increased
fibrinogen 2 2 7,278 erythrocyte aggregation or
reduced red cell deformability have been detected
and blamed for the increase in viscosity. Other 
studies have however been unable to detect any 
elevation of blood viscosity 40,297^
Various haemostatic factors have been implicated in 
retinal vein occlusion, eg., increased Factor 8 which
,
has a coagulant activity, reduced Antithrombin 3 which
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table 11.1Retinal Vein Occlusion and Blood Viscosity.
Ring 1975 44 patients with retinal vein occlusion in a controlled study 227,
He used fluorescein anoiographic evidence of capillary dro p - o u t  
to classify the r e t i n t  vein occlusion as ischaemic or non-is- chaemic but the duration of the retinal vein occlusions is not 
clear from his paper. After correction for haematocrit, whi c h  
was incre a s e d  in the group of patients w i t h  i s c h a e m i c  r e t i n a l  
vein occlusion, whole blood viscosity was found to be s i g n i f i ­
cantly i n c r e a s e d  in c o m p a r i s o n  to controls. T h e r e  was a 35% 
increase in whole blood viscosity in the ischaemic group (at a 
shear rate of Q.77/sec) w h i c h  was i n c r e a s e d  in c o m p a r i s o n  to 
p a t i e n t s  w i t h  n o n  i s c h a e m i c  r e t i n a l  v e i n  o c c l u s i o n .  P l a s m a  
v i scosity i n c r e a s e d  w i t h  age and was i n c r e a s e d  in the r e t i n a l  
vein occlusion group as a whole, but no difference was e n c o u n ­
t e r e d  b e t w e e n  the i s c h a e m i c  v e r s u s  n o n - i s c h a e m i c  g r o u p s  of retinal vein occlusion.
Fibrinogen increased with age and was increased in the patients 
with retinal vein o c c l u s i o n  but was not d i f f e r e n t  b e t w e e n  i s ­
chaemic and non-ischaemic groups. F ibrinogen levels were found 
to relate well to plasma viscosity and may contribute to the non- 
Newtonian behaviour of whole blood.
Trope 1983 examined 42 patients with retinal vein occlusion after 
the acute stage in order to remove the possible influence of the acute thrombotic event on the rheological parameters 278^ The 
control group was m a t c h e d  for s y s t e m i c  v a s c u l a r  a b n o r m a l i t i e s  
such as hypertension as well as for age and sex. Blood viscosity 
was raised in the patients with retinal vein occlusion, and was 
found to be 36% higher in the ischaemic group compared with the 
non-ischaemic group at a shear rate of 0.94/sec. Plasma viscosi­
ty was increased in this group in comparison to controls and this 
was c l o s e l y  r e l a t e d  w i t h  fib r i n o g e n  levels. T h e r e  was also a 
raised i mmunoglobulin level in the study group but there was no 
correlation of this with viscosity measurements.
Peduzzi 1936 p e r f o r m e d  a c o n t r o l l e d  s t udy of 34 p a tients w i t h  
retinal vein occlusion excluding patients with hypertension, a 
history of oral contraceptive administration, diabetes or heavy 
smoking. I n c r e a s e d  w h o l e  b l o o d  viscosity, pl a s m a  vis c o s i t y , 
fibrinogen, h a e m a t o c r i t  and r e d u c e d  w h o l e  b l o o d  f i l t e r a b i l l t y  
were detected in his patients with retinal vein occlusion 210_ 
A difference between the ischaemic and non-ischaemic groups was 
found for whole blood viscosity and fibrinogen levels.
Wiek 1990 examined viscosity prior to isovolemic h a emodiiution 
for t r e a t m e n t  of retinal ve i n  o c c l u s i o n  u s i n g  as co n t r o l s  p a ­
tients going for cataract and retinal detachment surgery 297^ &
large group of the p a t i e n t s  w e r e  und e r  SO years old. In this 
study, the fluorescein angiographic feature of time to maximal 
venous f i l l i n g  of dye of more than or equal to 20 seconds was 
u s e d  for the c l a s s i f i c a t i o n  of the i s c h a e m i c  v a r i a n t  of the 
d i s o r d e r .  No s i g n i f i c a n t  d i f f e r e n c e  in h a e m a t o c r i t ,  p l a s m a  
viscosity, red cell aggregation, red cell filterabillty or whole 
blood viscosity was detected. In addition, the results for non- 
i s c h a e m i c  or i s c h a e m i c  r e t i n a l  v e i n  o c c l u s i o n  w e r e  s i m i l a r .  A f t e r  i s o v o l a e m i c  h a e m o d i i u t i o n ,  h a e m a t o c r i t  and w h o l e  b l o o d  viscosity were reduced.
Dodson 1982 also found no difference in plasma viscosity between 
99 pa t i e n t s  w i t h  r e t i n a l  ve i n  o c c l u s i o n  and con t r o l s  d e s p i t e  
finding a correlation between plasma viscosity and elevated serum 
lipid levels in the retinal vein occlusion patients
P i e r m a r o c c h i  1990, in a c o n t r o l l e d  s t u d y  of 54 p a t i e n t s  w i t h  
b r a n c h  reti n a l  vein o c c l u s i o n  d e t e c t e d  r a i s e d  b l o o d  v i s c o s i t y  
which was worse in patients with ischaemia of the retina 21^.
Chabanel 1990 in 64 pataints with retinal vein occlusion found an 
increase in mean erythrocyte aggregation compared with controls 
^ ^t no d i f f e r e n c e  w i t h  the g r a d e  of i s c h a e m i a  of the r e t i n a
Table 11,2, Retinal Vein Occlusion and Haemostasis.
T r o p e  1933 in 42 p a t i e n t s  w i t h  r e t i n a l  v e i n  o c c l u s i o n  273^ 
Factor 8 antigen which is released from vascular endothelium and 
has a c o agulant activity was increased in patients wi t h  retinal 
vein occlusion. Raised levels of this clotting factor have also 
been seen in d i a b e t i c  p r o l i f e r a t i v e  r e t i n o p a t h y  (Trope 1983). 
A n tithrombin 3 w h ich is known to be a m a jor i nhibitor of b l o o d 
coagulation was s i g n i ficantly lower in the study group. In the 
patients with ischaemic retinal vein occlusion fibrinopeptide A, 
an indicator of a ctivation of blood c o a gulation was increased. 
Increased beta thromboglobulin (a platelet specific protein) and 
reduced numbers of platelets in the ischaemic retinal vein o c clu­
sion group signified increased platelet consumption.
Dodson 1983 also found increased beta thromboglobulin as well as 
p l a t e l e t  f a c t o r  4 in r e t i n a l  v e i n  o c c l u s i o n  ^ ^ . L e v e l s  of 
beta t h r o m b o globulin are influenced by lipop r o t e i n  cholesterol 
levels w h i c h  are k n o w n  to be i n c r e a s e d  in ve i n  o c c l u s i o n  
T h e  p r o t e i n  is r e l e a s e d  fr o m  p l a t e l e t  a l p h a  g r a n u l e s  d u r i n g  
aggregation of platelets. *'
Walsh 1977 found a 2-4% increase in platelet coagulant activities 
in acute retinal vein occlusion in which there was no contributo­
ry systemic or ocular disease but did not find this in a chronic group (in an uncontr o l l e d  study) 29 0_ xe also mea s u r e d  levels 
of platelet factor 3, platelet aggregation, serotonin release by 
by platelets and plasma coagulation and found these to be normal.
Gender 1983 examined young patients with vein occlusion and found 
abnormal platelet function in the form usually of platelet coagu­
lant hyoer activity in those with associated mitral valve p r o ­lapse 73,
Pandolfi 1972 in an uncontrolled study of patients with retinal 
vein occlusion discovered increased platelet adhesiveness, factor 
5, factor 8 and increased inhibitors of u r o k i n a s e  and plasmin. 
He also examined peripheral venous walls and found reduced fibri­nolytic activity in these 206^
$
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is an inhibitor of blood coagulation and increased 
fibrinopeptide A which indicates the activation of 
blood coagulation have all been detected^5,278^ in
some studies platelet activation was increased in these 
patients 45,73,206,290^
Despite these investigations there has been no 
comparison of the results of blood coagulation and 
rheology in patients with CRVO and individuals from a 
population based control group. In this study, 
patients with CRVO (or its variant, hemiretinal vein 
occlusion) were examined. The patients were age 
matched to individuals attending population surveys 
to allow comparison of blood viscosity and coagulation.
11.3 Patients and Methods.
Seventy seven patients with central retinal vein 
occlusion and ten patients with hemiretinal vein 
occlusion were examined. The patients with CRVO and 
rheology studies were compared to a control group taken 
from a local population study of rheology 259^ The 
results were compared in a case controlled manner with 
each case matched for year of age. This provided 69 
patients and 69 controls for comparison. The mean age 
of the patients and the controls was 64.2 years (SD
12.8, range 27 to 84) and the mean duration from onset 
of the occlusion was 3.8 months (SD 4.7). There were
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39 male and 30 female patients with a mean diastolic 
blood pressure of 148,4 mmHg (SD 20.4) and diastolic 
blood pressure of 85.0 mmHg (SD 11.1).
Forty seven patients with CRVO and haemostatic variable 
investigations were age matched to 47 controls from 
another population study for comparison (Lowe et al, 
unpublished data). The mean age of these subjects was
61.7 years (SD 13.3, range 27 to 78 years).
Thirty five patients were age matched to 35 controls 
for analysis of activated protein C (mean age 61.0 
years, SD 12.2). In a similar fashion twenty five 
patients were age matched to 25 controls for comparison 
of protein C and S (mean age 62.3 years, SD 11.9).
Age matching in a case controlled manner was unavail­
able for Von Willebrands factor and for tissue 
plasminogen activator and plasminogen activator 
inhibitor. The results from the patients over the age 
of 64 years were therefore compared to the results from 
a population study of individuals above this age (Lowe 
et al, unpublished data).
Twenty five patients with an ischaemic grade of 
retinopathy were age matched to 2 5 with nonischaemic 
CRVO. The protocol employed in the ischaemic grading 
has been provided in chapter 9 (table 9.1). The mean 
age of the ischaemic and nonischaemic CRVOs was 69.5 
years (SD 9.3 years, range 51 to 85).
The patients were examined again at least one year 
after the onset of their occlusion for the development
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of complications. Only the results from patients 
examined in the acute stage of the condition, ie, less 
than three months from onset, were analysed. The 
results from nine patients who went on to develop iris 
neovascularisation were compared to the results from 
twenty two patients who did not develop this complica­
tion. Three patients who presented with neovasculari­
sation and one patient who developed retinal neovascu­
larisation were excluded.
Blood Sampling
15 mis of venous blood was sampled from an antecubital 
vein through a 21 gauge butterfly needle after minimal 
use of a tourniquet. Five mis of blood was anticoagu­
lated with dipotassium edetate (KgEDTA, 1.5mg/ml) for 
viscosity examination which was performed within four 
hours of sampling. 9 mis of blood was placed directly 
into a tube with 1ml trisodium citrate (0.109 M) and 
within one hour of the sampling centrifuged at 15,000 
rpm (25,000 g) for ten minutes. The plasma was then 
alliquoted into seven separate sample tubes and stored 
at -3 0 degrees Celsius for 48 hrs. The samples were 
then transported in ice to a -7 0 degree Celsius 
freezer. In a group of 20 patients examined within one 
month of the onset of the occlusion the rheology 
samples were repeated at 6 months and at 1 year.
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Blood Rheology
Viscosity variables were measured as previously 
described in chapter 6.
Haemostatic Variables
Fibrinogen was measured by the Clauss method on a Coag- 
A-mate X2 coagulometer using the manufacturer's 
reagents and international standard (Organon Teknika, 
Cambridge, UK). Clotting factors VII, VIII and IX were 
recorded by one-stage clotting methods on an ACL3 00 
coagulometer similarly employing the manufacturer's 
reagents and international standards (Instrumentation 
laboratories, Warrington, UK). Antithrombin III was 
measured by the manufacturer's chromogenic assay in the 
same instrument. Plasminogen activator inhibitor 
activity was measured chromogenically (Quadratec,
Epsom, Surrey, UK) and tissue plasminogen activator 
antigen measured by an ELISA technique (Biopool, 
Stockholm, Sweden). These two factors were assessed 
only on the patients with CRVO as was von Willebrand 
factor antigen which was recorded using an ELISA 
technique (Dako ltd.,High Wycombe, Bucks, UK).
Activated protein C was also measured 14,204 ^^C^ 3DOR, 
Instrumentation laboratories, Warrington, UK).
Statistical Analysis
The results were compared by 2 tailed students T-test 
and analysis of covariance (with the covariant the age
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of the patient) where appropriate, 95% confidence limits 
are provided.
11.4 Results
Blood Viscosity - whole group (Table 11.3).
The corrected blood viscosity was higher in the
patients with CRVO (mean 3.44 mPa s, SD 0.42, upper
confidence limit 3.55 and lower 3.33), than the 
controls (mean 3.24 mPa s, SD 0.41 upper confidence 
limit 3.34 and lower 3.12, p==0.007, figure 11.1). The 
relative blood viscosity was also higher in the
patients with CRVO (mean 2.57 mPa s, SD 0.24, upper
confidence limit 2.63 and lower 2.51) than the controls 
(mean 2.42 mPa s, SD 0.30, upper confidence limit 2.50 
and lower 2.35, p=0.005, figure 11.2).
Haemostatic Variables - whole group (table 11.4).
Antithrombin III was significantly higher in the 
patients (mean 101.8 iu/dl, SD 13.0, upper confidence 
limit 107.0 and lower 98.9) than the controls (mean
95.1 iu/dl, SD 11.5, upper limit 99.1 and lower 92.5,
p— 0.02) .
VWF was significantly higher in the patients with CRVO 
(mean 141 iu/dl, SD 56, upper confidence limit 157, 
lower 126) than in the control population (mean 126 
iu/dl, SD 49, upper limit 134 and lower 119, p=0.05).
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Table 11.3
Controls CRVO p value
(n=69) (n=69)mean (SD)
Whole Blood Viscosity
(mPa s) 3.19 (0.50) 3.35 (0.57) 0.23
Plasma Viscosity 1.34 (0.07) 1.35 (0.12) 0.91
(mPa s)
Haematocrit 43.9 (4.16) 43.6 (4.60) 0.72
(%)
Red Cell Aggregation
(arbitary units) 4.37 (1.09) 4.15 (1.20) 0.37
Corrected Blood Viscosity(mPa s) 3.24 (0 .41) 3.44 (0 .42) 0.007
Relative Blood Viscosity2.42 (0 .30) 2.57 (0 .24) 0.005
Table 11.3. The results of the measures of blood 
viscosity (mean and SDs) in the patients with CRVO and 
the controls showing that the haematocrit corrected and 
relative blood viscosities are higher in the patients 
(p-0.03 and p=0.015, respectively).
Corrected Blood Viscosity
m«3Dh
4.8
4.4
4
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2.8
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Controls CRVO
Figure 11.1. The me a n  haematocrit corrected b l o o d  viscosities 
from the patients with CRVO and the controls are shown (including 
2xSD and 2 x S E ) .
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Relative Blood Viscosity
• MEAN 
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Figure 11.2. The mean relative blood v i s cosities from the p a ­
tients w i t h  CRVO and the controls are shown (including the 2xSD 
and 2 x S E ) .
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Table 11.4
Factor VII 
(iu/dl)
Factor VIII 
(iu/dl)
Factor IX (iu/dl)
Controls CRVO
(n=47) (n=47)
mean (SD)
Antithrombin III(iu/dl) 95.1 (11,5) 101.8 (13.0)
p value
113.4 (28.3) 112.9 (27.6) 0.93
142.4 (50.3) 141.4 (60.1) 0.59
128.2 (44.8) 136.3 (41.9) 0.30
0.02
Fibrinogen(g/l) 2.91 (0.91)
Von Willebrand's Factor126 (49)
3.10 (0.78) 0.15
142 (56) 0.05
Tissue Plasminogen Activator
8.3 (3.3) 9.8 (14.8)
Plasminogen Activator Inhibitor75,7 (32.8) 95.8 (35.3)
Protein C 
Protein S
APC
(n=25)
110 (38)
142 (18)
(n=35)2.85 (0.50)
127 (23)
135 (17)
2.62 (0.50)
0.43
0.004
0.055 
0. 15
0.05
Table 11.4. The results of the comparison of 
haemostatic variables in the patients with CRVO and the 
controls showing an increase in mean antithrombin III, 
von Willebrands factor and plasminogen activator 
inhibitor in the patients with CRVO and reduced 
activated protein C.
as was PAI (CRVO patients mean 9 6 iu/dl, SD 35, upper 
limit 107 and lower 84 and controls mean 76 iu/dl, SD 
33, upper limit 83 and lower 68, p<0.0001). APC was 
higher in the controls (mean 2.85, SD 0.5, upper limit
3.01 and lower 2.69) than in the patients (mean 2.62,
SD 0.5, upper 2.78 and lower 2.46, p=0.05).
Retinal ischaemia
The plasma viscosity was lower in the ischaemic group 
(mean 1.31 mPa s, SD 0.07, upper confidence limit 1,34 
and lower 1.28) than in the nonischaemic patients (mean 
1.38 mPas, SD 0.11, upper confidence limit 1.43 and 
lower 1.33, p=0.03). Protein S was significantly 
higher in the non ischaemic group (mean 140, SD 22.5, 
upper limit 151, lower 129) than the ischaemic (123, SD
15.9, upper 135 and lower 112, p=0.05). No difference 
was found in any of the other parameters (table 11.5 
and 11.6).
The Development of Iris Neovascularisation
Patients who were examined in the acute stage of the 
condition and who went on to develop iris neovasculari­
sation had significantly lower factor VII (mean 95.7 
iu/dl, SD 16.3, upper limit 114 and lower 77), 
Antithrombin III (92.8 iu/dl, SD 12.1, upper limit 109 
and lower 76) and tissue plasminogen activator (4.62 
iu/dl, SD 2.0, upper 7.5 and lower 1.7) compared to 
those who did not develop neovascular complications.
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Table 11.5
Non Ischaemic Ischaemic p value
(n=25) (n=25)
mean (SD)
Whole Blood Viscosity
(mPa s) 3.49 (0.76) 3.26 (0.52) 0.34
Plasma Viscosity
(mPa s) 1.38 (0.11) 1.31 (0,07) 0.03
Haematocrit 43.8 (5.05) 43.9 (4.70) 0.46(%)
Red Cell Aggregation 
(arbitrary units)
4.16 (1.14) 4.54 (1.12) 0.22
Corrected Blood Viscosity
(mPa s) 3.54 (0,49) 3.33 (0.41) 0.13
Relative Blood Viscosity
2.57 (0.26) 2.53 (0.27) 0.69
Table 11.5, The results of blood viscosity measurements 
for those patients with retinal ischaemia and those 
without. Only the plasma viscosity was significantly different being higher in the nonischaemic group
(p=0.02).
Table 11.6
Non Ischaemic Ischaemic p value
(n=lS)
mean
(n=18)
(SD)
Factor VII 
(iu/dl)
118.9 (17.9) 121.1 (31.6) 0.86
Factor VIII 
(iu/dl)
141.6 (37.4) 159.8 (85.9) 0.96
Factor IX 
(iu/dl)
142.0 (29.5) 160.1 (37.6) 0.13
Antithrombin III 
(iu/dl) 106.0 (10.1) 103.1 (14.2) 0. 69
Fibrinogen(g/1) 3.28 (0.87) 3.26 (0.80) 1.00
Tissue Plasminogen 
Activator 12.7 (21.8) 
(iu/dl)
7.3 (2.8) 0.95
Plasminogen Activator Inhibitor 89.1 (25.4) 
(iu/dl)
80.1 (28.3) 0.44
Von Willebrand's 
(iu/dl)
Factor 
97.8 (30.2) 105.7 (46.2) 0.88
Protein C 127 (26) 121 (24) 0.56
Protein S 140 (22) 123 (16) 0.05
APC 2.6 (0.4) 2.4 (0.5) 0.34
Table 11.6. The haemostatic variables showing a 
signifcant difference between the values for the 
patients with ischaemia of the retina and those with no 
ischaemia only for protein S.
■a
_____
factor VII (125.8 iu/dl, SD 20.8, upper limit 136 and 
lower 116), Antithrombin III (107.4 iu/dl, SD 9.9, 
upper limit 113 and lower 102), and tissue plasminogen 
activator (7.25 iu/dl, SD 2.5, upper 8.5 and lower 
6.0). The results are shown on table 11.7.
There was no difference in blood viscosity parameters.
Serial Viscosities in Patients Examined Within Three 
Months of Onset.
At 6 months only haematocrit was lower than the result 
at onset (p=0.01). At one year however, whole blood
viscosity, haematocrit-corrected blood viscosity and
11.5Discussion
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relative blood viscosity were all lower at one year 
after the occlusion than at the onset (all, p<0.05.
-:;Wfigures 11.3 and 11.4). Haematocrit corrected blood 
viscosity was also lower at 1 year than 6 months
(p<0.05).
' if:I
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Blood Viscosity
In this study, both haematocrit-corrected and relative
blood viscosity were higher in patients with CRVO than 
in the age matched control population, but no 
significant elevation was detected in erythrocyte 
aggregation or fibrinogen. These findings confirm the 
results of previous studies which have indicated that
If
Table 11.7. No Rubeosis Rubeosis p value
n 17 7mean (SD)
Factor VII 125.8 (20.8) 95.7 (16.3) 0.005
(iu/dl)
Factor VIII 152.9 (53.0) 138.3 (29.5) 0.50
(iu/dl)
Factor IX 142.7 (33.3) 118.6 (29.0) 0.15(iu/dl)
Antithrombin III(iu/dl) 107.4 (9.9) 92.8 (12.1) 0.04
Fibrinogen 3.26 (0.84) 3.04 (0.68) 0.48(g/l)
Tissue Plasminogen
Activator 7.25 (2.5) 4.62 (2.0) 0.03
(iu/dl)
Plasminogen Activator
Inhibitor 92.1 (29.4) 91.0 (17.1) 0.61(iu/dl)
Von Willebrand 105.8 (57.9) 117.7 (24.6) 0.30
Factor (iu/dl)
Protein C 126 (25) 106 (34) 0.21
Protein S 141 (21) 130 (30) 0.47
APC 2.53 (0.53) 2.94 (0.35) 0.10
Table 11.7. The values obtained for the haemostatic 
variables are shown for those patients examined within 
three months who did or did not develop iris neovascu­
larisation by one year of follow up.
Corrected Blood Viscosity
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F i gure 11.3. T he h a e m a t o c r i t - c o r r e c t e d  b l o o d  v i s c o s i t i e s  in 
patients e x a m i n e d  w i t h i n  one m o nth of the o n s e t  of venous o b ­
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Figure 11.4. The relative blood viscosities in patients examined 
w i t h i n  1 m o n t h  of the o n s e t  of venous o c c l u s i o n  are s h own at 
presentation and after one year of follow up.
patients may be at risk of retinal venous occlusion 
because of the presence of systemic rheological 
abnormalities. The results from this study also 
suggest that cellular factors, ie., cellular deform­
ability, were most important because relative blood 
viscosity was higher in these patients. In explana­
tion, first haematocrit corrected blood viscosity was 
calculated to remove the contribution of haematocrit on 
blood viscosity and secondly relative blood viscosity 
was calculated to negate the influence of plasma 
viscosity. Relative blood viscosity therefore provides 
an indirect measure of the viscosity resultant from 
cellular factors in the blood such as deformability and 
aggregation. As there was no difference in red cell 
aggregation between the two groups blood cell 
deformability was likely to be the main cause of the 
increased viscosity in these patients.
It would appear that in CRVO there is a higher 
viscosity at the time of onset of the occlusion and 
that the viscosity slowly drops over the year 
following. It is possible that the occlusion occurred 
at a time of raised viscosity for some as yet 
undetermined reason, or that general medical advice 
after the presentation of the patient, eg., on reducing 
blood pressure or lipid levels, resulted in a reduction 
in viscosity.
Significantly higher whole blood viscosities in the 
ischaemic form of retinal vein occlusion (mixed retinal
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vein occlusion) than nonischaemic have been described 
previously 210,213,227,278^ Indeed, stagnation of
blood flow in the microcirculation secondary to the 
elevated viscosity may explain why capillary nonperfu­
sion is seen on fluorescein angiography in ischaemic 
cases. The force required to induce movement in static 
blood (yield stress) has also been found to be 
significantly elevated in the blood of patients with 
ischaemic vein occlusions and is evidence of this 
increased tendency to stagnation of blood flow . In 
this study viscosity does not appear to determine 
whether ischaemia occurred or not. Indeed a relatively 
lower plasma viscosity was found in the patients with 
ischaemic features.
Haemostasis
The production of a blood clot first involves 
aggregation of platelets upon a site of damaged 
vascular endothelium, followed by the stabilisation and 
extension of this aggregate by fibrin, which is 
converted from the soluble protein fibrinogen via the 
intrinsic and extrinsic cascade reactions of various 
clotting factors. This thrombotic mechanism is 
balanced by factors which prevent formation of the 
clot, eg., Antithrombin III, protein C, protein S and 
by the fibrinolytic system which converts plasminogen 
to plasmin which in turn acts to lyse fibrin and
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fibrinogen. The fibrinolytic system involves the 
interaction of factors such as tissue plasminogen 
activator (increasing fibrinolysis) and plasminogen 
activator inhibitor (reducing fibrinolysis). In some 
circumstances an imbalance of these systems help to 
cause thrombosis.
The role of increased coagulation activity and reduced 
fibrinlysis in CRVO is as yet unknown. Histological 
studies suggest that thrombus formation occurs in the 
retinal vein, therefore the haemostatic systems may be 
important 80,225^ However, most of the cases that have 
been reported have had rubeotic glaucoma and the few 
who have been examined in the acute stage of the 
disorder without rubeosis have all presented atypical- 
ly. Deficiencies of antithrombin III, protein C and 
protein S have been detected in a longstanding mixed 
group of retinal vein occlusions signifying an 
increased risk of thrombosis Also raised
coagulation factor VIII has been found which signifies 
increased coagulant activity, and elevated fibrinopep­
tide A levels have provided a measure of increased 
activation of coagulation .
In this study, an increase in the antithrombin III 
level in the patients with CRVO was observed. This is 
in contradiction to the deficiency of antithrombin III 
which was detected in longstanding retinal vein 
occlusions in a previous study . It may be that the 
antithrombin III levels were reduced in the previous
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study because of the inclusion of patients with branch 
vein occlusion. Alternatively it has been suggested 
that an increase in antithrombin III may sometimes 
occur, possibly as a compensatory reaction to increased 
coagulation factors because both low and high 
antithrombin III levels are predictive of ischaemic 
heart disease .
In contrast those patients who subsequently developed 
iris neovascularisation did show changes which suggest 
a tendency to thrombosis and impaired fibrinolysis 
(table 11.7). The lower levels of antithrombin III in 
these patients signifies an increased tendency to the 
formation of thrombus. A reduction in fibrinolytic 
activity was evident in these patients from lower 
levels of tissue plasminogen activator than controls 
(in the presence of unchanged plasminogen activator 
inhibitor), indicating a relative inability to lyse 
thrombus. Defective fibrinolysis has been associated 
before with new vessel formation . The patients 
with rubeosis iridis also had lower levels of 
coagulation factor VII and a trend to lower factor IX 
(table 11.7), changes which may partly balance the 
prothrombotic effects of low antithrombin III and 
tissue plasminogen activator. Although the patients 
classified as ischaemic had lower protein S (an 
anticoagulant nonenzymatic cofactor for Protein C) no 
difference was detected in those patients who went on
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to develop rubeosis.
Low activated protein C (APC resistance) has recently 
been described in patients with thrombotic tendencies 
. Inheritance of the deficiency is thought to be 
considerably more common in the general population than 
deficiencies of Protein C, S and antithrombin III, In 
this study 12.5% of the patients with CRVO had APC 
resistance compared with 5% of the controls.
A Pathogenetic Mechanism for CRVO
The results suggest that increased viscosity produces a 
risk of CRVO and that abnormalities of haemostasis (by 
increasing the chance of thrombus formation) are 
associated with the development of iris neovascularisa­
tion. Ring has previously suggested that a "rheologi­
cal obstruction" may occur in patients with retinal 
vein occlusion 227^ These results imply that 
viscosity produces stasis of blood in the vein without 
the formation of thrombus in most patients. This would 
explain why reduction of blood viscosity (isovolaemic 
heamodilution) in the treatment of CRVO aids the 
recovery of vision whilst anticoagulation has been 
unsuccessful ^82^ Stasis of blood flow in some "at 
risk" individuals may then result in the development of 
thrombosis within the vein, further reducing blood 
flow. The thrombus persists in patients with a 
deficient fibrinolytic system, chronically reducing 
their retinal blood flow and thereby resulting in the
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development of neovascular complications. The risk of 
this complication is reduced by the use of streptoki­
nase to break down the thrombus but unfortunately
this agent has also produced vitreous haemorrhage in 
some patients and has had little overall effect upon 
visual recovery.
In summary our results suggest that raised blood 
viscosity (from reduced cell deformability) is present 
in patients with central retinal vein occlusion and may 
cause a reduction or stasis of blood flow in the vein. 
Those patients who develop neovascular complications 
have abnormalities of haemostasis and may develop 
complications because thrombus formation in the vein 
further reduces their retinal blood flow.
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12 Chapter 12.
THE INTERRELATIONSHIP OF BLOOD VISCOSITY AND BLOOD FLOW 
IN CENTRAL RETINAL VEIN OCCLUSION.
12.1 Summary
In normal individuals there is a compensation for 
increased blood viscosity by reduction of peripheral 
resistance. Having discovered a pattern of blood 
viscosity elevation in the patients with CRVO, the 
relationship between the blood viscosity and the 
orbital velocities was investigated with particular 
relevance to the unaffected fellow eyes of these 
patients. Increased viscosity in these cases resulted 
in reduced blood velocities without any reduction in 
the peripheral resistance. Whereas normal healthy 
individuals compensate for increased viscosity, 
patients with CRVO appear to be unable to do so 
resulting in a risk of occlusion of the central retinal 
vein.
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12.2 Introduction.
The blood flow in a vessel is dependent upon a number 
of parameters including the diameter and length of the 
vessel, the perfusion pressure and the viscosity of the 
blood. In turn, viscosity is altered by a complex 
interaction of the cellular and plasma components of 
the blood (see chapter 7). Abnormalities of blood flow 
and blood rheology in patients with the condition of 
CRVO have been demonstrated in chapters 9 and 11 
respectively. Also a relationship has been shown to 
exist between blood viscosity and blood flow in normal 
individuals in chapter 7. In this chapter the 
relationships between the these two factors were 
investigated in the patients with CRVO.
Patients and methods.
The patients affected by CRVO were examined by colour 
Doppler imaging and had blood sampling for rheology and 
coagulation examination within 2 hours of each other. 
Those patients examined within 1 month of onset of the 
occlusion of the central retinal vein were also 
examined by CDI and rheology at one year after onset. 
The results of colour Doppler imaging and blood 
rheology were analysed by multiple linear regression 
analysis allowing a correction for age (and also 
systolic blood pressure for PSV in the ophthalmic
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artery, significance taken as p<0.05). The results for
both the fellow eye and the eye affected by the 
occlusion were examined.
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Fellow Eye
Correlations were discovered between the PSV in the 
ophthalmic artery and plasma viscosity (b=-0.35), whole 
blood viscosity (b=-0.42) and haematocrit corrected 
blood viscosity (b=-0.42), and also red cell aggrega­
tion (b=-0.34, figures 12.1 to 12.4). Only corrected 
blood viscosity varied with EDV in this artery (b=- 
0.30, figure 12.3). Relative blood viscosity was 
weakly negatively correlated with PSV (b=-0.28) and 
Vmax (b--0.29) in the central retinal artery and vein 
respectively (figure 12.5). Haematocrit was negatively 
correlated with the resistive index in the central 
retinal artery (b=-0.29) but this appeared to be 
influenced by one patient with anaemia and a low 
haematocrit.
Eyes with Central Retinal Vein Occlusion.
Red cell aggregation negatively correlated with the 
Vmin in the central retinal vein (b=-0.29, figure 
12.6). Pulsatility index in the central retinal vein 
negatively correlated with the relative blood viscosity
I
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Figura 12.2. A  scattargram showing the relationship between the 
PSV in the ophthalmic artery in una f f e c t e d  fallow eyes and the 
plasma viscosity showing a negative correlation (a linear regres­
sion line and 95% confidence levels are s h o w n ) .
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Figure 12.3. A scattergram showing the relationship between the 
PSV and EDV in the ophthalmic artery of u n a f f f e c t e d  fellow eyes 
and the haematocrit corrected blood viscosity (linear regression 
lines are p r o v i d e d ) .
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Figure 12.4. A scatt a r g r a m  of the PSV in the oph t h a l m i c  artery 
oc u n a z f a c t e d  f a l l o w  ayes and red cell a g g r e g a t i o n  s h o w i n g  a 
negative correlation (a linear regression line and 95% confidence levels are s h o w n ) .
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Figure 12.5. A s c a t t e r g r a m  of the relative blood viscosity and 
the PSV in the c e n t r a l  r e t i n a l  ar t e r y  and V m a x  in the v e i n  of 
unaffected fellow eyes r e s p e c t i v e l y  showing a reduction in the 
velocities with elevated visco s i t y  (linear regression lines are 
p r o v i d e d ) .
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Figure 12.6. A sc a t t e r g r a m  of the Vmin in the central retinal 
vein of eyes affected by GRVQ and red call aggregation showing a 
negative correlation (a linear regression line and 95% confidence levels are s h o w n ) .
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(b=-0.27) and positively with the plasma viscosity,
:(b=0.33, figures 12.7 and 12.8).
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12.4 Discussion
As with the control population a relationship was 
discovered between blood rheology and the Doppler 
measurements in the orbital blood vessels. The pattern 
of the correlations was however different. Whereas in 
the normal eyes there was no correlation between the 
velocities in the ophthalmic artery and the viscosity 
measurements, in the fellow eyes of patients with CRVO 
whole blood and plasma viscosity, haematocrit corrected 
blood viscosity, haematocrit and red cell aggregation 
all correlated negatively with the velocities from this 
vessel. This may signify a lack of ability of the 
microcirculation of these patients to compensate for 
raised viscosity.
In the smaller blood vessels of the retinal circulation
relative blood viscosity negatively correlated with the
blood velocity. In contrast in the normal population 
.the velocities were unaffected by any of the measures 
of viscosity. Again in the normal individuals dilation
of the peripheral blood vessels may compensate for 
increased blood viscosity whereas the reduction in the 
velocities in the patients may signify an inability to 
make compensatory adjustments.
In the colour Doppler examination of the eyes affected 
by the occlusion, the blood velocities in the central
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Figure 12.7. A scattiergram of the venous pulsatility index in 
the central retinal vein of eyes affected, by CRVO and the r e l a ­
tive b l o o d  v i s c o s i t y  s h o w i n g  a n e g a t i v e  c o r r e l a t i o n  (a l inear 
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F i g u r e  12.3. T h e  i n t e r a c t i o n  of the p l a s m a  v i s c o s i t y  and the 
relative blo o d  visc o s i t y  upon the p u l s a t i l i t y  index in the vein 
of eyes affected by CRVO is shown, i e ., the pulsatility negative­
ly correlated with relative blood viscosity but positively corre­
lated w i t h  the p l a s m a  v i s c o s i t y  ( linear r e g r e s s i o n  lines are 
provided).
retinal vein were particularly reduced in those patients 
who developed iris neovascularisation. In this 
analysis red cell aggregation was negatively correlated 
with the Vmin and may therefore be important in 
reducing the blood flow in the vein thereby inducing a 
risk of neovascularisation. Red cell aggregation 
affects the viscosity more at low shear rates (low 
blood velocity) and therefore it is not surprising that 
the low venous velocities in the occluded circulations 
were reduced further by this factor.
In chapter 9 it was suggested that the pulsatility of 
flow in the vein may be important in avoiding stasis of 
blood flow. It was therefore interesting to observe 
that the venous pulsatility index was negatively 
correlated with relative blood viscosity but positively 
with plasma viscosity. The calculation of relative 
blood viscosity corrects for the plasma viscosity and 
provides a measure of the red cell deformability which 
therefore may have caused reduced pulsatility in the 
vein. Why then is increased plasma viscosity 
associated with increased venous blood pulsatility?
This can be explained by the fact that increased plasma 
viscosity causes reduced red cell deformation and 
therefore increased relative blood viscosity. This is 
because a cell which is bathed in a highly viscous 
fluid is less able to change its shape than a cell in 
low viscosity fluid.
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The deformability of blood cells therefore may be a 
determinant of the pulsatility of flow in the central 
retinal vein in these patients. This is in accordance 
with the results from chapter 7 and 11 in which the 
relative blood viscosity was shown to reduce the 
pulsatility index in the vein (in normal individuals) 
and to be raised in patients with CRVO. The relative 
blood viscosity and therefore red cell deformability
appears to be of predominant importance in the 
production of CRVO whereas the risk of iris neovascu­
larisation depends upon red cell aggregation and 
coagulation abnormalities which may reduce the blood 
flow further.
:
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13 Chapter 13
DISCUSSION OF THE RESULTS OF THE HAEMODYNAMIC STUDIES 
OF THE EYE AND SUGGESTIONS FOR FUTURE INVESTIGATIONS
In these studies a new method has been introduced for 
the assessment of blood flow in the eye, namely colour 
Doppler imaging, which has provided a reproducible 
means of assessing the pulsatile blood velocities in 
the ophthalmic artery, central retinal artery and vein. 
The velocities obtained are affected by certain 
systemic factors such as age, posture, systemic blood 
pressure and cigarette smoking and other factors such 
as intra-ocular pressure elevation, all of which should 
be controlled for in future studies.
The technique was employed in the examination of a 
cohort of patients suffering from central retinal vein 
occlusion. In these patients evidence of increased 
resistance to blood flow was found in the ophthalmic 
artery of the fellow unaffected eyes. In addition a 
reduction in the pulsatile component of the flow in the 
central retinal vein was discovered in these eyes 
compared to controls which may suggest a risk of 
occlusion in these patients.
In those eyes with central retinal vein occlusion 
reduced velocities were found in the retinal circula­
tion particularly in the central retinal vein and 
especially low velocities were found in patients in 
whom iris neovascularisation subsequently developed.
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Examination of receiver operator characteristic curves 
showed that a minimum velocity in the vein of less than 
3.0 cm/sec provided a highly predictive value for the 
detection of patients who developed this complication. 
For patients examined within three months from onset of 
the occlusion the sensitivity of 75% and specificity of 
86% for prediction of iris neovascularisation by CDI 
was superior to the results obtained for fluorescein 
angiography (sensitivity of 60% and specificity of 
67%). In addition, CDI was successfully applied to the 
investigation of all of these patients whereas 
angiography was unassessable in 2 0% of the patients 
because of opacities in the media, retinal haemorrhages 
or poor agreement amongst observers.
To determine the cause of the haemodynamic abnormali­
ties found in CRVO, blood viscosity and haemostasis 
were also assessed. As a group the patients with CRVO 
had raised blood viscosity compared with age matched 
normal individuals. In particular increased red cell 
deformability appeared to be most influential in the 
association with occlusion. The group of patients who 
developed iris neovascularisation had a relatively 
increased tendency to produce thrombus and a reduced 
capability to lyse fibrin. Consequently, I have 
proposed that thrombosis occurs only in at risk 
individuals who suffer a "functional" or "rheological" 
blockage to flow associated with elevated blood
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viscosity.
The interrelationship between measures of blood 
viscosity and the orbital blood velocities suggests 
that in normal individuals compensatory adjustments in 
the peripheral resistance to flow occur to maintain the 
blood flow (figure 13.1) because as the viscosity rises 
the peripheral resistance falls (perhaps from 
vasodilation) and the velocities remain stable. In the 
patients with CRVO, however, raised viscosity instead 
of being associated with a reduction in the resistance 
to flow was associated with a reduction in the blood 
velocities in the orbital vessels (figure 13.2). Red 
cell aggregation in the low flow venous circulation of 
eyes with CRVO negatively correlated with the blood 
velocities and may be important in further reducing the 
flow in the compromised circulation (figure 13.3).
Not only is there an increase in the blood viscosity in 
central retinal vein occlusion but there is also an 
apparent inability to compensate for changes in blood 
viscosity. This may result in a reduction of blood 
flow with a resultant formation of thrombosis in at 
risk individuals.
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Figura 13,1. The influence of the various measures of viscosity 
upon the Doppler indices from the control population showing that 
■there is a predominant effect upon reducing peripheral resistance 
in the ophthalmic artery and pulsatile flow in the central r e t i ­
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Figure 13.2. Blood v i s c o s i t y  shows negative correlations w i t h  
the blood velocities from the arteries of the una f f e c t e d  fallow 
eyes of patients with CRVO.
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Figure 13.3. The blood velocities in the central retinal vein of 
eyes with CRVO demonstrated a negative correlation with red cell 
aggregation. The pulsatility of flow in the vein was negatively 
correlated with red call deformability.
Future Studies
These studies have aided the planning of future 
investigations of blood flow in the eye. An area of 
interest in the normal physiology of the eye is the 
determination of the source of the pulsatile blood flow 
in the central retinal vein. In conjunction with the 
Department of Medical Physics of the West of Scotland a 
computer programme has been designed to analyse the 
complex interaction between the central retinal artery 
and vein at this site with the supposition that the 
expansions of the arterial wall have the effect of 
pumping blood out of the vein. A pathological study of 
the morphology of the vessels at the lamina cribrosa 
which detected a constriction in the vein is now
being followed by a study examining the vessels in 
their intraneural portion to allow a correlation of the 
dynamic properties of the blood flow in these vessels 
with their structure.
The colour Doppler imaging technique is applicable to a 
number of ophthalmological conditions and is now being 
used to examine patients with cranial arteritis 
caroticocavernous fistula, ocular ischaemic syndrome, 
intraocular tumours and retinal detachment (unpublished 
data). In addition, there is potential for the 
assessment of the effects of a number of pharmacologic 
agents on the eye, eg., beta blockers .
In the condition of central retinal vein occlusion the
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contribution of blood viscosity to the aetiology of the 
condition provides us with possible therapeutic 
strategies. Already isovolaemic haemodilution has been 
used to good effect and a study has been
commenced employing venesection in patients with 
central retinal vein occlusion. The effects of this 
treatment on blood flow in the eye are being monitored 
by CDI. In the future the effects of agents which 
increase the deformability of the red cells (eg., 
pentoxifyline) could also be assessed. In selected at 
risk individuals (detected by low venous velocities on 
CDI) other measures such as anticoagulation may also be 
tested in an attempt to reduce the incidence of iris 
neovascularisation 282^
Colour Doppler imaging is an accessible means of 
assessing the haemodynamics of the eye which has 
multiple applications in ophthalmology in both the 
research and clinical setting. In combination with the 
examination of blood viscosity and haemostasis the 
method has provided insights into the pathogenetic 
mechanism of central retinal vein occlusion. It is 
clinically applicable in this condition as means of 
estimating the risk of complications providing higher 
predictive values for the development of iris 
neovascularisation than fluorescein angiography.
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